GOName,GOID,DiseaseName,DiseaseID,InferenceChemicalQty,InferenceChemicalNames,InferenceGeneQty,InferenceGeneSymbols
"1,2-diacyl-sn-glycero-3-phosphocholine metabolic process",GO:0006653,Epilepsy,MESH:D004827,1,Calcium,0,
2-oxoglutarate metabolic process,GO:0006103,Epilepsy,MESH:D004827,0,,1,L2HGDH
4-hydroxyproline biosynthetic process,GO:0019472,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methylprednisolone,0,
4-hydroxyproline metabolic process,GO:0019471,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
4-hydroxyproline metabolic process,GO:0019471,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methylprednisolone,0,
5S class rRNA transcription by RNA polymerase III,GO:0042791,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
acetaldehyde biosynthetic process,GO:0046186,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
acetaldehyde catabolic process,GO:0046187,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
acetaldehyde metabolic process,GO:0006117,Epilepsy,MESH:D004827,1,"N-Methyl-3,4-methylenedioxyamphetamine",0,
acetate metabolic process,GO:0006083,Epilepsy,MESH:D004827,2,Propofol|Sevoflurane,0,
acetate metabolic process,GO:0006083,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
acetate metabolic process,GO:0006083,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
acetone metabolic process,GO:0043443,Epilepsy,MESH:D004827,1,Propofol,0,
acetone metabolic process,GO:0043443,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
acetone metabolic process,GO:0043443,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
acetylcholine biosynthetic process,GO:0008292,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
acetylcholine catabolic process,GO:0006581,Epilepsy,MESH:D004827,1,Midazolam,0,
acetylcholine catabolic process,GO:0006581,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Midazolam|Soman,1,BCHE
acetylcholine metabolic process,GO:0008291,Epilepsy,MESH:D004827,2,Cisplatin|Pentylenetetrazole,0,
acetylcholine metabolic process,GO:0008291,"Epilepsy, Absence",MESH:D004832,1,Pentylenetetrazole,0,
acetylcholine metabolic process,GO:0008291,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Pentylenetetrazole,0,
acetylcholine receptor signaling pathway,GO:0095500,"Epilepsy, Frontal Lobe",MESH:D017034,0,,2,CHRNA4|CHRNB2
acetylcholine receptor signaling pathway,GO:0095500,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
acetylcholine receptor signaling pathway,GO:0095500,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
acetylcholine receptor signaling pathway,GO:0095500,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
acetylcholine secretion,GO:0061526,Epilepsy,MESH:D004827,1,Midazolam,0,
acetylcholine secretion,GO:0061526,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Aluminum Hydroxide|Midazolam|Soman,0,
"acetylcholine secretion, neurotransmission",GO:0014055,Epilepsy,MESH:D004827,1,Dronabinol,0,
acetyl-CoA biosynthetic process,GO:0006085,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
acetyl-CoA biosynthetic process from pyruvate,GO:0006086,Epilepsy,MESH:D004827,0,,1,VDAC1
acidic amino acid transport,GO:0015800,Epilepsy,MESH:D004827,0,,2,SLC1A2|SLC1A3
acinar cell differentiation,GO:0090425,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CLCN2
acrosome assembly,GO:0001675,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Paroxetine,0,
acrosome reaction,GO:0007340,"Epilepsy, Absence",MESH:D004832,1,Progesterone,0,
acrosome reaction,GO:0007340,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chlorpromazine,0,
actin crosslink formation,GO:0051764,Epilepsy,MESH:D004827,0,,1,FLNA
actin cytoskeleton organization,GO:0030036,Epilepsy,MESH:D004827,1,Plant Extracts,4,ADRA2A|AUTS2|FLNA|IQSEC2
actin cytoskeleton organization,GO:0030036,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
actin cytoskeleton organization,GO:0030036,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
actin cytoskeleton organization,GO:0030036,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
actin filament depolymerization,GO:0030042,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,MICAL1
actin filament network formation,GO:0051639,Epilepsy,MESH:D004827,1,Adenosine,0,
actin filament network formation,GO:0051639,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Adenosine,0,
actin filament organization,GO:0007015,Epilepsy,MESH:D004827,1,Dronabinol,1,STX1B
actin filament organization,GO:0007015,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9",OMIM:616172,0,,1,STX1B
actin filament polymerization,GO:0030041,Epilepsy,MESH:D004827,1,Norepinephrine,1,ALG13
actin filament polymerization,GO:0030041,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
action potential,GO:0001508,Epilepsy,MESH:D004827,0,,6,GRIN2A|GRIN2B|KCNQ2|SCN1A|SCN2A|SCN8A
action potential,GO:0001508,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
action potential,GO:0001508,"Epilepsy, Benign Neonatal, 3",MESH:C564274,0,,1,SCN2A
action potential,GO:0001508,"Epilepsy, Complex Partial",MESH:D017029,0,,1,SCN3A
action potential,GO:0001508,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
action potential,GO:0001508,"Epilepsy, Frontal Lobe",MESH:D017034,0,,2,CHRNA4|CHRNB2
action potential,GO:0001508,"Epilepsy, Generalized",MESH:D004829,0,,1,SCN1A
action potential,GO:0001508,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
action potential,GO:0001508,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
action potential,GO:0001508,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
action potential,GO:0001508,"Generalized Epilepsy With Febrile Seizures Plus, Type 2",MESH:C565810,0,,1,SCN1A
action potential initiation,GO:0099610,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
action potential initiation,GO:0099610,Epilepsy,MESH:D004827,5,Carbamazepine|Fluoxetine|Lamotrigine|Lidocaine|Valproic Acid,2,CNTNAP2|KCNQ2
action potential initiation,GO:0099610,"Epilepsy, Absence",MESH:D004832,4,Carbamazepine|Lamotrigine|Riluzole|Valproic Acid,0,
action potential initiation,GO:0099610,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
action potential initiation,GO:0099610,"Epilepsy, Complex Partial",MESH:D017029,3,Carbamazepine|Lamotrigine|Valproic Acid,0,
action potential initiation,GO:0099610,"Epilepsy, Generalized",MESH:D004829,3,Carbamazepine|Lamotrigine|Valproic Acid,0,
action potential initiation,GO:0099610,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
action potential initiation,GO:0099610,"Epilepsy, Rolandic",MESH:D019305,2,Carbamazepine|Valproic Acid,0,
action potential initiation,GO:0099610,"Epilepsy, Temporal Lobe",MESH:D004833,3,Carbamazepine|Lamotrigine|Valproic Acid,0,
action potential initiation,GO:0099610,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Carbamazepine|Chloroquine|Lamotrigine|Lidocaine|Valproic Acid,0,
action potential initiation,GO:0099610,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
action potential propagation,GO:0098870,"Epilepsy, Tonic-Clonic",MESH:D004830,1,FG 9041,0,
activation-induced cell death of T cells,GO:0006924,Epilepsy,MESH:D004827,0,,1,AKT1
activation of adenylate cyclase activity,GO:0007190,Epilepsy,MESH:D004827,5,Dronabinol|Ketoconazole|Lithium Chloride|Morphine|Naloxone,0,
activation of adenylate cyclase activity,GO:0007190,"Epilepsy, Absence",MESH:D004832,2,Lithium Carbonate|Naloxone,0,
activation of adenylate cyclase activity,GO:0007190,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,0,
activation of adenylate cyclase activity,GO:0007190,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium Chloride,0,
activation of adenylate cyclase activity,GO:0007190,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Lithium Carbonate|Lithium Chloride|Morphine|Naloxone,0,
activation of cysteine-type endopeptidase activity,GO:0097202,Epilepsy,MESH:D004827,4,4-Aminopyridine|Calcium|Dronabinol|Folic Acid,0,
activation of cysteine-type endopeptidase activity,GO:0097202,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Deferoxamine,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,Epilepsy,MESH:D004827,6,"Cisplatin|Dexamethasone|Dextroamphetamine|Ketamine|Methotrexate|N-Methyl-3,4-methylenedioxyamphetamine",0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,"Epilepsy, Tonic-Clonic",MESH:D004830,7,Chloroquine|Diclofenac|Dizocilpine Maleate|Mebendazole|Methamphetamine|Methotrexate|Sertraline,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0008635,Epilepsy,MESH:D004827,1,Cisplatin,0,
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,GO:0008635,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Mechlorethamine|Melphalan,0,
activation of GTPase activity,GO:0090630,Epilepsy,MESH:D004827,1,Norepinephrine,1,TSC1
activation of GTPase activity,GO:0090630,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NTF3
activation of innate immune response,GO:0002218,Epilepsy,MESH:D004827,1,Methimazole,0,
activation of protein kinase A activity,GO:0034199,Epilepsy,MESH:D004827,3,Dexamethasone|Ketoconazole|Propofol,0,
activation of protein kinase A activity,GO:0034199,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
activation of protein kinase A activity,GO:0034199,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
activation of protein kinase activity,GO:0032147,Epilepsy,MESH:D004827,1,Cisplatin,1,ADRA2A
activation of protein kinase activity,GO:0032147,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
activation of protein kinase activity,GO:0032147,"Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy",MESH:C567020,0,,1,STRADA
activation of protein kinase B activity,GO:0032148,Epilepsy,MESH:D004827,12,Cisplatin|Clonidine|Dexamethasone|Dronabinol|Epinephrine|Ethosuximide|Etoposide|Folic Acid|Norepinephrine|Phenobarbital|Picrotoxin|Plant Extracts,2,ADRA2A|SLC1A1
activation of protein kinase B activity,GO:0032148,"Epilepsy, Absence",MESH:D004832,4,Doxorubicin|Ethosuximide|Phenobarbital|Picrotoxin,0,
activation of protein kinase B activity,GO:0032148,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
activation of protein kinase B activity,GO:0032148,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
activation of protein kinase B activity,GO:0032148,"Epilepsy, Temporal Lobe",MESH:D004833,2,Phenobarbital|Plant Extracts,1,SLC1A1
activation of protein kinase B activity,GO:0032148,"Epilepsy, Tonic-Clonic",MESH:D004830,9,Clonidine|Dizocilpine Maleate|Epinephrine|Ethanol|Ethosuximide|Mechlorethamine|Phenobarbital|Picrotoxin|Plant Extracts,1,NTF3
activation of protein kinase C activity,GO:1990051,Epilepsy,MESH:D004827,1,4-Aminopyridine,0,
activation of protein kinase C activity,GO:1990051,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
activation of protein kinase C activity,GO:1990051,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Paraoxon|Vincristine,0,
acute inflammatory response,GO:0002526,Epilepsy,MESH:D004827,1,Dexamethasone,0,
acute inflammatory response to antigenic stimulus,GO:0002438,Epilepsy,MESH:D004827,0,,1,OPRM1
acute inflammatory response to antigenic stimulus,GO:0002438,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,BDKRB2
acylglycerol metabolic process,GO:0006639,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
adaptive immune response,GO:0002250,Epilepsy,MESH:D004827,0,,1,TSC1
adaptive immune response,GO:0002250,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,GO:0002460,Epilepsy,MESH:D004827,0,,1,TGFB1
adaptive thermogenesis,GO:1990845,Epilepsy,MESH:D004827,2,Cimetidine|Norepinephrine,1,HNRNPU
adaptive thermogenesis,GO:1990845,"Epilepsy, Temporal Lobe",MESH:D004833,1,Capsaicin,0,
adaptive thermogenesis,GO:1990845,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Caffeine|Cimetidine|Phenylpropanolamine,0,
adenosine catabolic process,GO:0006154,Epilepsy,MESH:D004827,1,Adenosine,0,
adenosine catabolic process,GO:0006154,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Adenosine,0,
adenosine metabolic process,GO:0046085,Epilepsy,MESH:D004827,1,Adenosine,0,
adenosine metabolic process,GO:0046085,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Adenosine,0,
adenosine to inosine editing,GO:0006382,Epilepsy,MESH:D004827,1,Methotrexate,0,
adenosine to inosine editing,GO:0006382,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
adenosine to inosine editing,GO:0006382,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
adenosine to inosine editing,GO:0006382,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
adenylate cyclase-activating adrenergic receptor signaling pathway,GO:0071880,Epilepsy,MESH:D004827,0,,2,ADRA2A|CHRM2
adenylate cyclase-activating dopamine receptor signaling pathway,GO:0007191,Epilepsy,MESH:D004827,0,,1,OPRM1
adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,Epilepsy,MESH:D004827,0,,1,ADRA2A
adenylate cyclase-activating G protein-coupled receptor signaling pathway,GO:0007189,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,CNR1
adenylate cyclase-inhibiting adrenergic receptor signaling pathway,GO:0071881,Epilepsy,MESH:D004827,0,,1,ADRA2A
adenylate cyclase-inhibiting dopamine receptor signaling pathway,GO:0007195,Epilepsy,MESH:D004827,0,,1,FLNA
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,GO:0007197,Epilepsy,MESH:D004827,1,Dronabinol,3,CHRM1|CHRM2|OPRM1
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,GO:0007196,Epilepsy,MESH:D004827,0,,1,GRM1
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway,GO:0007196,"Epilepsy, Temporal Lobe",MESH:D004833,0,,5,GRM1|GRM2|GRM3|GRM4|GRM5
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,GO:0007193,Epilepsy,MESH:D004827,0,,4,ADRA2A|NPY2R|OPRD1|OPRM1
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,GO:0007193,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway,GO:0007193,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,NPY2R
adenylate cyclase-inhibiting opioid receptor signaling pathway,GO:0031635,Epilepsy,MESH:D004827,0,,1,OPRM1
adenylate cyclase-inhibiting serotonin receptor signaling pathway,GO:0007198,Epilepsy,MESH:D004827,0,,1,GNAO1
adenylate cyclase-modulating G protein-coupled receptor signaling pathway,GO:0007188,Epilepsy,MESH:D004827,0,,2,CHRM2|GNAO1
adenylate cyclase-modulating G protein-coupled receptor signaling pathway,GO:0007188,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,CNR1
adipose tissue development,GO:0060612,Epilepsy,MESH:D004827,7,Cimetidine|Ciprofloxacin|Clozapine|Dexamethasone|Folic Acid|Lithium Chloride|Plant Extracts,0,
adipose tissue development,GO:0060612,"Epilepsy, Absence",MESH:D004832,1,Heparin,0,
adipose tissue development,GO:0060612,"Epilepsy, Complex Partial",MESH:D017029,1,Clozapine,0,
adipose tissue development,GO:0060612,"Epilepsy, Generalized",MESH:D004829,2,Clozapine|Zidovudine,0,
adipose tissue development,GO:0060612,"Epilepsy, Temporal Lobe",MESH:D004833,3,Capsaicin|Lithium Chloride|Plant Extracts,0,
adipose tissue development,GO:0060612,"Epilepsy, Tonic-Clonic",MESH:D004830,8,Cimetidine|Ciprofloxacin|Clozapine|Heparin|Lithium Chloride|Methylprednisolone|Metronidazole|Plant Extracts,0,
ADP biosynthetic process,GO:0006172,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
ADP biosynthetic process,GO:0006172,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
ADP catabolic process,GO:0046032,Epilepsy,MESH:D004827,1,Adenosine,0,
ADP catabolic process,GO:0046032,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Adenosine,0,
ADP metabolic process,GO:0046031,Epilepsy,MESH:D004827,1,malic acid,0,
ADP metabolic process,GO:0046031,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Clomipramine,0,
adrenergic receptor signaling pathway,GO:0071875,Epilepsy,MESH:D004827,0,,1,ADRA2A
adult behavior,GO:0030534,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
adult behavior,GO:0030534,Epilepsy,MESH:D004827,0,,3,CNTNAP2|SLC1A1|SLC1A2
adult behavior,GO:0030534,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
adult behavior,GO:0030534,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Cocaine|tetramethylenedisulfotetramine,0,
adult feeding behavior,GO:0008343,Epilepsy,MESH:D004827,2,Fluoxetine|Ketamine,1,NPY
adult feeding behavior,GO:0008343,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,NPY
adult feeding behavior,GO:0008343,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Methylprednisolone,0,
adult locomotory behavior,GO:0008344,Epilepsy,MESH:D004827,8,Atropine|Dronabinol|Fluoxetine|Ketamine|Lidocaine|Methylmercury Compounds|Topiramate|Valproic Acid,3,MECP2|OPRD1|TSC1
adult locomotory behavior,GO:0008344,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
adult locomotory behavior,GO:0008344,"Epilepsy, Complex Partial",MESH:D017029,2,Topiramate|Valproic Acid,0,
adult locomotory behavior,GO:0008344,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
adult locomotory behavior,GO:0008344,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
adult locomotory behavior,GO:0008344,"Epilepsy, Rolandic",MESH:D019305,2,Topiramate|Valproic Acid,0,
adult locomotory behavior,GO:0008344,"Epilepsy, Temporal Lobe",MESH:D004833,2,Topiramate|Valproic Acid,0,
adult locomotory behavior,GO:0008344,"Epilepsy, Tonic-Clonic",MESH:D004830,10,Acetaminophen|Atropine|Cocaine|Ethanol|Lidocaine|Paroxetine|Sarin|Soman|Topiramate|Valproic Acid,1,NGF
adult locomotory behavior,GO:0008344,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
adult walking behavior,GO:0007628,Epilepsy,MESH:D004827,0,,2,SCN1A|SCN8A
adult walking behavior,GO:0007628,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
adult walking behavior,GO:0007628,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
adult walking behavior,GO:0007628,"Epilepsy, Generalized",MESH:D004829,0,,2,CACNB4|SCN1A
adult walking behavior,GO:0007628,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CACNB4
adult walking behavior,GO:0007628,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
adult walking behavior,GO:0007628,Generalized Epilepsy and Paroxysmal Dyskinesia,MESH:C563719,0,,1,KCNMA1
adult walking behavior,GO:0007628,"Generalized Epilepsy With Febrile Seizures Plus, Type 2",MESH:C565810,0,,1,SCN1A
adult walking behavior,GO:0007628,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,CACNB4
aerobic electron transport chain,GO:0019646,Epilepsy,MESH:D004827,1,Methotrexate,0,
aerobic electron transport chain,GO:0019646,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
aerobic electron transport chain,GO:0019646,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,1,COX3
aerobic electron transport chain,GO:0019646,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Bupivacaine|Diclofenac|Methotrexate,0,
aerobic respiration,GO:0009060,Epilepsy,MESH:D004827,3,Dronabinol|Norepinephrine|Valproic Acid,0,
aerobic respiration,GO:0009060,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
aerobic respiration,GO:0009060,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
aerobic respiration,GO:0009060,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
aerobic respiration,GO:0009060,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
aerobic respiration,GO:0009060,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
aerobic respiration,GO:0009060,"Epilepsy, Temporal Lobe",MESH:D004833,2,Capsaicin|Valproic Acid,0,
aerobic respiration,GO:0009060,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Acetaminophen|Methamphetamine|Valproic Acid,0,
aerobic respiration,GO:0009060,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
aggressive behavior,GO:0002118,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Sarin,0,
alanine metabolic process,GO:0006522,Epilepsy,MESH:D004827,2,Propofol|Sevoflurane,0,
alanine metabolic process,GO:0006522,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
alanine metabolic process,GO:0006522,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
aldosterone biosynthetic process,GO:0032342,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1H
alkaloid catabolic process,GO:0009822,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,CYP2D6
alkaloid metabolic process,GO:0009820,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
alkaloid metabolic process,GO:0009820,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,CYP2D6
allantois development,GO:1905069,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
alpha-tubulin acetylation,GO:0071929,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
aluminum ion homeostasis,GO:0055079,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Aluminum,0,
amide metabolic process,GO:0043603,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Ethanol,0,
amine metabolic process,GO:0009308,Epilepsy,MESH:D004827,1,Methotrexate,0,
amine metabolic process,GO:0009308,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
amine metabolic process,GO:0009308,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
amine metabolic process,GO:0009308,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
amino-acid betaine biosynthetic process,GO:0006578,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
amino-acid betaine metabolic process,GO:0006577,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
amino acid biosynthetic process,GO:0008652,Epilepsy,MESH:D004827,3,Folic Acid|Valproic Acid|Vitamin B 12,0,
amino acid biosynthetic process,GO:0008652,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
amino acid biosynthetic process,GO:0008652,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
amino acid biosynthetic process,GO:0008652,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
amino acid biosynthetic process,GO:0008652,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
amino acid biosynthetic process,GO:0008652,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
amino acid biosynthetic process,GO:0008652,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
amino acid biosynthetic process,GO:0008652,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Acetaminophen|Ethanol|Valproic Acid,0,
amino acid biosynthetic process,GO:0008652,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
amino acid export across plasma membrane,GO:0032973,Epilepsy,MESH:D004827,2,Dronabinol|gamma-Aminobutyric Acid,0,
amino acid metabolic process,GO:0006520,Epilepsy,MESH:D004827,2,Cisplatin|Methotrexate,0,
amino acid metabolic process,GO:0006520,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
amino acid metabolic process,GO:0006520,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
amino acid metabolic process,GO:0006520,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
amino acid metabolic process,GO:0006520,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
amino acid metabolic process,GO:0006520,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Methotrexate,0,
amino acid transmembrane transport,GO:0003333,Epilepsy,MESH:D004827,0,,1,SLC6A1
amino acid transmembrane transport,GO:0003333,MYOCLONIC-ATONIC EPILEPSY,OMIM:616421,0,,1,SLC6A1
amino acid transport,GO:0006865,Epilepsy,MESH:D004827,0,,2,SLC1A1|SLC1A3
amino acid transport,GO:0006865,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
aminophospholipid transport,GO:0015917,"EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE",OMIM:254900,0,,1,SCARB2
ammonium homeostasis,GO:0097272,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
ammonium transmembrane transport,GO:0072488,Epilepsy,MESH:D004827,0,,2,SLC12A2|SLC12A5
ammonium transmembrane transport,GO:0072488,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,SLC12A5
ammonium transmembrane transport,GO:0072488,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,SLC12A2|SLC12A5
AMPA selective glutamate receptor signaling pathway,GO:0098990,Epilepsy,MESH:D004827,3,Atropine|Methylmercury Compounds|Picrotoxin,1,MEF2C
AMPA selective glutamate receptor signaling pathway,GO:0098990,"Epilepsy, Absence",MESH:D004832,1,Picrotoxin,0,
AMPA selective glutamate receptor signaling pathway,GO:0098990,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Atropine|Picrotoxin,0,
AMP catabolic process,GO:0006196,Epilepsy,MESH:D004827,2,Adenosine|Haloperidol,0,
AMP catabolic process,GO:0006196,"Epilepsy, Absence",MESH:D004832,1,Haloperidol,0,
AMP catabolic process,GO:0006196,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Adenosine|Caffeine|Haloperidol,0,
AMP metabolic process,GO:0046033,Epilepsy,MESH:D004827,2,Folic Acid|malic acid,0,
AMP metabolic process,GO:0046033,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Clomipramine|Ethanol,0,
amyloid-beta formation,GO:0034205,Epilepsy,MESH:D004827,0,,1,DYRK1A
anagen,GO:0042640,Epilepsy,MESH:D004827,0,,1,AKT1
anatomical structure development,GO:0048856,Epilepsy,MESH:D004827,2,Propofol|Valproic Acid,1,SPARCL1
anatomical structure development,GO:0048856,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
anatomical structure development,GO:0048856,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
anatomical structure development,GO:0048856,"Epilepsy, Generalized",MESH:D004829,2,Propofol|Valproic Acid,0,
anatomical structure development,GO:0048856,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
anatomical structure development,GO:0048856,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
anatomical structure development,GO:0048856,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
anatomical structure development,GO:0048856,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Propofol|Valproic Acid,0,
anatomical structure development,GO:0048856,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
anatomical structure morphogenesis,GO:0009653,Epilepsy,MESH:D004827,1,Cytarabine,2,ANKRD11|PCDH19
anatomical structure morphogenesis,GO:0009653,"Epilepsy, Female-Restricted, with Mental Retardation",MESH:C564715,0,,1,PCDH19
anatomical structure morphogenesis,GO:0009653,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
anatomical structure morphogenesis,GO:0009653,"Epilepsy, Partial, with Variable Foci",MESH:C565785,0,,1,NPRL3
androgen biosynthetic process,GO:0006702,"Epilepsy, Absence",MESH:D004832,1,Progesterone,0,
androgen catabolic process,GO:0006710,Epilepsy,MESH:D004827,2,Erythromycin|Ketoconazole,0,
androgen catabolic process,GO:0006710,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Erythromycin,0,
androgen metabolic process,GO:0008209,Epilepsy,MESH:D004827,4,Chloramphenicol|Dexamethasone|Ketoconazole|Phenytoin,0,
androgen metabolic process,GO:0008209,"Epilepsy, Absence",MESH:D004832,1,Phenytoin,0,
androgen metabolic process,GO:0008209,"Epilepsy, Complex Partial",MESH:D017029,1,Phenytoin,0,
androgen metabolic process,GO:0008209,"Epilepsy, Generalized",MESH:D004829,1,Phenytoin,0,
androgen metabolic process,GO:0008209,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenytoin,0,
androgen metabolic process,GO:0008209,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Orphenadrine|Phenytoin,0,
androgen receptor signaling pathway,GO:0030521,Epilepsy,MESH:D004827,0,,1,UBE3A
"androst-4-ene-3,17-dione biosynthetic process",GO:1903449,Epilepsy,MESH:D004827,2,Clozapine|Haloperidol,0,
"androst-4-ene-3,17-dione biosynthetic process",GO:1903449,"Epilepsy, Absence",MESH:D004832,1,Haloperidol,0,
"androst-4-ene-3,17-dione biosynthetic process",GO:1903449,"Epilepsy, Complex Partial",MESH:D017029,1,Clozapine,0,
"androst-4-ene-3,17-dione biosynthetic process",GO:1903449,"Epilepsy, Generalized",MESH:D004829,1,Clozapine,0,
"androst-4-ene-3,17-dione biosynthetic process",GO:1903449,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Chlorpromazine|Clozapine|Haloperidol,0,
angioblast cell migration,GO:0035476,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
angiogenesis,GO:0001525,Epilepsy,MESH:D004827,4,Adenosine|Dexamethasone|Folic Acid|Thalidomide,1,FLNA
angiogenesis,GO:0001525,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
angiogenesis,GO:0001525,"Epilepsy, Temporal Lobe",MESH:D004833,0,,3,KDR|TEK|VEGFA
angiogenesis,GO:0001525,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Acetaminophen|Adenosine|Aluminum|Caffeine|Chloroquine|Ethanol,2,FGF2|HBEGF
angiogenesis,GO:0001525,"Rolandic Epilepsy, Mental Retardation, and Speech Dyspraxia, X-Linked",MESH:C564467,0,,1,SRPX2
angiogenesis involved in coronary vascular morphogenesis,GO:0060978,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
angiogenesis involved in coronary vascular morphogenesis,GO:0060978,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
angiogenesis involved in wound healing,GO:0060055,Epilepsy,MESH:D004827,1,Dexamethasone,1,GPX1
angiotensin maturation,GO:0002003,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
animal organ development,GO:0048513,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|SLIT2
animal organ development,GO:0048513,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
animal organ morphogenesis,GO:0009887,Epilepsy,MESH:D004827,0,,2,ASXL3|TGFB1
animal organ morphogenesis,GO:0009887,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VDR
animal organ morphogenesis,GO:0009887,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
animal organ morphogenesis,GO:0009887,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
animal organ regeneration,GO:0031100,Epilepsy,MESH:D004827,0,,1,TGFB1
anoikis,GO:0043276,Epilepsy,MESH:D004827,0,,2,AKT1|TSC2
anterior neural tube closure,GO:0061713,Epilepsy,MESH:D004827,0,,1,FOLR1
anterior neuropore closure,GO:0021506,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
anterior/posterior axis specification,GO:0009948,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
anterior/posterior axon guidance,GO:0033564,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
anterior visceral endoderm cell migration,GO:1905070,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
anterograde axonal transport,GO:0008089,Epilepsy,MESH:D004827,1,Lithium Chloride,0,
anterograde axonal transport,GO:0008089,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium Chloride,0,
anterograde axonal transport,GO:0008089,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Lithium Chloride,0,
antibacterial humoral response,GO:0019731,Epilepsy,MESH:D004827,0,,1,NPY
antibacterial humoral response,GO:0019731,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,NPY
antifungal humoral response,GO:0019732,Epilepsy,MESH:D004827,0,,1,NPY
antifungal humoral response,GO:0019732,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,NPY
antigen processing and presentation of exogenous antigen,GO:0019884,Epilepsy,MESH:D004827,1,Methimazole,0,
antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061844,Epilepsy,MESH:D004827,0,,2,NPY|POMC
antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061844,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,NPY
antimicrobial humoral immune response mediated by antimicrobial peptide,GO:0061844,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,POMC
antral ovarian follicle growth,GO:0001547,Epilepsy,MESH:D004827,1,Cisplatin,0,
antral ovarian follicle growth,GO:0001547,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
antral ovarian follicle growth,GO:0001547,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
aorta development,GO:0035904,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
aorta morphogenesis,GO:0035909,"Epilepsy, Partial, with Variable Foci",MESH:C565785,0,,1,NPRL3
aortic valve morphogenesis,GO:0003180,Epilepsy,MESH:D004827,0,,1,TGFB1
aortic valve morphogenesis,GO:0003180,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
apical dendrite arborization,GO:0150023,Epilepsy,MESH:D004827,1,Methotrexate,0,
apical dendrite arborization,GO:0150023,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
apical dendrite arborization,GO:0150023,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
apical dendrite arborization,GO:0150023,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
apical protein localization,GO:0045176,Epilepsy,MESH:D004827,1,Valproic Acid,1,HCN1
apical protein localization,GO:0045176,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
apical protein localization,GO:0045176,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
apical protein localization,GO:0045176,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
apical protein localization,GO:0045176,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
apical protein localization,GO:0045176,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
apical protein localization,GO:0045176,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
apical protein localization,GO:0045176,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
apical protein localization,GO:0045176,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
apical protein localization,GO:0045176,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
apoptosome assembly,GO:0097314,Epilepsy,MESH:D004827,0,,1,KCNQ2
apoptosome assembly,GO:0097314,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
apoptotic cell clearance,GO:0043277,Epilepsy,MESH:D004827,5,Ciprofloxacin|Dexamethasone|Lidocaine|Norepinephrine|Phentolamine,0,
apoptotic cell clearance,GO:0043277,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
apoptotic cell clearance,GO:0043277,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ciprofloxacin|Lidocaine,0,
apoptotic chromosome condensation,GO:0030263,Epilepsy,MESH:D004827,12,Bicuculline|Cisplatin|Epinephrine|Kainic Acid|Lithium|Methotrexate|Pentylenetetrazole|Plant Extracts|Propofol|Strychnine|Topiramate|Valproic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Epilepsy, Absence",MESH:D004832,4,Doxorubicin|Lithium Carbonate|Pentylenetetrazole|Valproic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Epilepsy, Complex Partial",MESH:D017029,3,Methotrexate|Topiramate|Valproic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Epilepsy, Generalized",MESH:D004829,2,Propofol|Valproic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Epilepsy, Rolandic",MESH:D019305,2,Topiramate|Valproic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Epilepsy, Temporal Lobe",MESH:D004833,7,Kainic Acid|Lithium|Methotrexate|Plant Extracts|Tacrolimus|Topiramate|Valproic Acid,0,
apoptotic chromosome condensation,GO:0030263,"Epilepsy, Tonic-Clonic",MESH:D004830,15,Acetaminophen|Aluminum|Chloroquine|Epinephrine|Ethanol|Lithium|Lithium Carbonate|Methotrexate|Pentylenetetrazole|Plant Extracts|Propofol|Tacrolimus|Topiramate|Valproic Acid|Vincristine,0,
apoptotic chromosome condensation,GO:0030263,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
apoptotic DNA fragmentation,GO:0006309,Epilepsy,MESH:D004827,29,Adenosine|Amitriptyline|Calcium|Carbachol|Cisplatin|Citalopram|Clonidine|Cytarabine|Dexamethasone|Epinephrine|Etoposide|Fluoxetine|Haloperidol|Imipramine|Kainic Acid|Ketamine|Lidocaine|Lithium|Lithium Chloride|Magnesium|Morphine|Naloxone|nimesulide|Norepinephrine|Phenobarbital|Pilocarpine|Plant Extracts|Thalidomide|Valproic Acid,0,
apoptotic DNA fragmentation,GO:0006309,"Epilepsy, Absence",MESH:D004832,7,Doxorubicin|Haloperidol|Heparin|Naloxone|Phenobarbital|Pilocarpine|Valproic Acid,0,
apoptotic DNA fragmentation,GO:0006309,"Epilepsy, Complex Partial",MESH:D017029,2,Phenobarbital|Valproic Acid,0,
apoptotic DNA fragmentation,GO:0006309,"Epilepsy, Generalized",MESH:D004829,4,Naloxone|Phenobarbital|Prednisolone|Valproic Acid,0,
apoptotic DNA fragmentation,GO:0006309,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
apoptotic DNA fragmentation,GO:0006309,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
apoptotic DNA fragmentation,GO:0006309,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
apoptotic DNA fragmentation,GO:0006309,"Epilepsy, Temporal Lobe",MESH:D004833,10,Capsaicin|Kainic Acid|Lithium|Lithium Chloride|Medroxyprogesterone Acetate|Phenobarbital|Pilocarpine|Plant Extracts|Tacrolimus|Valproic Acid,0,
apoptotic DNA fragmentation,GO:0006309,"Epilepsy, Tonic-Clonic",MESH:D004830,33,Acetaminophen|Adenosine|Amitriptyline|Bupivacaine|Caffeine|Chloroquine|Citalopram|Clomipramine|Clonidine|Cocaine|Diclofenac|Disulfiram|Epinephrine|Ethanol|Haloperidol|Heparin|Imipramine|Lidocaine|Lithium|Lithium Chloride|Mechlorethamine|Methylprednisolone|Morphine|Naloxone|Phenobarbital|Pilocarpine|Plant Extracts|Ropivacaine|Tacrolimus|Tetracaine|Theophylline|Valproic Acid|Vincristine,0,
apoptotic DNA fragmentation,GO:0006309,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
apoptotic mitochondrial changes,GO:0008637,Epilepsy,MESH:D004827,0,,1,AKT1
apoptotic nuclear changes,GO:0030262,Epilepsy,MESH:D004827,3,Cisplatin|Etoposide|Plant Extracts,0,
apoptotic nuclear changes,GO:0030262,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
apoptotic nuclear changes,GO:0030262,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
apoptotic nuclear changes,GO:0030262,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Chloroquine|Ethanol|Plant Extracts,0,
apoptotic process,GO:0006915,Epilepsy,MESH:D004827,64,"6-Cyano-7-nitroquinoxaline-2,3-dione|Acetazolamide|Adenosine|Amitriptyline|Amphetamine|Ampicillin|Atropine|Bicuculline|Busulfan|Calcium|Carbachol|Cephalothin|Chloramphenicol|Cimetidine|Ciprofloxacin|Cisplatin|Citalopram|Clozapine|Cytarabine|Dexamethasone|Diatrizoate Meglumine|Diazepam|Dronabinol|Enkephalin, Ala(2)-MePhe(4)-Gly(5)-|Epinephrine|Estrogens|Etoposide|Fluoxetine|Folic Acid|gamma-Aminobutyric Acid|Gentamicins|Haloperidol|Imipramine|Kainic Acid|Ketamine|Ketoconazole|Lidocaine|Lithium|Lithium Chloride|Maprotiline|Methimazole|Methotrexate|Methylmercury Compounds|Morphine|Muscimol|Naloxone|nimesulide|N-Methyl-3,4-methylenedioxyamphetamine|Norepinephrine|Oxcarbazepine|Pefloxacin|Penicillamine|Pentobarbital|Pentylenetetrazole|Phenobarbital|Phenytoin|Pilocarpine|Plant Extracts|Propofol|Quetiapine Fumarate|Sevoflurane|Thalidomide|Valproic Acid|Vitamin B 12",3,GPX1|MEF2C|VDAC1
apoptotic process,GO:0006915,"Epilepsy, Absence",MESH:D004832,14,Diazepam|Doxorubicin|Haloperidol|Heparin|Leuprolide|Naloxone|Oxcarbazepine|Pentylenetetrazole|Phenobarbital|Phenytoin|Pilocarpine|Progesterone|Riluzole|Valproic Acid,0,
apoptotic process,GO:0006915,"Epilepsy, Complex Partial",MESH:D017029,7,Clozapine|Diazepam|Methotrexate|Oxcarbazepine|Phenobarbital|Phenytoin|Valproic Acid,0,
apoptotic process,GO:0006915,"Epilepsy, Generalized",MESH:D004829,9,Clozapine|Diazepam|Naloxone|Phenobarbital|Phenytoin|Prednisolone|Propofol|Valproic Acid|Zidovudine,0,
apoptotic process,GO:0006915,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
apoptotic process,GO:0006915,"Epilepsy, Reflex",MESH:D020195,2,Polychlorinated Biphenyls|Valproic Acid,0,
apoptotic process,GO:0006915,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
apoptotic process,GO:0006915,"Epilepsy, Temporal Lobe",MESH:D004833,13,Capsaicin|Clioquinol|Kainic Acid|Lithium|Lithium Chloride|Medroxyprogesterone Acetate|Methotrexate|Phenobarbital|Phenytoin|Pilocarpine|Plant Extracts|Tacrolimus|Valproic Acid,1,VEGFA
apoptotic process,GO:0006915,"Epilepsy, Tonic-Clonic",MESH:D004830,75,Acetaminophen|Adenosine|Aluminum|Aminophylline|Amitriptyline|Atropine|Bupivacaine|Buspirone|Busulfan|Caffeine|Chlorambucil|Chlormethiazole|chloroprocaine|Chloroquine|Chlorpromazine|Cimetidine|Ciprofloxacin|Citalopram|Clomiphene|Clomipramine|Clozapine|Cocaine|Deferoxamine|Diazepam|Diclofenac|Dinoprost|Disulfiram|Dizocilpine Maleate|Ephedrine|Epinephrine|Ethanol|Haloperidol|Heparin|Hexachlorocyclohexane|Imipramine|Lidocaine|Lithium|Lithium Chloride|Maprotiline|Mebendazole|Mechlorethamine|Melphalan|Methamphetamine|Methotrexate|Methylphenidate|Methylprednisolone|Metronidazole|Morphine|Naloxone|Nortriptyline|Oxcarbazepine|Paraoxon|Paroxetine|Pefloxacin|Pentazocine|Pentylenetetrazole|Phenobarbital|Phenytoin|Pilocarpine|Pimozide|Plant Extracts|pralidoxime|Procaine|Propofol|Pyridoxal Phosphate|Ropivacaine|Sertraline|Sodium Chloride|Tacrolimus|Tetracaine|Theophylline|Thiopental|Valproic Acid|Venlafaxine Hydrochloride|Vincristine,0,
apoptotic process,GO:0006915,"Myoclonic Epilepsy, Juvenile",MESH:D020190,2,Acetazolamide|Valproic Acid,0,
apoptotic process,GO:0006915,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
apoptotic process involved in luteolysis,GO:0061364,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
apoptotic process involved in mammary gland involution,GO:0060057,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VDR
apoptotic signaling pathway,GO:0097190,Epilepsy,MESH:D004827,0,,1,P2RX4
apoptotic signaling pathway,GO:0097190,"Epilepsy, Temporal Lobe",MESH:D004833,0,,3,P2RX4|P2RX7|VDR
apposition of dorsal and ventral imaginal disc-derived wing surfaces,GO:0007475,Epilepsy,MESH:D004827,0,,1,ILK
arachidonic acid metabolic process,GO:0019369,Epilepsy,MESH:D004827,3,Ampicillin|Dronabinol|Morphine,1,GPX1
arachidonic acid metabolic process,GO:0019369,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Metronidazole|Morphine,1,CYP2D6
arachidonic acid secretion,GO:0050482,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,BDKRB2
arginine metabolic process,GO:0006525,Epilepsy,MESH:D004827,1,Propofol,0,
arginine metabolic process,GO:0006525,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
arginine metabolic process,GO:0006525,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
arsenate ion transmembrane transport,GO:1901684,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Foscarnet,0,
arsenite transport,GO:0015700,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
artery morphogenesis,GO:0048844,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
artery smooth muscle contraction,GO:0014824,Epilepsy,MESH:D004827,1,Norepinephrine,0,
articular cartilage development,GO:0061975,Epilepsy,MESH:D004827,1,Dexamethasone,0,
articular cartilage development,GO:0061975,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
asparagine biosynthetic process,GO:0006529,Epilepsy,MESH:D004827,1,Phenobarbital,0,
asparagine biosynthetic process,GO:0006529,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
asparagine biosynthetic process,GO:0006529,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
asparagine biosynthetic process,GO:0006529,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
asparagine biosynthetic process,GO:0006529,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
asparagine biosynthetic process,GO:0006529,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
asparagine biosynthetic process,GO:0006529,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Phenobarbital,0,
aspartate biosynthetic process,GO:0006532,Epilepsy,MESH:D004827,1,"N-Methyl-3,4-methylenedioxyamphetamine",0,
aspartate biosynthetic process,GO:0006532,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Methylprednisolone,0,
aspartate catabolic process,GO:0006533,Epilepsy,MESH:D004827,1,Plant Extracts,0,
aspartate catabolic process,GO:0006533,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
aspartate catabolic process,GO:0006533,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
aspartate metabolic process,GO:0006531,Epilepsy,MESH:D004827,1,Cisplatin,0,
aspartate metabolic process,GO:0006531,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
associative learning,GO:0008306,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
associative learning,GO:0008306,Epilepsy,MESH:D004827,1,Dronabinol,6,CNTNAP2|GRIN2B|MECP2|SLC6A1|SNAP25|TSC1
associative learning,GO:0008306,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
associative learning,GO:0008306,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
associative learning,GO:0008306,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNB2
associative learning,GO:0008306,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
associative learning,GO:0008306,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
associative learning,GO:0008306,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Fentanyl|Sarin,0,
associative learning,GO:0008306,MYOCLONIC-ATONIC EPILEPSY,OMIM:616421,0,,1,SLC6A1
astrocyte activation,GO:0048143,Epilepsy,MESH:D004827,2,Dronabinol|Kainic Acid,0,
astrocyte activation,GO:0048143,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
astrocyte activation,GO:0048143,"Epilepsy, Temporal Lobe",MESH:D004833,1,Kainic Acid,0,
astrocyte activation,GO:0048143,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Methamphetamine|Sarin,0,
astrocyte development,GO:0014002,Epilepsy,MESH:D004827,1,Plant Extracts,1,GFAP
astrocyte development,GO:0014002,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
astrocyte development,GO:0014002,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Plant Extracts,0,
ATP biosynthetic process,GO:0006754,Epilepsy,MESH:D004827,9,Chloramphenicol|Cisplatin|Clozapine|Etoposide|Haloperidol|Ketoconazole|malic acid|Plant Extracts|Valproic Acid,1,TGFB1
ATP biosynthetic process,GO:0006754,"Epilepsy, Absence",MESH:D004832,4,Doxorubicin|Haloperidol|Lithium Carbonate|Valproic Acid,0,
ATP biosynthetic process,GO:0006754,"Epilepsy, Complex Partial",MESH:D017029,2,Clozapine|Valproic Acid,0,
ATP biosynthetic process,GO:0006754,"Epilepsy, Generalized",MESH:D004829,2,Clozapine|Valproic Acid,0,
ATP biosynthetic process,GO:0006754,"Epilepsy, Reflex",MESH:D020195,2,Polychlorinated Biphenyls|Valproic Acid,0,
ATP biosynthetic process,GO:0006754,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
ATP biosynthetic process,GO:0006754,"Epilepsy, Temporal Lobe",MESH:D004833,2,Plant Extracts|Valproic Acid,0,
ATP biosynthetic process,GO:0006754,"Epilepsy, Tonic-Clonic",MESH:D004830,10,Acetaminophen|Bupropion|Caffeine|Chlorpromazine|Clozapine|Ethanol|Haloperidol|Lithium Carbonate|Plant Extracts|Valproic Acid,0,
ATP biosynthetic process,GO:0006754,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
ATP export,GO:1904669,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
ATP metabolic process,GO:0046034,Epilepsy,MESH:D004827,14,"Adenosine|carbidopa, levodopa drug combination|Cisplatin|Dexamethasone|Dextroamphetamine|Dronabinol|malic acid|Methotrexate|N-Methyl-3,4-methylenedioxyamphetamine|Phenobarbital|Plant Extracts|Sevoflurane|Thalidomide|Valproic Acid",0,
ATP metabolic process,GO:0046034,"Epilepsy, Absence",MESH:D004832,3,Doxorubicin|Phenobarbital|Valproic Acid,0,
ATP metabolic process,GO:0046034,"Epilepsy, Complex Partial",MESH:D017029,3,Methotrexate|Phenobarbital|Valproic Acid,0,
ATP metabolic process,GO:0046034,"Epilepsy, Generalized",MESH:D004829,2,Phenobarbital|Valproic Acid,0,
ATP metabolic process,GO:0046034,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
ATP metabolic process,GO:0046034,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
ATP metabolic process,GO:0046034,"Epilepsy, Temporal Lobe",MESH:D004833,5,Capsaicin|Methotrexate|Phenobarbital|Plant Extracts|Valproic Acid,0,
ATP metabolic process,GO:0046034,"Epilepsy, Tonic-Clonic",MESH:D004830,16,Acetaminophen|Adenosine|Bupivacaine|Chloroquine|Chlorpromazine|Clomipramine|Diclofenac|Disulfiram|Ethanol|Hexachlorocyclohexane|Methamphetamine|Methotrexate|Phenobarbital|Plant Extracts|Sertraline|Valproic Acid,0,
ATP metabolic process,GO:0046034,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,GO:0051316,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
auditory behavior,GO:0031223,Epilepsy,MESH:D004827,4,Calcium|Dronabinol|Gentamicins|Methylmercury Compounds,3,GRIN2A|GRIN2B|SLC1A3
auditory behavior,GO:0031223,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
auditory behavior,GO:0031223,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
auditory receptor cell development,GO:0060117,Epilepsy,MESH:D004827,1,Cisplatin,0,
autophagic cell death,GO:0048102,"Epilepsy, Temporal Lobe",MESH:D004833,1,Sialic Acids,0,
autophagic cell death,GO:0048102,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
autophagosome assembly,GO:0000045,Epilepsy,MESH:D004827,5,"Cisplatin|Dexamethasone|Estrogens|Lithium Chloride|N-Methyl-3,4-methylenedioxyamphetamine",1,WDR45
autophagosome assembly,GO:0000045,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
autophagosome assembly,GO:0000045,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium Chloride,0,
autophagosome assembly,GO:0000045,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Caffeine|Chloroquine|Ethanol|Lithium Chloride|Sodium Chloride,0,
autophagosome-endosome fusion,GO:0061910,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
autophagosome-lysosome fusion,GO:0061909,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
autophagosome-lysosome fusion,GO:0061909,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Chloroquine|Methamphetamine,0,
autophagosome membrane disassembly,GO:0030399,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
autophagosome organization,GO:1905037,Epilepsy,MESH:D004827,2,Cisplatin|Sevoflurane,0,
autophagosome organization,GO:1905037,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
autophagosome organization,GO:1905037,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
autophagy,GO:0006914,Epilepsy,MESH:D004827,13,Busulfan|Cisplatin|Clonidine|Dexamethasone|Fluoxetine|Lithium|Lithium Chloride|Maprotiline|Methylmercury Compounds|Morphine|Pilocarpine|Sevoflurane|Thalidomide,2,RAB39B|WDR45
autophagy,GO:0006914,"Epilepsy, Absence",MESH:D004832,3,Doxorubicin|Pilocarpine|Riluzole,0,
autophagy,GO:0006914,"Epilepsy, Temporal Lobe",MESH:D004833,6,Capsaicin|Clioquinol|Lithium|Lithium Chloride|Medroxyprogesterone Acetate|Pilocarpine,0,
autophagy,GO:0006914,"Epilepsy, Tonic-Clonic",MESH:D004830,17,Busulfan|Caffeine|Chlormethiazole|Chloroquine|Clonidine|Cocaine|Deferoxamine|Disulfiram|Ethanol|Lithium|Lithium Chloride|Maprotiline|Methamphetamine|Morphine|Pilocarpine|Sertraline|Sodium Chloride,0,
autophagy of mitochondrion,GO:0000422,Epilepsy,MESH:D004827,0,,1,WDR45
autophagy of mitochondrion,GO:0000422,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
autophagy of mitochondrion,GO:0000422,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Aluminum,0,
autophagy of nucleus,GO:0044804,Epilepsy,MESH:D004827,0,,1,WDR45
axo-dendritic transport,GO:0008088,Epilepsy,MESH:D004827,4,Clonidine|Lidocaine|Methylmercury Compounds|Morphine,0,
axo-dendritic transport,GO:0008088,"Epilepsy, Absence",MESH:D004832,1,Riluzole,0,
axo-dendritic transport,GO:0008088,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Clonidine|Lidocaine|Morphine,0,
axonal defasciculation,GO:0007414,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
axonal fasciculation,GO:0007413,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
axonal fasciculation,GO:0007413,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,CNR1
axonal transport,GO:0098930,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Vincristine,0,
axonal transport,GO:0098930,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
axonal transport of mitochondrion,GO:0019896,Epilepsy,MESH:D004827,1,"N-Methyl-3,4-methylenedioxyamphetamine",0,
axon arborization,GO:0140060,Epilepsy,MESH:D004827,1,Dronabinol,0,
axon development,GO:0061564,Epilepsy,MESH:D004827,1,Dronabinol,2,MECP2|SCN2A
axon development,GO:0061564,"Epilepsy, Benign Neonatal, 3",MESH:C564274,0,,1,SCN2A
axon development,GO:0061564,"Epilepsy, rolandic with paroxysmal exercise-induced dystonia and writer's cramp",MESH:C535499,0,,1,TBC1D24
axon development,GO:0061564,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KCNC4
axon development,GO:0061564,"MYOCLONIC EPILEPSY, FAMILIAL INFANTILE",OMIM:605021,0,,1,TBC1D24
axon extension,GO:0048675,Epilepsy,MESH:D004827,1,Cisplatin,2,AUTS2|BDNF
axon extension,GO:0048675,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,2,BDNF|NGF
axon extension involved in axon guidance,GO:0048846,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
axon extension involved in regeneration,GO:0048677,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
axon guidance,GO:0007411,Epilepsy,MESH:D004827,0,,2,BDNF|MEF2C
axon guidance,GO:0007411,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
axon guidance,GO:0007411,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,2,LGI1|RELN
axon guidance,GO:0007411,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
axon guidance,GO:0007411,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
axon guidance,GO:0007411,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,2,BDNF|NTF3
axon guidance,GO:0007411,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",MESH:C565809,0,,1,SCN1B
axon midline choice point recognition,GO:0016199,Epilepsy,MESH:D004827,0,,1,FOXG1
axonogenesis,GO:0007409,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
axonogenesis,GO:0007409,Epilepsy,MESH:D004827,1,Methylmercury Compounds,3,CNTNAP2|SNAP25|SYNGAP1
axonogenesis,GO:0007409,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
axonogenesis,GO:0007409,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,CNR1|SLIT2
axonogenesis,GO:0007409,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
axonogenesis,GO:0007409,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
axonogenesis involved in innervation,GO:0060385,Epilepsy,MESH:D004827,0,,1,MECP2
axon regeneration,GO:0031103,Epilepsy,MESH:D004827,0,,1,FOLR1
axon target recognition,GO:0007412,Epilepsy,MESH:D004827,0,,2,BDNF|STXBP1
axon target recognition,GO:0007412,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BDNF
baroreceptor detection of arterial stretch,GO:0001981,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
basal dendrite arborization,GO:0150020,Epilepsy,MESH:D004827,1,Methotrexate,0,
basal dendrite arborization,GO:0150020,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
basal dendrite arborization,GO:0150020,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
basal dendrite arborization,GO:0150020,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
base-excision repair,GO:0006284,Epilepsy,MESH:D004827,0,,1,POLG
"base-excision repair, gap-filling",GO:0006287,Epilepsy,MESH:D004827,0,,1,POLG
basement membrane organization,GO:0071711,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
basophil chemotaxis,GO:0002575,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
B cell activation,GO:0042113,"Epilepsy, Frontal Lobe",MESH:D017034,0,,2,CHRNA4|CHRNB2
B cell activation,GO:0042113,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
B cell activation,GO:0042113,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
B cell activation,GO:0042113,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
B cell homeostasis,GO:0001782,Epilepsy,MESH:D004827,0,,1,MEF2C
B cell proliferation,GO:0042100,Epilepsy,MESH:D004827,1,Plant Extracts,2,MEF2C|TSC2
B cell proliferation,GO:0042100,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNB2
B cell proliferation,GO:0042100,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
B cell proliferation,GO:0042100,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
B cell proliferation,GO:0042100,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
B cell receptor signaling pathway,GO:0050853,Epilepsy,MESH:D004827,0,,1,MEF2C
behavior,GO:0007610,Epilepsy,MESH:D004827,5,Atropine|Dronabinol|Fluoxetine|Pregabalin|Topiramate,1,KCNQ2
behavior,GO:0007610,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
behavior,GO:0007610,"Epilepsy, Complex Partial",MESH:D017029,1,Topiramate,0,
behavior,GO:0007610,"Epilepsy, Generalized",MESH:D004829,1,Pregabalin,0,
behavior,GO:0007610,"Epilepsy, Rolandic",MESH:D019305,1,Topiramate,0,
behavior,GO:0007610,"Epilepsy, Temporal Lobe",MESH:D004833,1,Topiramate,0,
behavior,GO:0007610,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Atropine|Topiramate,0,
behavioral defense response,GO:0002209,Epilepsy,MESH:D004827,1,Morphine,0,
behavioral defense response,GO:0002209,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Morphine,0,
behavioral fear response,GO:0001662,Epilepsy,MESH:D004827,3,Citalopram|Dronabinol|Folic Acid,6,BDNF|GRIN2B|MECP2|NPY2R|SLC1A1|VDAC1
behavioral fear response,GO:0001662,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,NPY2R|SLC1A1
behavioral fear response,GO:0001662,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Aluminum Hydroxide|Citalopram|Cocaine|Ethanol,1,BDNF
behavioral response to acetic acid induced pain,GO:0061367,Epilepsy,MESH:D004827,4,Dronabinol|Morphine|Naloxone|Plant Extracts,0,
behavioral response to acetic acid induced pain,GO:0061367,"Epilepsy, Absence",MESH:D004832,1,Naloxone,0,
behavioral response to acetic acid induced pain,GO:0061367,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,0,
behavioral response to acetic acid induced pain,GO:0061367,"Epilepsy, Temporal Lobe",MESH:D004833,2,Capsaicin|Plant Extracts,0,
behavioral response to acetic acid induced pain,GO:0061367,"Epilepsy, Tonic-Clonic",MESH:D004830,7,Acetaminophen|Diclofenac|Morphine|Naloxone|Plant Extracts|Sodium Chloride|Vincristine,0,
behavioral response to chemical pain,GO:0061366,Epilepsy,MESH:D004827,6,Dronabinol|Ketoconazole|makatoxin I|Morphine|Naloxone|Plant Extracts,0,
behavioral response to chemical pain,GO:0061366,"Epilepsy, Absence",MESH:D004832,1,Naloxone,0,
behavioral response to chemical pain,GO:0061366,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,0,
behavioral response to chemical pain,GO:0061366,"Epilepsy, Temporal Lobe",MESH:D004833,2,Capsaicin|Plant Extracts,0,
behavioral response to chemical pain,GO:0061366,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Dizocilpine Maleate|Morphine|Naloxone|Plant Extracts,0,
behavioral response to cocaine,GO:0048148,Epilepsy,MESH:D004827,1,Dronabinol,2,BDNF|FOSB
behavioral response to cocaine,GO:0048148,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Cocaine,1,BDNF
behavioral response to ethanol,GO:0048149,Epilepsy,MESH:D004827,1,Gabapentin,1,OPRM1
behavioral response to ethanol,GO:0048149,"Epilepsy, Complex Partial",MESH:D017029,1,Gabapentin,0,
behavioral response to ethanol,GO:0048149,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
behavioral response to ethanol,GO:0048149,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Buspirone|Ethanol|Gabapentin,1,FGF2
behavioral response to formalin induced pain,GO:0061368,Epilepsy,MESH:D004827,4,Dronabinol|Morphine|Naloxone|Plant Extracts,0,
behavioral response to formalin induced pain,GO:0061368,"Epilepsy, Absence",MESH:D004832,1,Naloxone,0,
behavioral response to formalin induced pain,GO:0061368,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,0,
behavioral response to formalin induced pain,GO:0061368,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
behavioral response to formalin induced pain,GO:0061368,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Dizocilpine Maleate|Morphine|Naloxone|Plant Extracts,0,
behavioral response to nicotine,GO:0035095,Epilepsy,MESH:D004827,1,Dronabinol,0,
behavioral response to nicotine,GO:0035095,"Epilepsy, Frontal Lobe",MESH:D017034,0,,2,CHRNA4|CHRNB2
behavioral response to nicotine,GO:0035095,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
behavioral response to nicotine,GO:0035095,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
behavioral response to nicotine,GO:0035095,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
behavioral response to nicotine,GO:0035095,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,GRM2
behavioral response to nicotine,GO:0035095,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Cocaine,0,
behavioral response to pain,GO:0048266,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
behavioral response to pain,GO:0048266,Epilepsy,MESH:D004827,14,"6-Cyano-7-nitroquinoxaline-2,3-dione|Cisplatin|Dexamethasone|Dronabinol|Gabapentin|Ketamine|Ketoconazole|Lidocaine|Methotrexate|Morphine|Muscimol|Naloxone|Plant Extracts|Valproic Acid",5,AKT1|CNTNAP2|GRIN2B|P2RX2|P2RX4
behavioral response to pain,GO:0048266,"Epilepsy, Absence",MESH:D004832,2,Naloxone|Valproic Acid,1,CACNA1A
behavioral response to pain,GO:0048266,"Epilepsy, Complex Partial",MESH:D017029,3,Gabapentin|Methotrexate|Valproic Acid,1,SCN3A
behavioral response to pain,GO:0048266,"Epilepsy, Generalized",MESH:D004829,2,Naloxone|Valproic Acid,0,
behavioral response to pain,GO:0048266,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
behavioral response to pain,GO:0048266,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
behavioral response to pain,GO:0048266,"Epilepsy, Temporal Lobe",MESH:D004833,4,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer|Methotrexate|Plant Extracts|Valproic Acid",2,P2RX4|TRPV1
behavioral response to pain,GO:0048266,"Epilepsy, Tonic-Clonic",MESH:D004830,13,Acetaminophen|Diclofenac|Dizocilpine Maleate|Fentanyl|Gabapentin|Lidocaine|Meperidine|Methotrexate|Morphine|Naloxone|Plant Extracts|Valproic Acid|Vincristine,0,
behavioral response to pain,GO:0048266,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
benzene-containing compound metabolic process,GO:0042537,Epilepsy,MESH:D004827,1,Cisplatin,1,TXNRD1
benzoate transport,GO:0042919,Epilepsy,MESH:D004827,1,Valproic Acid,0,
benzoate transport,GO:0042919,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
benzoate transport,GO:0042919,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
benzoate transport,GO:0042919,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
benzoate transport,GO:0042919,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
benzoate transport,GO:0042919,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
benzoate transport,GO:0042919,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
benzoate transport,GO:0042919,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
benzoate transport,GO:0042919,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
Bergmann glial cell differentiation,GO:0060020,Epilepsy,MESH:D004827,0,,1,GFAP
bicarbonate transport,GO:0015701,Epilepsy,MESH:D004827,0,,1,SLC4A10
bicarbonate transport,GO:0015701,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,SLC4A10
bile acid and bile salt transport,GO:0015721,Epilepsy,MESH:D004827,0,,1,SLCO1A5
bile acid and bile salt transport,GO:0015721,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chlorpromazine,0,
bile acid biosynthetic process,GO:0006699,Epilepsy,MESH:D004827,1,Dexamethasone,0,
bile acid biosynthetic process,GO:0006699,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
bile acid catabolic process,GO:0030573,Epilepsy,MESH:D004827,1,Ketoconazole,0,
bile acid metabolic process,GO:0008206,Epilepsy,MESH:D004827,4,Ampicillin|Ketoconazole|Phenobarbital|Vitamin B 6,0,
bile acid metabolic process,GO:0008206,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
bile acid metabolic process,GO:0008206,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
bile acid metabolic process,GO:0008206,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
bile acid metabolic process,GO:0008206,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
bile acid metabolic process,GO:0008206,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Acetaminophen|Diclofenac|Ethanol|Metronidazole|Phenobarbital,0,
bile acid secretion,GO:0032782,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
bile acid secretion,GO:0032782,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chlorpromazine,0,
bile acid signaling pathway,GO:0038183,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VDR
bilirubin transport,GO:0015723,Epilepsy,MESH:D004827,4,Folic Acid|Methotrexate|nimesulide|Plant Extracts,0,
bilirubin transport,GO:0015723,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
bilirubin transport,GO:0015723,"Epilepsy, Generalized",MESH:D004829,1,Prednisolone,0,
bilirubin transport,GO:0015723,"Epilepsy, Temporal Lobe",MESH:D004833,2,Methotrexate|Plant Extracts,0,
bilirubin transport,GO:0015723,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Acetaminophen|Methotrexate|Plant Extracts,0,
binding of sperm to zona pellucida,GO:0007339,Epilepsy,MESH:D004827,0,,1,VDAC2
biogenic amine metabolic process,GO:0006576,Epilepsy,MESH:D004827,0,,1,MECP2
biological_process,GO:0008150,Epilepsy,MESH:D004827,0,,3,ANKRD11|STAMBP|VDAC2
biological_process,GO:0008150,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 5",OMIM:614417,0,,1,CPA6
biological_process,GO:0008150,"Epilepsy, Myoclonic, Benign Adult Familial, Type 1",MESH:C563399,0,,1,SAMD12
biological_process,GO:0008150,"Epilepsy, Partial, with Variable Foci",MESH:C565785,0,,1,NPRL3
biological_process,GO:0008150,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,COX3
biological_process,GO:0008150,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
biological_process,GO:0008150,Pyridoxine-dependent epilepsy,MESH:C536254,0,,1,PLPBP
biological process involved in interaction with symbiont,GO:0051702,Epilepsy,MESH:D004827,0,,1,GPX1
biological process involved in symbiotic interaction,GO:0044403,Epilepsy,MESH:D004827,1,"Cilastatin, Imipenem Drug Combination",0,
biological process involved in symbiotic interaction,GO:0044403,"Epilepsy, Absence",MESH:D004832,2,"Cilastatin, Imipenem Drug Combination|Doxorubicin",0,
biological process involved in symbiotic interaction,GO:0044403,"Epilepsy, Tonic-Clonic",MESH:D004830,1,"Cilastatin, Imipenem Drug Combination",0,
blastocyst development,GO:0001824,Epilepsy,MESH:D004827,1,gamma-Aminobutyric Acid,0,
blastocyst formation,GO:0001825,Epilepsy,MESH:D004827,1,Dronabinol,0,
blastocyst growth,GO:0001832,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,1,HBEGF
blastoderm segmentation,GO:0007350,Epilepsy,MESH:D004827,0,,1,ALB
bleb assembly,GO:0032060,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
blood circulation,GO:0008015,Epilepsy,MESH:D004827,1,Haloperidol,0,
blood circulation,GO:0008015,"Epilepsy, Absence",MESH:D004832,1,Haloperidol,0,
blood circulation,GO:0008015,"Epilepsy, Temporal Lobe",MESH:D004833,1,Capsaicin,1,BDKRB2
blood circulation,GO:0008015,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Diclofenac|Haloperidol,0,
blood coagulation,GO:0007596,Epilepsy,MESH:D004827,1,Plant Extracts,0,
blood coagulation,GO:0007596,"Epilepsy, Absence",MESH:D004832,1,Heparin,0,
blood coagulation,GO:0007596,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
blood coagulation,GO:0007596,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Heparin|Plant Extracts,0,
"blood coagulation, fibrin clot formation",GO:0072378,Epilepsy,MESH:D004827,1,Calcium,0,
"blood coagulation, fibrin clot formation",GO:0072378,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
"blood coagulation, intrinsic pathway",GO:0007597,Epilepsy,MESH:D004827,1,Cisplatin,1,FLNA
blood vessel development,GO:0001568,Epilepsy,MESH:D004827,0,,2,ILK|MEF2C
blood vessel development,GO:0001568,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|VEGFA
blood vessel diameter maintenance,GO:0097746,Generalized Epilepsy and Paroxysmal Dyskinesia,MESH:C563719,0,,1,KCNMA1
blood vessel endothelial cell differentiation,GO:0060837,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
blood vessel endothelial cell migration,GO:0043534,Epilepsy,MESH:D004827,0,,1,GPX1
blood vessel morphogenesis,GO:0048514,Epilepsy,MESH:D004827,1,Penicillamine,1,SLC1A1
blood vessel morphogenesis,GO:0048514,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,SLC1A1|VEGFA
blood vessel remodeling,GO:0001974,Epilepsy,MESH:D004827,0,,2,FLNA|MEF2C
blood vessel remodeling,GO:0001974,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
BMP signaling pathway,GO:0030509,Epilepsy,MESH:D004827,0,,1,TGFB1
bone development,GO:0060348,Epilepsy,MESH:D004827,2,Chondroitin Sulfates|Dexamethasone,1,ANKRD11
bone development,GO:0060348,"Epilepsy, Generalized",MESH:D004829,1,Prednisolone,0,
bone development,GO:0060348,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Caffeine|Ethanol,0,
bone growth,GO:0098868,Epilepsy,MESH:D004827,1,Dexamethasone,0,
bone growth,GO:0098868,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Caffeine,0,
bone mineralization,GO:0030282,Epilepsy,MESH:D004827,1,Dexamethasone,1,CDKL5
bone mineralization,GO:0030282,"Epilepsy, Generalized",MESH:D004829,1,Prednisolone,0,
bone mineralization,GO:0030282,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Prednisone,0,
bone mineralization,GO:0030282,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
bone morphogenesis,GO:0060349,Epilepsy,MESH:D004827,1,Estrogens,0,
bone regeneration,GO:1990523,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Theophylline,0,
bone remodeling,GO:0046849,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Methamphetamine,0,
bone resorption,GO:0045453,Epilepsy,MESH:D004827,1,Estrogens,0,
bone resorption,GO:0045453,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Deferoxamine|Methylprednisolone,0,
bone trabecula formation,GO:0060346,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
bone trabecula morphogenesis,GO:0061430,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
brain-derived neurotrophic factor receptor signaling pathway,GO:0031547,Epilepsy,MESH:D004827,1,Plant Extracts,1,BDNF
brain-derived neurotrophic factor receptor signaling pathway,GO:0031547,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,2,KDR|TEK
brain-derived neurotrophic factor receptor signaling pathway,GO:0031547,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,1,BDNF
brain development,GO:0007420,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
brain development,GO:0007420,Epilepsy,MESH:D004827,1,Folic Acid,11,BDNF|CDKL5|CNTNAP2|FOXG1|GABRB3|GRIN2A|GRIN2B|KCNQ2|MECP2|SLC1A1|UBE3A
brain development,GO:0007420,"Epilepsy, Absence",MESH:D004832,0,,1,GABRB3
brain development,GO:0007420,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
brain development,GO:0007420,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
brain development,GO:0007420,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
brain development,GO:0007420,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
brain development,GO:0007420,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
brain development,GO:0007420,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
brain development,GO:0007420,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
brain development,GO:0007420,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Caffeine|Ethanol,3,BDNF|NES|NTF3
brain development,GO:0007420,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1",OMIM:614231,0,,1,IER3IP1
brain morphogenesis,GO:0048854,Epilepsy,MESH:D004827,0,,2,PCDH19|SLC4A10
brain morphogenesis,GO:0048854,"Epilepsy, Female-Restricted, with Mental Retardation",MESH:C564715,0,,1,PCDH19
brain morphogenesis,GO:0048854,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,SLC4A10
brain morphogenesis,GO:0048854,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
branch elongation involved in mammary gland duct branching,GO:0060751,Epilepsy,MESH:D004827,0,,1,TGFB1
branching involved in blood vessel morphogenesis,GO:0001569,"Epilepsy, Temporal Lobe",MESH:D004833,0,,3,KDR|TEK|VEGFA
branching involved in mammary gland duct morphogenesis,GO:0060444,Epilepsy,MESH:D004827,0,,1,SLC12A2
branching involved in mammary gland duct morphogenesis,GO:0060444,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
branching involved in ureteric bud morphogenesis,GO:0001658,Epilepsy,MESH:D004827,0,,1,ILK
branching involved in ureteric bud morphogenesis,GO:0001658,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
branching morphogenesis of an epithelial tube,GO:0048754,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
branching morphogenesis of an epithelial tube,GO:0048754,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|SLIT2
bronchiole development,GO:0060435,Epilepsy,MESH:D004827,0,,1,TGFB1
brown fat cell differentiation,GO:0050873,Epilepsy,MESH:D004827,1,Dexamethasone,0,
butyrate metabolic process,GO:0019605,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
C21-steroid hormone biosynthetic process,GO:0006700,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Caffeine|Ethanol,0,
C21-steroid hormone metabolic process,GO:0008207,Epilepsy,MESH:D004827,1,Ketoconazole,0,
C21-steroid hormone metabolic process,GO:0008207,"Epilepsy, Absence",MESH:D004832,1,Progesterone,0,
C-5 methylation of cytosine,GO:0090116,Epilepsy,MESH:D004827,1,Morphine,0,
C-5 methylation of cytosine,GO:0090116,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
C-5 methylation of cytosine,GO:0090116,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Morphine,0,
calcineurin-NFAT signaling cascade,GO:0033173,Epilepsy,MESH:D004827,0,,1,DYRK1A
calcitriol biosynthetic process from calciol,GO:0036378,Epilepsy,MESH:D004827,1,Ketoconazole,0,
calcium import into the mitochondrion,GO:0036444,Epilepsy,MESH:D004827,4,Dextroamphetamine|Lithium|Lithium Chloride|Valproic Acid,2,VDAC1|VDAC2
calcium import into the mitochondrion,GO:0036444,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
calcium import into the mitochondrion,GO:0036444,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
calcium import into the mitochondrion,GO:0036444,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
calcium import into the mitochondrion,GO:0036444,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
calcium import into the mitochondrion,GO:0036444,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
calcium import into the mitochondrion,GO:0036444,"Epilepsy, Temporal Lobe",MESH:D004833,3,Lithium|Lithium Chloride|Valproic Acid,0,
calcium import into the mitochondrion,GO:0036444,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Lithium|Lithium Chloride|Valproic Acid,0,
calcium import into the mitochondrion,GO:0036444,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
calcium ion export,GO:1901660,Epilepsy,MESH:D004827,1,Calcium,0,
calcium ion homeostasis,GO:0055074,Epilepsy,MESH:D004827,13,"Azathioprine|Calcium|Carbachol|Dexamethasone|Estrogens|Etoposide|Ketoconazole|Lithium|Methotrexate|N-Methyl-3,4-methylenedioxyamphetamine|Pilocarpine|Sevoflurane|Valproic Acid",0,
calcium ion homeostasis,GO:0055074,"Epilepsy, Absence",MESH:D004832,5,Doxorubicin|Heparin|Pilocarpine|Progesterone|Valproic Acid,0,
calcium ion homeostasis,GO:0055074,"Epilepsy, Complex Partial",MESH:D017029,2,Methotrexate|Valproic Acid,0,
calcium ion homeostasis,GO:0055074,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
calcium ion homeostasis,GO:0055074,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
calcium ion homeostasis,GO:0055074,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
calcium ion homeostasis,GO:0055074,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
calcium ion homeostasis,GO:0055074,"Epilepsy, Temporal Lobe",MESH:D004833,4,Lithium|Methotrexate|Pilocarpine|Valproic Acid,1,KDR
calcium ion homeostasis,GO:0055074,"Epilepsy, Tonic-Clonic",MESH:D004830,11,Acetaminophen|Chlorpromazine|Dizocilpine Maleate|Ethanol|Heparin|Lithium|Methotrexate|Methylprednisolone|Pilocarpine|Theophylline|Valproic Acid,0,
calcium ion homeostasis,GO:0055074,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
calcium ion import,GO:0070509,Epilepsy,MESH:D004827,5,"6-Cyano-7-nitroquinoxaline-2,3-dione|Calcium|Flumazenil|gamma-Aminobutyric Acid|Lidocaine",0,
calcium ion import,GO:0070509,"Epilepsy, Absence",MESH:D004832,0,,2,CACNA1A|CACNA1H
calcium ion import,GO:0070509,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
calcium ion import,GO:0070509,"Epilepsy, Temporal Lobe",MESH:D004833,1,Capsaicin,0,
calcium ion import,GO:0070509,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Dizocilpine Maleate|Lidocaine|Methamphetamine|Procaine|Tetracaine,0,
calcium ion import across plasma membrane,GO:0098703,Epilepsy,MESH:D004827,2,Ketamine|Methylmercury Compounds,0,
calcium ion import across plasma membrane,GO:0098703,"Epilepsy, Absence",MESH:D004832,0,,2,CACNA1A|CACNA1H
calcium ion import across plasma membrane,GO:0098703,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,P2RX7|TRPV1
calcium ion import across plasma membrane,GO:0098703,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Dizocilpine Maleate,0,
calcium ion import into cytosol,GO:1902656,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Dizocilpine Maleate,0,
calcium-ion regulated exocytosis,GO:0017156,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
calcium ion-regulated exocytosis of neurotransmitter,GO:0048791,Epilepsy,MESH:D004827,0,,2,SNAP25|STX1B
calcium ion-regulated exocytosis of neurotransmitter,GO:0048791,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
calcium ion-regulated exocytosis of neurotransmitter,GO:0048791,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9",OMIM:616172,0,,1,STX1B
calcium ion transmembrane import into cytosol,GO:0097553,Epilepsy,MESH:D004827,0,,2,GRIN2A|GRIN2B
calcium ion transmembrane import into cytosol,GO:0097553,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
calcium ion transmembrane import into cytosol,GO:0097553,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
calcium ion transmembrane transport,GO:0070588,Epilepsy,MESH:D004827,1,Calcium,5,GRIN2A|OPRM1|P2RX2|P2RX4|SMC1A
calcium ion transmembrane transport,GO:0070588,"Epilepsy, Absence",MESH:D004832,0,,3,CACNA1A|CACNA1H|CACNA2D2
calcium ion transmembrane transport,GO:0070588,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
calcium ion transmembrane transport,GO:0070588,"Epilepsy, Generalized",MESH:D004829,0,,2,CACNB4|CHRNA7
calcium ion transmembrane transport,GO:0070588,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CACNB4
calcium ion transmembrane transport,GO:0070588,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
calcium ion transmembrane transport,GO:0070588,"Epilepsy, Temporal Lobe",MESH:D004833,0,,3,P2RX4|P2RX7|TRPV1
calcium ion transmembrane transport,GO:0070588,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,CACNB4
calcium ion transport,GO:0006816,Epilepsy,MESH:D004827,3,Calcium|Dextroamphetamine|Ketamine,3,GRIN2A|GRIN2B|P2RX4
calcium ion transport,GO:0006816,"Epilepsy, Absence",MESH:D004832,0,,3,CACNA1A|CACNA1H|CACNA2D2
calcium ion transport,GO:0006816,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
calcium ion transport,GO:0006816,"Epilepsy, Frontal Lobe",MESH:D017034,0,,2,CHRNA4|CHRNB2
calcium ion transport,GO:0006816,"Epilepsy, Generalized",MESH:D004829,0,,2,CACNB4|CHRNA7
calcium ion transport,GO:0006816,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CACNB4
calcium ion transport,GO:0006816,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
calcium ion transport,GO:0006816,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
calcium ion transport,GO:0006816,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
calcium ion transport,GO:0006816,"Epilepsy, Temporal Lobe",MESH:D004833,0,,4,P2RX4|P2RX7|TRPV1|VDR
calcium ion transport,GO:0006816,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
calcium ion transport,GO:0006816,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,CACNB4
calcium-mediated signaling,GO:0019722,Epilepsy,MESH:D004827,18,4-Aminopyridine|Calcium|Carbachol|Dexamethasone|Estrogens|Gentamicins|Kainic Acid|Ketamine|Lidocaine|Maprotiline|Morphine|Norepinephrine|Pentobarbital|Sevoflurane|Thalidomide|Topiramate|Vitamin B 12|Xylazine,5,GRIN2A|GRIN2B|GRM1|P2RX4|POMC
calcium-mediated signaling,GO:0019722,"Epilepsy, Complex Partial",MESH:D017029,1,Topiramate,0,
calcium-mediated signaling,GO:0019722,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
calcium-mediated signaling,GO:0019722,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
calcium-mediated signaling,GO:0019722,"Epilepsy, Rolandic",MESH:D019305,1,Topiramate,1,GRIN2A
calcium-mediated signaling,GO:0019722,"Epilepsy, Temporal Lobe",MESH:D004833,3,Capsaicin|Kainic Acid|Topiramate,6,BDKRB1|BDKRB2|GRM1|P2RX4|P2RX7|TRPV1
calcium-mediated signaling,GO:0019722,"Epilepsy, Tonic-Clonic",MESH:D004830,14,Caffeine|Chlorambucil|chloroprocaine|Diclofenac|Dinoprost|Dizocilpine Maleate|Lidocaine|Maprotiline|Methylprednisolone|Morphine|Procaine|Ropivacaine|Tetracaine|Topiramate,1,POMC
calcium-mediated signaling using intracellular calcium source,GO:0035584,Epilepsy,MESH:D004827,1,Calcium,0,
calcium-mediated signaling using intracellular calcium source,GO:0035584,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
camera-type eye development,GO:0043010,Pyridoxine-dependent epilepsy,MESH:C536254,0,,1,ALDH7A1
camera-type eye morphogenesis,GO:0048593,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
cAMP biosynthetic process,GO:0006171,Epilepsy,MESH:D004827,8,Adenosine|Atropine|Carbachol|Dronabinol|Ketoconazole|Morphine|Naloxone|Norepinephrine,0,
cAMP biosynthetic process,GO:0006171,"Epilepsy, Absence",MESH:D004832,1,Naloxone,0,
cAMP biosynthetic process,GO:0006171,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,0,
cAMP biosynthetic process,GO:0006171,"Epilepsy, Tonic-Clonic",MESH:D004830,11,Adenosine|Aluminum|Atropine|Caffeine|Chloroquine|Dinoprost|Ethanol|Morphine|Naloxone|Paraoxon|Phenylpropanolamine,0,
cAMP catabolic process,GO:0006198,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Theophylline,0,
cAMP-mediated signaling,GO:0019933,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 8",OMIM:616461,0,,1,GAL
cAMP metabolic process,GO:0046058,Epilepsy,MESH:D004827,4,Cisplatin|Dronabinol|Methimazole|Pentylenetetrazole,0,
cAMP metabolic process,GO:0046058,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Pentylenetetrazole,0,
cAMP metabolic process,GO:0046058,"Epilepsy, Generalized",MESH:D004829,0,,1,CACNB4
cAMP metabolic process,GO:0046058,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CACNB4
cAMP metabolic process,GO:0046058,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Caffeine|Ethanol|Pentylenetetrazole,0,
cAMP metabolic process,GO:0046058,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,CACNB4
cAMP transport,GO:0070730,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Aminophylline,0,
cannabinoid signaling pathway,GO:0038171,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,CNR1
canonical Wnt signaling pathway,GO:0060070,Epilepsy,MESH:D004827,0,,1,TGFB1
canonical Wnt signaling pathway,GO:0060070,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Disulfiram,1,FGF2
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,GO:0044338,Epilepsy,MESH:D004827,1,Methotrexate,0,
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,GO:0044338,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,GO:0044338,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,GO:0044338,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
carbohydrate derivative metabolic process,GO:1901135,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
carbohydrate metabolic process,GO:0005975,Epilepsy,MESH:D004827,1,Cisplatin,0,
carbohydrate metabolic process,GO:0005975,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
carbohydrate metabolic process,GO:0005975,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 8",OMIM:616461,0,,1,GAL
carbohydrate metabolic process,GO:0005975,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
carboxylic acid metabolic process,GO:0019752,Epilepsy,MESH:D004827,3,gamma-Aminobutyric Acid|malic acid|Methotrexate,0,
carboxylic acid metabolic process,GO:0019752,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
carboxylic acid metabolic process,GO:0019752,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
carboxylic acid metabolic process,GO:0019752,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
carboxylic acid metabolic process,GO:0019752,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
carboxylic acid transmembrane transport,GO:1905039,Epilepsy,MESH:D004827,0,,1,ABCB1
cardiac conduction,GO:0061337,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",MESH:C565809,0,,1,SCN1B
cardiac left ventricle formation,GO:0003218,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cardiac left ventricle morphogenesis,GO:0003214,Epilepsy,MESH:D004827,0,,1,NPY2R
cardiac left ventricle morphogenesis,GO:0003214,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,NPY2R
cardiac muscle atrophy,GO:0014899,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cardiac muscle cell action potential,GO:0086001,Epilepsy,MESH:D004827,1,Dronabinol,0,
cardiac muscle cell action potential,GO:0086001,"Epilepsy, Complex Partial",MESH:D017029,1,Trazodone,0,
cardiac muscle cell action potential,GO:0086001,"Epilepsy, Generalized",MESH:D004829,1,Trazodone,0,
cardiac muscle cell action potential involved in contraction,GO:0086002,Epilepsy,MESH:D004827,0,,1,SCN1A
cardiac muscle cell action potential involved in contraction,GO:0086002,"Epilepsy, Generalized",MESH:D004829,0,,1,SCN1A
cardiac muscle cell action potential involved in contraction,GO:0086002,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",MESH:C565809,0,,1,SCN1B
cardiac muscle cell action potential involved in contraction,GO:0086002,"Generalized Epilepsy With Febrile Seizures Plus, Type 2",MESH:C565810,0,,1,SCN1A
cardiac muscle cell contraction,GO:0086003,Epilepsy,MESH:D004827,5,Amitriptyline|Calcium|Clonidine|Epinephrine|Haloperidol,0,
cardiac muscle cell contraction,GO:0086003,"Epilepsy, Absence",MESH:D004832,3,Doxorubicin|Haloperidol|Progesterone,0,
cardiac muscle cell contraction,GO:0086003,"Epilepsy, Tonic-Clonic",MESH:D004830,9,Amitriptyline|Caffeine|Chloroquine|Clonidine|Epinephrine|Ethanol|Haloperidol|Paroxetine|Tetracaine,0,
cardiac muscle cell development,GO:0055013,Epilepsy,MESH:D004827,0,,2,HNRNPU|ILK
cardiac muscle cell development,GO:0055013,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
cardiac muscle cell development,GO:0055013,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
cardiac muscle cell differentiation,GO:0055007,Epilepsy,MESH:D004827,2,Ketoconazole|Valproic Acid,2,MEF2C|TSC1
cardiac muscle cell differentiation,GO:0055007,"Epilepsy, Absence",MESH:D004832,2,Progesterone|Valproic Acid,0,
cardiac muscle cell differentiation,GO:0055007,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
cardiac muscle cell differentiation,GO:0055007,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
cardiac muscle cell differentiation,GO:0055007,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cardiac muscle cell differentiation,GO:0055007,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cardiac muscle cell differentiation,GO:0055007,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
cardiac muscle cell differentiation,GO:0055007,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
cardiac muscle cell differentiation,GO:0055007,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cardiac muscle cell proliferation,GO:0060038,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
cardiac muscle contraction,GO:0060048,Epilepsy,MESH:D004827,6,Atropine|Calcium|Naloxone|Norepinephrine|Pentobarbital|Sevoflurane,0,
cardiac muscle contraction,GO:0060048,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Naloxone,0,
cardiac muscle contraction,GO:0060048,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,0,
cardiac muscle contraction,GO:0060048,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Atropine|Enflurane|Naloxone|Theophylline|Thiopental,0,
cardiac muscle contraction,GO:0060048,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",MESH:C565809,0,,1,SCN1B
cardiac muscle hypertrophy,GO:0003300,Epilepsy,MESH:D004827,0,,1,DYRK1A
cardiac muscle hypertrophy,GO:0003300,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cardiac muscle hypertrophy,GO:0003300,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
cardiac muscle hypertrophy in response to stress,GO:0014898,Epilepsy,MESH:D004827,0,,1,MEF2C
cardiac muscle tissue development,GO:0048738,"Epilepsy, Partial, with Variable Foci",MESH:C565785,0,,1,NPRL3
cardiac myofibril assembly,GO:0055003,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cardiac neural crest cell differentiation involved in heart development,GO:0061307,Epilepsy,MESH:D004827,0,,1,ANKRD11
cardiac neural crest cell migration involved in outflow tract morphogenesis,GO:0003253,Epilepsy,MESH:D004827,0,,1,FOLR1
cardiac vascular smooth muscle cell development,GO:0060948,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
cardiac ventricle formation,GO:0003211,Epilepsy,MESH:D004827,0,,2,ILK|MEF2C
cardiolipin biosynthetic process,GO:0032049,Epilepsy,MESH:D004827,1,Cisplatin,0,
cardiolipin metabolic process,GO:0032048,Epilepsy,MESH:D004827,0,,1,MECP2
carnitine metabolic process,GO:0009437,Epilepsy,MESH:D004827,2,Cisplatin|Dronabinol,0,
carnitine metabolic process,GO:0009437,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
carnitine transmembrane transport,GO:1902603,Epilepsy,MESH:D004827,1,Clozapine,0,
carnitine transmembrane transport,GO:1902603,"Epilepsy, Complex Partial",MESH:D017029,1,Clozapine,0,
carnitine transmembrane transport,GO:1902603,"Epilepsy, Generalized",MESH:D004829,1,Clozapine,0,
carnitine transmembrane transport,GO:1902603,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Caffeine|Clozapine,0,
carnitine transport,GO:0015879,Epilepsy,MESH:D004827,1,Cisplatin,0,
carnosine metabolic process,GO:0035498,Epilepsy,MESH:D004827,1,Cisplatin,0,
carnosine metabolic process,GO:0035498,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cartilage development,GO:0051216,Epilepsy,MESH:D004827,2,Dexamethasone|Valproic Acid,1,CDKL5
cartilage development,GO:0051216,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
cartilage development,GO:0051216,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
cartilage development,GO:0051216,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
cartilage development,GO:0051216,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cartilage development,GO:0051216,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cartilage development,GO:0051216,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
cartilage development,GO:0051216,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Valproic Acid,0,
cartilage development,GO:0051216,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cartilage development,GO:0051216,Pyridoxine-dependent epilepsy,MESH:C536254,0,,1,ALDH7A1
cartilage morphogenesis,GO:0060536,Epilepsy,MESH:D004827,1,Ketamine,1,MEF2C
catagen,GO:0042637,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
catecholamine secretion,GO:0050432,Epilepsy,MESH:D004827,0,,1,MECP2
caveola assembly,GO:0070836,Epilepsy,MESH:D004827,0,,1,ILK
"CD4-positive, alpha-beta T cell cytokine production",GO:0035743,Epilepsy,MESH:D004827,1,Carbamazepine,0,
"CD4-positive, alpha-beta T cell cytokine production",GO:0035743,"Epilepsy, Absence",MESH:D004832,1,Carbamazepine,0,
"CD4-positive, alpha-beta T cell cytokine production",GO:0035743,"Epilepsy, Complex Partial",MESH:D017029,1,Carbamazepine,0,
"CD4-positive, alpha-beta T cell cytokine production",GO:0035743,"Epilepsy, Generalized",MESH:D004829,1,Carbamazepine,0,
"CD4-positive, alpha-beta T cell cytokine production",GO:0035743,"Epilepsy, Rolandic",MESH:D019305,1,Carbamazepine,0,
"CD4-positive, alpha-beta T cell cytokine production",GO:0035743,"Epilepsy, Temporal Lobe",MESH:D004833,1,Carbamazepine,0,
"CD4-positive, alpha-beta T cell cytokine production",GO:0035743,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Carbamazepine,0,
"CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment",GO:0002362,Epilepsy,MESH:D004827,0,,1,TGFB1
CD80 biosynthetic process,GO:0035780,Epilepsy,MESH:D004827,1,Plant Extracts,0,
CD80 biosynthetic process,GO:0035780,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
CD80 biosynthetic process,GO:0035780,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
CD86 biosynthetic process,GO:0035781,Epilepsy,MESH:D004827,1,Plant Extracts,0,
CD86 biosynthetic process,GO:0035781,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
CD86 biosynthetic process,GO:0035781,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
cell-abiotic substrate adhesion,GO:0036164,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cell-abiotic substrate adhesion,GO:0036164,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
cell activation,GO:0001775,Epilepsy,MESH:D004827,1,Carbachol,1,TGFB1
cell adhesion,GO:0007155,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
cell adhesion,GO:0007155,Epilepsy,MESH:D004827,2,Folic Acid|Plant Extracts,4,CNTNAP2|ERN1|FOLR1|PCDH19
cell adhesion,GO:0007155,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
cell adhesion,GO:0007155,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
cell adhesion,GO:0007155,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
cell adhesion,GO:0007155,"Epilepsy, Female-Restricted, with Mental Retardation",MESH:C564715,0,,1,PCDH19
cell adhesion,GO:0007155,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
cell adhesion,GO:0007155,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Aluminum|Plant Extracts,0,
cell adhesion,GO:0007155,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",MESH:C565809,0,,1,SCN1B
cell adhesion,GO:0007155,"Rolandic Epilepsy, Mental Retardation, and Speech Dyspraxia, X-Linked",MESH:C564467,0,,1,SRPX2
cell aggregation,GO:0098743,Epilepsy,MESH:D004827,2,Cisplatin|Plant Extracts,0,
cell aggregation,GO:0098743,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cell aggregation,GO:0098743,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
cell aggregation,GO:0098743,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Aluminum|Chlorpromazine|Diclofenac|Plant Extracts,0,
cell-cell adhesion,GO:0098609,Epilepsy,MESH:D004827,4,Cisplatin|Dexamethasone|Plant Extracts|Sevoflurane,1,PCDH19
cell-cell adhesion,GO:0098609,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
cell-cell adhesion,GO:0098609,"Epilepsy, Female-Restricted, with Mental Retardation",MESH:C564715,0,,1,PCDH19
cell-cell adhesion,GO:0098609,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,3,SLIT2|TEK|VEGFA
cell-cell adhesion,GO:0098609,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Chloroquine|Plant Extracts,0,
cell-cell adhesion,GO:0098609,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
cell-cell adhesion,GO:0098609,"Rolandic Epilepsy, Mental Retardation, and Speech Dyspraxia, X-Linked",MESH:C564467,0,,1,SRPX2
cell-cell fusion,GO:0140253,Epilepsy,MESH:D004827,1,Valproic Acid,0,
cell-cell fusion,GO:0140253,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
cell-cell fusion,GO:0140253,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
cell-cell fusion,GO:0140253,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
cell-cell fusion,GO:0140253,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cell-cell fusion,GO:0140253,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cell-cell fusion,GO:0140253,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
cell-cell fusion,GO:0140253,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
cell-cell fusion,GO:0140253,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cell-cell junction assembly,GO:0007043,Epilepsy,MESH:D004827,1,Calcium,0,
cell-cell junction organization,GO:0045216,Epilepsy,MESH:D004827,0,,2,FLNA|TGFB1
cell-cell signaling,GO:0007267,Epilepsy,MESH:D004827,0,,1,POMC
cell-cell signaling,GO:0007267,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TEK
cell-cell signaling,GO:0007267,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,2,NTF3|POMC
cell-cell signaling via exosome,GO:0099156,Epilepsy,MESH:D004827,1,Cisplatin,0,
cell-cell signaling via exosome,GO:0099156,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Methamphetamine,0,
cell chemotaxis,GO:0060326,Epilepsy,MESH:D004827,17,Calcium|Cisplatin|Clonidine|Dexamethasone|Diazepam|Dronabinol|Folic Acid|Lithium Chloride|Magnesium|Morphine|Naloxone|Norepinephrine|Phentolamine|Plant Extracts|Propofol|Sevoflurane|Valproic Acid,0,
cell chemotaxis,GO:0060326,"Epilepsy, Absence",MESH:D004832,5,Diazepam|Doxorubicin|Heparin|Naloxone|Valproic Acid,0,
cell chemotaxis,GO:0060326,"Epilepsy, Complex Partial",MESH:D017029,2,Diazepam|Valproic Acid,0,
cell chemotaxis,GO:0060326,"Epilepsy, Generalized",MESH:D004829,4,Diazepam|Naloxone|Propofol|Valproic Acid,0,
cell chemotaxis,GO:0060326,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cell chemotaxis,GO:0060326,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cell chemotaxis,GO:0060326,"Epilepsy, Temporal Lobe",MESH:D004833,3,Lithium Chloride|Plant Extracts|Valproic Acid,3,BDKRB1|BDKRB2|VEGFA
cell chemotaxis,GO:0060326,"Epilepsy, Tonic-Clonic",MESH:D004830,17,Acetaminophen|Aluminum|chloroprocaine|Chloroquine|Clonidine|Diazepam|Diclofenac|Dinoprost|Heparin|Lithium Chloride|Morphine|Naloxone|Plant Extracts|Propofol|Ropivacaine|Tetracaine|Valproic Acid,1,HBEGF
cell chemotaxis,GO:0060326,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cell communication,GO:0007154,Epilepsy,MESH:D004827,1,Methylmercury Compounds,3,CDKL5|GRM1|NPY2R
cell communication,GO:0007154,"Epilepsy, Temporal Lobe",MESH:D004833,0,,7,CNR1|GRM1|GRM2|GRM3|GRM4|GRM5|NPY2R
cell cycle,GO:0007049,Epilepsy,MESH:D004827,18,Ciprofloxacin|Cisplatin|Cytarabine|Dexamethasone|Estrogens|Etoposide|Lidocaine|Lithium|Lithium Chloride|Methimazole|Methotrexate|Morphine|nimesulide|Penicillamine|Pentobarbital|Plant Extracts|Thalidomide|Valproic Acid,1,FOXG1
cell cycle,GO:0007049,"Epilepsy, Absence",MESH:D004832,3,Doxorubicin|Heparin|Valproic Acid,0,
cell cycle,GO:0007049,"Epilepsy, Complex Partial",MESH:D017029,2,Methotrexate|Valproic Acid,0,
cell cycle,GO:0007049,"Epilepsy, Generalized",MESH:D004829,3,Prednisolone|Valproic Acid|Zidovudine,0,
cell cycle,GO:0007049,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cell cycle,GO:0007049,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cell cycle,GO:0007049,"Epilepsy, Temporal Lobe",MESH:D004833,7,Capsaicin|Lithium|Lithium Chloride|Methotrexate|Plant Extracts|Tacrolimus|Valproic Acid,0,
cell cycle,GO:0007049,"Epilepsy, Tonic-Clonic",MESH:D004830,20,Acetaminophen|Caffeine|Chloroquine|Ciprofloxacin|Cocaine|Deferoxamine|Heparin|Lidocaine|Lithium|Lithium Chloride|Mechlorethamine|Melphalan|Methotrexate|Morphine|Plant Extracts|Pyridoxal Phosphate|Quinine|Tacrolimus|Valproic Acid|Vincristine,0,
cell cycle,GO:0007049,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cell cycle G1/S phase transition,GO:0044843,Epilepsy,MESH:D004827,1,Cisplatin,0,
cell cycle G1/S phase transition,GO:0044843,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cell death,GO:0008219,Epilepsy,MESH:D004827,57,"4-Aminopyridine|6-Cyano-7-nitroquinoxaline-2,3-dione|Adenosine|Aminooxyacetic Acid|Amitriptyline|Atropine|Azathioprine|Busulfan|Calcium|Carbamazepine|Chloramphenicol|Cimetidine|Cisplatin|Clonazepam|Clonidine|Clozapine|Cytarabine|Dexamethasone|Diazepam|Dronabinol|Estrogens|Ethosuximide|Etoposide|Excitatory Amino Acid Agents|Fluoxetine|Folic Acid|gamma-Aminobutyric Acid|Gentamicins|Griseofulvin|Haloperidol|Imipramine|Kainic Acid|Ketamine|Ketoconazole|Lidocaine|Lithium|Lithium Chloride|Magnesium|Maprotiline|Methimazole|Methotrexate|Methylmercury Compounds|Morphine|Naloxone|nimesulide|N-Methyl-3,4-methylenedioxyamphetamine|Norepinephrine|Penicillamine|Phenobarbital|Phenytoin|Pilocarpine|Plant Extracts|Sevoflurane|Strychnine|Thalidomide|Topiramate|Valproic Acid",0,
cell death,GO:0008219,"Epilepsy, Absence",MESH:D004832,14,Carbamazepine|Clonazepam|Diazepam|Doxorubicin|Ethosuximide|Haloperidol|Heparin|Naloxone|Phenobarbital|Phenytoin|Pilocarpine|Progesterone|Riluzole|Valproic Acid,0,
cell death,GO:0008219,"Epilepsy, Complex Partial",MESH:D017029,9,Carbamazepine|Clonazepam|Clozapine|Diazepam|Methotrexate|Phenobarbital|Phenytoin|Topiramate|Valproic Acid,0,
cell death,GO:0008219,"Epilepsy, Generalized",MESH:D004829,8,Carbamazepine|Clozapine|Diazepam|Naloxone|Phenobarbital|Phenytoin|Valproic Acid|Zidovudine,0,
cell death,GO:0008219,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
cell death,GO:0008219,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cell death,GO:0008219,"Epilepsy, Rolandic",MESH:D019305,3,Carbamazepine|Topiramate|Valproic Acid,0,
cell death,GO:0008219,"Epilepsy, Temporal Lobe",MESH:D004833,15,Capsaicin|Carbamazepine|Clioquinol|Clonazepam|Kainic Acid|Lithium|Lithium Chloride|Methotrexate|Phenobarbital|Phenytoin|Pilocarpine|Plant Extracts|Tacrolimus|Topiramate|Valproic Acid,0,
cell death,GO:0008219,"Epilepsy, Tonic-Clonic",MESH:D004830,57,Acetaminophen|Adenosine|Aluminum|Amitriptyline|Atropine|Bupivacaine|Bupropion|Busulfan|Caffeine|Carbamazepine|Chlorambucil|Chloroquine|Chlorpromazine|Cimetidine|Clonazepam|Clonidine|Clozapine|Cocaine|Deferoxamine|Diazepam|Diclofenac|Disulfiram|Dizocilpine Maleate|Ethanol|Ethosuximide|Haloperidol|Heparin|Hexachlorocyclohexane|Imipramine|Lidocaine|Lithium|Lithium Chloride|Maprotiline|Mefloquine|Melphalan|Methamphetamine|Methotrexate|Methylprednisolone|Morphine|Naloxone|Nortriptyline|Phenelzine|Phenobarbital|Phenytoin|Pilocarpine|Plant Extracts|Pyridoxal Phosphate|Quinine|Soman|Tacrolimus|Tetracaine|Theophylline|Thiopental|Topiramate|Valproic Acid|Venlafaxine Hydrochloride|Vincristine,0,
cell death,GO:0008219,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cell development,GO:0048468,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
cell differentiation,GO:0030154,Epilepsy,MESH:D004827,15,Calcium|Chloramphenicol|Clozapine|Cytarabine|Dexamethasone|Estrogens|Etoposide|Lithium|Morphine|nimesulide|Norepinephrine|Pentobarbital|Plant Extracts|Thalidomide|Valproic Acid,3,AKT1|DDX3X|MEF2C
cell differentiation,GO:0030154,"Epilepsy, Absence",MESH:D004832,3,Heparin|Progesterone|Valproic Acid,0,
cell differentiation,GO:0030154,"Epilepsy, Complex Partial",MESH:D017029,2,Clozapine|Valproic Acid,0,
cell differentiation,GO:0030154,"Epilepsy, Generalized",MESH:D004829,2,Clozapine|Valproic Acid,0,
cell differentiation,GO:0030154,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cell differentiation,GO:0030154,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cell differentiation,GO:0030154,"Epilepsy, Temporal Lobe",MESH:D004833,6,Capsaicin|Lithium|Medroxyprogesterone Acetate|Plant Extracts|Tacrolimus|Valproic Acid,4,KDR|SLIT2|VDR|VEGFA
cell differentiation,GO:0030154,"Epilepsy, Tonic-Clonic",MESH:D004830,15,Caffeine|Chloroquine|Clozapine|Cocaine|Deferoxamine|Diclofenac|Ethanol|Heparin|Lithium|Morphine|Plant Extracts|Quinine|Sodium Chloride|Tacrolimus|Valproic Acid,1,FGF2
cell differentiation,GO:0030154,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cell differentiation involved in salivary gland development,GO:0060689,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CLCN2
cell division,GO:0051301,Epilepsy,MESH:D004827,0,,2,HNRNPU|SMC1A
cell division,GO:0051301,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Vincristine,0,
cell fate commitment,GO:0045165,Epilepsy,MESH:D004827,0,,1,MEF2C
cell fate commitment,GO:0045165,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
cell growth,GO:0016049,Epilepsy,MESH:D004827,17,Ampicillin|Azathioprine|Carbamazepine|Chondroitin Sulfates|Cisplatin|Dexamethasone|Etoposide|Fluoxetine|Folic Acid|Gentamicins|Ketoconazole|Lithium Chloride|Methotrexate|Methylmercury Compounds|Plant Extracts|Thalidomide|Valproic Acid,0,
cell growth,GO:0016049,"Epilepsy, Absence",MESH:D004832,3,Carbamazepine|Doxorubicin|Valproic Acid,0,
cell growth,GO:0016049,"Epilepsy, Complex Partial",MESH:D017029,3,Carbamazepine|Methotrexate|Valproic Acid,0,
cell growth,GO:0016049,"Epilepsy, Generalized",MESH:D004829,2,Carbamazepine|Valproic Acid,0,
cell growth,GO:0016049,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cell growth,GO:0016049,"Epilepsy, Rolandic",MESH:D019305,2,Carbamazepine|Valproic Acid,0,
cell growth,GO:0016049,"Epilepsy, Temporal Lobe",MESH:D004833,6,Capsaicin|Carbamazepine|Lithium Chloride|Methotrexate|Plant Extracts|Valproic Acid,0,
cell growth,GO:0016049,"Epilepsy, Tonic-Clonic",MESH:D004830,18,Acetaminophen|Caffeine|Carbamazepine|Chloroquine|Chlorpromazine|Cocaine|Deferoxamine|Diclofenac|Dizocilpine Maleate|Ethanol|Lithium Chloride|Mebendazole|Methotrexate|Plant Extracts|Ropivacaine|Valproic Acid|Venlafaxine Hydrochloride|Vincristine,0,
cell growth,GO:0016049,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cell killing,GO:0001906,Epilepsy,MESH:D004827,1,Cisplatin,0,
cell killing,GO:0001906,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cell-matrix adhesion,GO:0007160,Epilepsy,MESH:D004827,0,,2,ILK|TSC1
cell-matrix adhesion,GO:0007160,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
cell-matrix adhesion,GO:0007160,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TEK
cell maturation,GO:0048469,Epilepsy,MESH:D004827,1,Dronabinol,0,
cell maturation,GO:0048469,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
cell maturation,GO:0048469,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
cell maturation,GO:0048469,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1",OMIM:614231,0,,1,IER3IP1
cell migration,GO:0016477,Epilepsy,MESH:D004827,11,Carbamazepine|Cisplatin|Clozapine|Dexamethasone|Dronabinol|Folic Acid|Gentamicins|Lithium Chloride|Phenytoin|Plant Extracts|Valproic Acid,0,
cell migration,GO:0016477,"Epilepsy, Absence",MESH:D004832,5,Carbamazepine|Doxorubicin|Phenytoin|Progesterone|Valproic Acid,0,
cell migration,GO:0016477,"Epilepsy, Complex Partial",MESH:D017029,4,Carbamazepine|Clozapine|Phenytoin|Valproic Acid,0,
cell migration,GO:0016477,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
cell migration,GO:0016477,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
cell migration,GO:0016477,"Epilepsy, Generalized",MESH:D004829,4,Carbamazepine|Clozapine|Phenytoin|Valproic Acid,0,
cell migration,GO:0016477,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cell migration,GO:0016477,"Epilepsy, Rolandic",MESH:D019305,2,Carbamazepine|Valproic Acid,0,
cell migration,GO:0016477,"Epilepsy, Temporal Lobe",MESH:D004833,6,Carbamazepine|Clioquinol|Lithium Chloride|Phenytoin|Plant Extracts|Valproic Acid,3,BDKRB1|KDR|VEGFA
cell migration,GO:0016477,"Epilepsy, Tonic-Clonic",MESH:D004830,10,Aluminum|Carbamazepine|Chlorambucil|Clozapine|Ethanol|Lithium Chloride|Mebendazole|Phenytoin|Plant Extracts|Valproic Acid,1,HBEGF
cell migration,GO:0016477,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cell migration,GO:0016477,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
cell migration involved in sprouting angiogenesis,GO:0002042,Epilepsy,MESH:D004827,0,,1,AKT1
cell migration involved in sprouting angiogenesis,GO:0002042,"Epilepsy, Temporal Lobe",MESH:D004833,0,,3,KDR|SLIT2|VEGFA
cell migration involved in sprouting angiogenesis,GO:0002042,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
cell migration involved in vasculogenesis,GO:0035441,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
cell morphogenesis,GO:0000902,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
cell morphogenesis,GO:0000902,Epilepsy,MESH:D004827,2,Methylmercury Compounds|Plant Extracts,4,CERT1|CNTNAP2|ILK|TGFB1
cell morphogenesis,GO:0000902,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cell morphogenesis,GO:0000902,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
cell morphogenesis,GO:0000902,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
cell morphogenesis,GO:0000902,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,2,P2RX7|VDR
cell morphogenesis,GO:0000902,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
cell morphogenesis involved in neuron differentiation,GO:0048667,Epilepsy,MESH:D004827,0,,3,FOXG1|MEF2C|SLC1A3
cell morphogenesis involved in neuron differentiation,GO:0048667,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Paraoxon,0,
cell motility,GO:0048870,"Rolandic Epilepsy, Mental Retardation, and Speech Dyspraxia, X-Linked",MESH:C564467,0,,1,SRPX2
cell population proliferation,GO:0008283,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
cell population proliferation,GO:0008283,Epilepsy,MESH:D004827,60,"Adenosine|Amitriptyline|Amphetamine|Atropine|Busulfan|Calcium|Carbachol|Cimetidine|Ciprofloxacin|Cisplatin|Citalopram|Clonazepam|Clozapine|Cytarabine|Dexamethasone|Diazepam|Dronabinol|Epinephrine|Estrogens|Etoposide|Excitatory Amino Acid Agents|Fluoxetine|Folic Acid|Gentamicins|Griseofulvin|Ifosfamide|Imipramine|Kainic Acid|Ketamine|Ketoconazole|Lidocaine|Lithium|Lithium Chloride|Maprotiline|Metaraminol|Methimazole|Methotrexate|Methylmercury Compounds|Morphine|Naloxone|nimesulide|N-Methyl-3,4-methylenedioxyamphetamine|Norepinephrine|Penicillamine|Pentobarbital|Pentylenetetrazole|Phenobarbital|Phentolamine|Phenytoin|Pilocarpine|Plant Extracts|Pregabalin|Propofol|rufinamide|Sevoflurane|Thalidomide|Topiramate|Valproic Acid|Vitamin B 12|Vitamin U",10,AKT1|CERT1|CNTNAP2|ILK|MECP2|PURA|TGFB1|TSC1|TSC2|TXNRD1
cell population proliferation,GO:0008283,"Epilepsy, Absence",MESH:D004832,12,Clonazepam|Diazepam|Doxorubicin|Heparin|Naloxone|Pentylenetetrazole|Phenobarbital|Phenytoin|Pilocarpine|Progesterone|Riluzole|Valproic Acid,0,
cell population proliferation,GO:0008283,"Epilepsy, Complex Partial",MESH:D017029,8,Clonazepam|Clozapine|Diazepam|Methotrexate|Phenobarbital|Phenytoin|Topiramate|Valproic Acid,0,
cell population proliferation,GO:0008283,"Epilepsy, Generalized",MESH:D004829,10,Clozapine|Diazepam|Naloxone|Phenobarbital|Phenytoin|Prednisolone|Pregabalin|Propofol|Valproic Acid|Zidovudine,0,
cell population proliferation,GO:0008283,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
cell population proliferation,GO:0008283,"Epilepsy, Reflex",MESH:D020195,2,Polychlorinated Biphenyls|Valproic Acid,0,
cell population proliferation,GO:0008283,"Epilepsy, Rolandic",MESH:D019305,2,Topiramate|Valproic Acid,0,
cell population proliferation,GO:0008283,"Epilepsy, Temporal Lobe",MESH:D004833,16,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer|Capsaicin|Clioquinol|Clonazepam|Kainic Acid|Lithium|Lithium Chloride|Medroxyprogesterone Acetate|Methotrexate|Phenobarbital|Phenytoin|Pilocarpine|Plant Extracts|Tacrolimus|Topiramate|Valproic Acid",1,VEGFA
cell population proliferation,GO:0008283,"Epilepsy, Tonic-Clonic",MESH:D004830,60,Acetaminophen|Adenosine|Aluminum Hydroxide|Amitriptyline|Atropine|Busulfan|Caffeine|cefodizime|chloroprocaine|Chloroquine|Chlorpromazine|Cimetidine|Ciprofloxacin|Citalopram|Clomiphene|Clonazepam|Clozapine|Cocaine|Deferoxamine|Diazepam|Diclofenac|Dinoprost|Disulfiram|Dizocilpine Maleate|Epinephrine|Ethanol|Heparin|Imipramine|Lidocaine|Lithium|Lithium Chloride|Maprotiline|Mebendazole|Mechlorethamine|Melphalan|Methamphetamine|Methotrexate|Morphine|Naloxone|Paraoxon|Paroxetine|Pentylenetetrazole|Phenobarbital|Phenytoin|Pilocarpine|Pimozide|Plant Extracts|Proguanil|Propofol|Pyridoxal Phosphate|Ropivacaine|Sertraline|Sodium Chloride|Tacrolimus|tetramethylenedisulfotetramine|Theophylline|Thiopental|Topiramate|Valproic Acid|Vincristine,2,FGF2|NGF
cell population proliferation,GO:0008283,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cell projection assembly,GO:0030031,Epilepsy,MESH:D004827,1,Plant Extracts,0,
cell projection assembly,GO:0030031,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
cell projection assembly,GO:0030031,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
cell projection morphogenesis,GO:0048858,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,1,NES
cell projection organization,GO:0030030,Epilepsy,MESH:D004827,0,,4,AKT1|ILK|TSC1|TSC2
cell proliferation in bone marrow,GO:0071838,Epilepsy,MESH:D004827,0,,1,MEF2C
cell proliferation in forebrain,GO:0021846,Epilepsy,MESH:D004827,2,"Ethosuximide|N-Methyl-3,4-methylenedioxyamphetamine",0,
cell proliferation in forebrain,GO:0021846,"Epilepsy, Absence",MESH:D004832,1,Ethosuximide,0,
cell proliferation in forebrain,GO:0021846,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethosuximide|Methamphetamine,1,NGF
cell proliferation in midbrain,GO:0033278,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
cell quiescence,GO:0044838,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Aluminum,0,
cell redox homeostasis,GO:0045454,Epilepsy,MESH:D004827,7,Calcium|Cisplatin|Folic Acid|Levetiracetam|Methotrexate|Plant Extracts|Vitamin B 12,2,GPX1|TXNRD1
cell redox homeostasis,GO:0045454,"Epilepsy, Absence",MESH:D004832,3,Doxorubicin|Levetiracetam|Lithium Carbonate,0,
cell redox homeostasis,GO:0045454,"Epilepsy, Complex Partial",MESH:D017029,2,Levetiracetam|Methotrexate,0,
cell redox homeostasis,GO:0045454,"Epilepsy, Generalized",MESH:D004829,1,Prednisolone,0,
cell redox homeostasis,GO:0045454,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
cell redox homeostasis,GO:0045454,"Epilepsy, Temporal Lobe",MESH:D004833,3,Levetiracetam|Methotrexate|Plant Extracts,0,
cell redox homeostasis,GO:0045454,"Epilepsy, Tonic-Clonic",MESH:D004830,7,Acetaminophen|Ethanol|Levetiracetam|Lithium Carbonate|Methotrexate|Plant Extracts|Sodium Chloride,0,
cell redox homeostasis,GO:0045454,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Levetiracetam,0,
cell-substrate adhesion,GO:0031589,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Tetracaine,0,
cell surface receptor signaling pathway,GO:0007166,Epilepsy,MESH:D004827,1,"6-Cyano-7-nitroquinoxaline-2,3-dione",0,
cell surface receptor signaling pathway,GO:0007166,"Epilepsy, Temporal Lobe",MESH:D004833,0,,4,BDKRB2|P2RX7|TEK|TRPV1
cellular aldehyde metabolic process,GO:0006081,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chlorpromazine,0,
cellular aldehyde metabolic process,GO:0006081,Pyridoxine-dependent epilepsy,MESH:C536254,0,,1,ALDH7A1
cellular biogenic amine catabolic process,GO:0042402,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
cellular calcium ion homeostasis,GO:0006874,Epilepsy,MESH:D004827,27,"4-Aminopyridine|6-Cyano-7-nitroquinoxaline-2,3-dione|Acetazolamide|Amitriptyline|Amphetamine|Azathioprine|Bicuculline|Calcium|Carbachol|Cisplatin|Dexamethasone|Erythromycin|Fluvoxamine|Folic Acid|Gabapentin|gamma-Aminobutyric Acid|Imipramine|Kainic Acid|Ketamine|Ketoconazole|Lithium Chloride|Magnesium|Methotrexate|Methylmercury Compounds|Norepinephrine|Plant Extracts|Valproic Acid",2,GRIN2B|TGFB1
cellular calcium ion homeostasis,GO:0006874,"Epilepsy, Absence",MESH:D004832,3,Heparin|Progesterone|Valproic Acid,1,EFHC1
cellular calcium ion homeostasis,GO:0006874,"Epilepsy, Complex Partial",MESH:D017029,3,Gabapentin|Methotrexate|Valproic Acid,0,
cellular calcium ion homeostasis,GO:0006874,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,1,CHRNA7
cellular calcium ion homeostasis,GO:0006874,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
cellular calcium ion homeostasis,GO:0006874,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
cellular calcium ion homeostasis,GO:0006874,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cellular calcium ion homeostasis,GO:0006874,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cellular calcium ion homeostasis,GO:0006874,"Epilepsy, Temporal Lobe",MESH:D004833,7,Capsaicin|Clioquinol|Kainic Acid|Lithium Chloride|Methotrexate|Plant Extracts|Valproic Acid,1,VDR
cellular calcium ion homeostasis,GO:0006874,"Epilepsy, Tonic-Clonic",MESH:D004830,19,Amitriptyline|Bupivacaine|Caffeine|Chloroquine|Chlorpromazine|Clomipramine|Diclofenac|Dizocilpine Maleate|Erythromycin|Ethanol|Gabapentin|Heparin|Imipramine|Lithium Chloride|Methotrexate|Plant Extracts|Procaine|Theophylline|Valproic Acid,0,
cellular calcium ion homeostasis,GO:0006874,"Myoclonic Epilepsy, Juvenile",MESH:D020190,2,Acetazolamide|Valproic Acid,1,EFHC1
cellular chloride ion homeostasis,GO:0030644,Epilepsy,MESH:D004827,0,,2,SLC12A2|SLC12A5
cellular chloride ion homeostasis,GO:0030644,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
cellular chloride ion homeostasis,GO:0030644,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,SLC12A5
cellular chloride ion homeostasis,GO:0030644,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,SLC12A2|SLC12A5
cellular component organization,GO:0016043,Epilepsy,MESH:D004827,2,Dexamethasone|Etoposide,0,
cellular component organization,GO:0016043,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
cellular copper ion homeostasis,GO:0006878,Epilepsy,MESH:D004827,1,Cisplatin,0,
cellular detoxification of aldehyde,GO:0110095,Epilepsy,MESH:D004827,1,Felbamate,0,
cellular detoxification of aldehyde,GO:0110095,"Epilepsy, Reflex",MESH:D020195,1,Felbamate,0,
cellular extravasation,GO:0045123,Epilepsy,MESH:D004827,1,Dexamethasone,0,
cellular glucose homeostasis,GO:0001678,Epilepsy,MESH:D004827,1,Valproic Acid,0,
cellular glucose homeostasis,GO:0001678,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
cellular glucose homeostasis,GO:0001678,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
cellular glucose homeostasis,GO:0001678,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
cellular glucose homeostasis,GO:0001678,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cellular glucose homeostasis,GO:0001678,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cellular glucose homeostasis,GO:0001678,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
cellular glucose homeostasis,GO:0001678,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
cellular glucose homeostasis,GO:0001678,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cellular glutamate homeostasis,GO:0090461,Epilepsy,MESH:D004827,1,Dronabinol,1,SLC1A1
cellular glutamate homeostasis,GO:0090461,"EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS",OMIM:611726,0,,1,KCTD7
cellular glutamate homeostasis,GO:0090461,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,GRM2|SLC1A1
cellular heat acclimation,GO:0070370,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Disulfiram,0,
cellular hyperosmotic salinity response,GO:0071475,Epilepsy,MESH:D004827,0,,1,AKT1
cellular hypotonic response,GO:0071476,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CLCN2
cellular iron ion homeostasis,GO:0006879,Epilepsy,MESH:D004827,2,Cisplatin|Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Acetaminophen|Chloroquine|Deferoxamine|Ethanol|Ropivacaine|Valproic Acid,0,
cellular iron ion homeostasis,GO:0006879,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cellular lipid catabolic process,GO:0044242,Epilepsy,MESH:D004827,4,Cisplatin|Dexamethasone|Methotrexate|Plant Extracts,0,
cellular lipid catabolic process,GO:0044242,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cellular lipid catabolic process,GO:0044242,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
cellular lipid catabolic process,GO:0044242,"Epilepsy, Temporal Lobe",MESH:D004833,2,Methotrexate|Plant Extracts,0,
cellular lipid catabolic process,GO:0044242,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Caffeine|Ethanol|Methotrexate|Plant Extracts,0,
cellular lipid metabolic process,GO:0044255,Epilepsy,MESH:D004827,1,Dexamethasone,0,
cellular metabolic process,GO:0044237,Epilepsy,MESH:D004827,47,"6-Cyano-7-nitroquinoxaline-2,3-dione|Acetazolamide|Adenosine|Aminooxyacetic Acid|Amitriptyline|Atropine|Azathioprine|Busulfan|Calcium|Ciprofloxacin|Cisplatin|Clonidine|Cytarabine|Dexamethasone|Diatrizoate Meglumine|Dronabinol|Enoxacin|Erythromycin|Etoposide|Fluoxetine|Fluvoxamine|Folic Acid|Gabapentin|Gentamicins|Imipramine|Kainic Acid|Ketamine|Ketoconazole|Lidocaine|Lithium|Lithium Chloride|Methotrexate|Methylmercury Compounds|N-Methyl-3,4-methylenedioxyamphetamine|Oxcarbazepine|Penicillamine|Penicillin G|perampanel|Phenytoin|Pilocarpine|Plant Extracts|Propofol|Quetiapine Fumarate|Sevoflurane|Thalidomide|trimethyltin chloride|Valproic Acid",0,
cellular metabolic process,GO:0044237,"Epilepsy, Absence",MESH:D004832,6,Doxorubicin|Oxcarbazepine|Phenytoin|Pilocarpine|Progesterone|Valproic Acid,0,
cellular metabolic process,GO:0044237,"Epilepsy, Complex Partial",MESH:D017029,5,Gabapentin|Methotrexate|Oxcarbazepine|Phenytoin|Valproic Acid,0,
cellular metabolic process,GO:0044237,"Epilepsy, Generalized",MESH:D004829,3,Phenytoin|Propofol|Valproic Acid,0,
cellular metabolic process,GO:0044237,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
cellular metabolic process,GO:0044237,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cellular metabolic process,GO:0044237,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cellular metabolic process,GO:0044237,"Epilepsy, Temporal Lobe",MESH:D004833,11,Capsaicin|Clioquinol|Kainic Acid|Lithium|Lithium Chloride|Methotrexate|Phenytoin|Pilocarpine|Plant Extracts|Tacrolimus|Valproic Acid,0,
cellular metabolic process,GO:0044237,"Epilepsy, Tonic-Clonic",MESH:D004830,47,Acetaminophen|Adenosine|Aluminum|Amitriptyline|Atropine|Bupivacaine|Busulfan|Caffeine|chloroprocaine|Chloroquine|Chlorpromazine|Ciprofloxacin|Clomipramine|Clonidine|Deferoxamine|Diclofenac|Disulfiram|Dizocilpine Maleate|Enoxacin|Erythromycin|Ethanol|Etomidate|Gabapentin|Imipramine|Lidocaine|Lithium|Lithium Chloride|Mebendazole|Mechlorethamine|Methamphetamine|Methotrexate|Methylphenidate|Oxcarbazepine|Paraoxon|Paroxetine|Penicillin G|Phenytoin|Pilocarpine|Plant Extracts|Propofol|Ropivacaine|Sodium Chloride|Tacrolimus|Tetracaine|Tranexamic Acid|Valproic Acid|Vincristine,0,
cellular metabolic process,GO:0044237,"Myoclonic Epilepsy, Juvenile",MESH:D020190,2,Acetazolamide|Valproic Acid,0,
cellular nitric oxide homeostasis,GO:0033484,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Deferoxamine,0,
cellular oxidant detoxification,GO:0098869,Epilepsy,MESH:D004827,0,,4,ALB|GPX1|SELENOW|TXNRD1
cellular oxygen homeostasis,GO:0032364,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
cellular phosphate ion homeostasis,GO:0030643,"Epilepsy, Temporal Lobe",MESH:D004833,1,Chlorides,0,
cellular pigmentation,GO:0033059,Epilepsy,MESH:D004827,0,,1,POMC
cellular pigmentation,GO:0033059,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,POMC
cellular potassium ion homeostasis,GO:0030007,Epilepsy,MESH:D004827,0,,1,SLC12A2
cellular potassium ion homeostasis,GO:0030007,"EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS",OMIM:611726,0,,1,KCTD7
cellular potassium ion homeostasis,GO:0030007,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
cellular potassium ion homeostasis,GO:0030007,Generalized Epilepsy and Paroxysmal Dyskinesia,MESH:C563719,0,,1,KCNMA1
cellular respiration,GO:0045333,Epilepsy,MESH:D004827,10,Clozapine|Dexamethasone|Dronabinol|Etoposide|Folic Acid|Ketoconazole|Lidocaine|malic acid|Methylmercury Compounds|Valproic Acid,0,
cellular respiration,GO:0045333,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
cellular respiration,GO:0045333,"Epilepsy, Complex Partial",MESH:D017029,2,Clozapine|Valproic Acid,0,
cellular respiration,GO:0045333,"Epilepsy, Generalized",MESH:D004829,3,Clozapine|Valproic Acid|Zidovudine,0,
cellular respiration,GO:0045333,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cellular respiration,GO:0045333,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cellular respiration,GO:0045333,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,1,COX3
cellular respiration,GO:0045333,"Epilepsy, Tonic-Clonic",MESH:D004830,8,Caffeine|Clomipramine|Clozapine|Deferoxamine|Lidocaine|Mechlorethamine|Sodium Chloride|Valproic Acid,0,
cellular respiration,GO:0045333,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cellular response to acetaldehyde,GO:1905641,Epilepsy,MESH:D004827,0,,1,TGFB1
cellular response to acid chemical,GO:0071229,Epilepsy,MESH:D004827,0,,1,BDNF
cellular response to acid chemical,GO:0071229,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,2,BDNF|NGF
cellular response to acidic pH,GO:0071468,"Epilepsy, Absence",MESH:D004832,0,,1,KCNK9
cellular response to acidic pH,GO:0071468,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
cellular response to aldehyde,GO:0110096,Epilepsy,MESH:D004827,1,Plant Extracts,0,
cellular response to aldehyde,GO:0110096,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
cellular response to aldehyde,GO:0110096,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
cellular response to alkaloid,GO:0071312,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
cellular response to amino acid starvation,GO:0034198,"Epilepsy, Partial, with Variable Foci",MESH:C565785,0,,3,DEPDC5|NPRL2|NPRL3
cellular response to amino acid stimulus,GO:0071230,Epilepsy,MESH:D004827,0,,2,GRIN2A|GRIN2B
cellular response to amino acid stimulus,GO:0071230,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
cellular response to amino acid stimulus,GO:0071230,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
cellular response to ammonium ion,GO:0071242,Epilepsy,MESH:D004827,0,,1,SLC1A1
cellular response to ammonium ion,GO:0071242,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
cellular response to amphetamine,GO:0071419,Epilepsy,MESH:D004827,2,"Dextroamphetamine|N-Methyl-3,4-methylenedioxyamphetamine",0,
cellular response to amphetamine,GO:0071419,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
cellular response to amyloid-beta,GO:1904646,Epilepsy,MESH:D004827,1,Dronabinol,0,
cellular response to amyloid-beta,GO:1904646,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
cellular response to amyloid-beta,GO:1904646,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,GRM5|VDR
cellular response to angiotensin,GO:1904385,Epilepsy,MESH:D004827,0,,1,ARID1B
cellular response to antibiotic,GO:0071236,"Epilepsy, Complex Partial",MESH:D017029,0,,1,SCN3A
cellular response to arsenic-containing substance,GO:0071243,Epilepsy,MESH:D004827,0,,1,DDX3X
cellular response to ATP,GO:0071318,Epilepsy,MESH:D004827,0,,1,P2RX4
cellular response to ATP,GO:0071318,"Epilepsy, Temporal Lobe",MESH:D004833,0,,3,P2RX4|P2RX7|TRPV1
cellular response to bisphenol A,GO:1903926,Epilepsy,MESH:D004827,0,,1,SLC1A1
cellular response to bisphenol A,GO:1903926,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
cellular response to blue light,GO:0071483,Epilepsy,MESH:D004827,1,Plant Extracts,0,
cellular response to blue light,GO:0071483,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
cellular response to blue light,GO:0071483,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
cellular response to brain-derived neurotrophic factor stimulus,GO:1990416,Epilepsy,MESH:D004827,0,,1,UBE3A
cellular response to cadmium ion,GO:0071276,Epilepsy,MESH:D004827,0,,2,AKT1|FOS
cellular response to calcium ion,GO:0071277,Epilepsy,MESH:D004827,0,,5,FOS|FOSB|KCNH1|KCNQ2|MEF2C
cellular response to calcium ion,GO:0071277,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
cellular response to calcium ion starvation,GO:0072732,Epilepsy,MESH:D004827,0,,1,ALB
cellular response to cAMP,GO:0071320,Epilepsy,MESH:D004827,0,,1,HCN1
cellular response to chemical stimulus,GO:0070887,Epilepsy,MESH:D004827,2,Folic Acid|Ketoconazole,0,
cellular response to chemical stress,GO:0062197,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cellular response to chemokine,GO:1990869,Epilepsy,MESH:D004827,0,,1,SLC12A2
cellular response to chemokine,GO:1990869,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
cellular response to chloroquine,GO:1902350,Epilepsy,MESH:D004827,0,,1,TSC1
cellular response to cisplatin,GO:0072719,Epilepsy,MESH:D004827,1,Cisplatin,0,
cellular response to cisplatin,GO:0072719,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Chloroquine|Diclofenac,0,
cellular response to cocaine,GO:0071314,Epilepsy,MESH:D004827,0,,3,SLC1A1|SLC1A2|SLC1A3
cellular response to cocaine,GO:0071314,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
cellular response to cocaine,GO:0071314,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Cocaine,0,
cellular response to copper ion,GO:0071280,Epilepsy,MESH:D004827,0,,1,TXNRD1
cellular response to corticosterone stimulus,GO:0071386,Epilepsy,MESH:D004827,0,,1,GRIN2B
cellular response to curcumin,GO:1904644,Epilepsy,MESH:D004827,0,,1,GRIN2B
cellular response to cytokine stimulus,GO:0071345,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
cellular response to decreased oxygen levels,GO:0036294,Epilepsy,MESH:D004827,0,,2,AKT1|TSC1
cellular response to dexamethasone stimulus,GO:0071549,Epilepsy,MESH:D004827,0,,2,HNRNPU|TGFB1
cellular response to dexamethasone stimulus,GO:0071549,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
cellular response to dexamethasone stimulus,GO:0071549,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
cellular response to dexamethasone stimulus,GO:0071549,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
cellular response to diterpene,GO:1904630,Epilepsy,MESH:D004827,1,Calcium,0,
cellular response to DNA damage stimulus,GO:0006974,Epilepsy,MESH:D004827,20,"Azathioprine|carbidopa, levodopa drug combination|Ciprofloxacin|Cisplatin|daidzin|Dexamethasone|Diazepam|Dronabinol|Etoposide|Folic Acid|Gentamicins|Kainic Acid|Methotrexate|Methylmercury Compounds|Pentylenetetrazole|Phenobarbital|Phenytoin|Plant Extracts|Thalidomide|Valproic Acid",2,AKT1|CHD2
cellular response to DNA damage stimulus,GO:0006974,"Epilepsy, Absence",MESH:D004832,6,Diazepam|Doxorubicin|Pentylenetetrazole|Phenobarbital|Phenytoin|Valproic Acid,0,
cellular response to DNA damage stimulus,GO:0006974,"Epilepsy, Complex Partial",MESH:D017029,6,Diazepam|Methotrexate|Phenobarbital|Phenytoin|Trazodone|Valproic Acid,0,
cellular response to DNA damage stimulus,GO:0006974,"Epilepsy, Generalized",MESH:D004829,6,Diazepam|Phenobarbital|Phenytoin|Trazodone|Valproic Acid|Zidovudine,0,
cellular response to DNA damage stimulus,GO:0006974,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
cellular response to DNA damage stimulus,GO:0006974,"Epilepsy, Reflex",MESH:D020195,2,Polychlorinated Biphenyls|Valproic Acid,0,
cellular response to DNA damage stimulus,GO:0006974,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cellular response to DNA damage stimulus,GO:0006974,"Epilepsy, Temporal Lobe",MESH:D004833,6,Kainic Acid|Methotrexate|Phenobarbital|Phenytoin|Plant Extracts|Valproic Acid,0,
cellular response to DNA damage stimulus,GO:0006974,"Epilepsy, Tonic-Clonic",MESH:D004830,21,Acetaminophen|Aminophylline|Bupivacaine|Caffeine|Ciprofloxacin|Cocaine|Deferoxamine|Diazepam|Diclofenac|Ethanol|Mebendazole|Mechlorethamine|Methamphetamine|Methotrexate|Paraoxon|Pentylenetetrazole|Phenobarbital|Phenytoin|Plant Extracts|Valproic Acid|Vincristine,0,
cellular response to DNA damage stimulus,GO:0006974,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cellular response to dsRNA,GO:0071359,Epilepsy,MESH:D004827,0,,2,GRIN2A|GRIN2B
cellular response to dsRNA,GO:0071359,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
cellular response to dsRNA,GO:0071359,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
cellular response to dsRNA,GO:0071359,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
cellular response to electrical stimulus,GO:0071257,Epilepsy,MESH:D004827,0,,1,GRM1
cellular response to electrical stimulus,GO:0071257,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,GRM1
cellular response to epidermal growth factor stimulus,GO:0071364,Epilepsy,MESH:D004827,0,,2,AKT1|FOS
cellular response to estrogen stimulus,GO:0071391,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
cellular response to fibroblast growth factor stimulus,GO:0044344,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
cellular response to fluid shear stress,GO:0071498,Epilepsy,MESH:D004827,0,,1,MEF2C
cellular response to folic acid,GO:0071231,Epilepsy,MESH:D004827,0,,1,FOLR1
cellular response to forskolin,GO:1904322,Epilepsy,MESH:D004827,0,,1,GRIN2B
cellular response to gamma radiation,GO:0071480,Epilepsy,MESH:D004827,2,Adenosine|Calcium,0,
cellular response to gamma radiation,GO:0071480,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Adenosine,0,
cellular response to glucocorticoid stimulus,GO:0071385,Epilepsy,MESH:D004827,0,,1,HNRNPU
cellular response to glucose stimulus,GO:0071333,Epilepsy,MESH:D004827,0,,5,ERN1|GPX1|MEF2C|POLG|TGFB1
cellular response to glucose stimulus,GO:0071333,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
cellular response to glycine,GO:1905430,Epilepsy,MESH:D004827,0,,1,GRIN2A
cellular response to glycine,GO:1905430,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
cellular response to glycine,GO:1905430,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
cellular response to glyoxal,GO:0036471,"Epilepsy, Temporal Lobe",MESH:D004833,1,Capsaicin,0,
cellular response to granulocyte macrophage colony-stimulating factor stimulus,GO:0097011,Epilepsy,MESH:D004827,0,,1,AKT1
cellular response to growth factor stimulus,GO:0071363,Epilepsy,MESH:D004827,0,,6,AKT1|GRIN2A|GRIN2B|MEF2C|OPRD1|TGFB1
cellular response to growth factor stimulus,GO:0071363,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
cellular response to growth factor stimulus,GO:0071363,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
cellular response to growth factor stimulus,GO:0071363,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
cellular response to heat,GO:0034605,Epilepsy,MESH:D004827,0,,1,AKT1
cellular response to heat,GO:0034605,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
cellular response to heparin,GO:0071504,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
cellular response to hepatocyte growth factor stimulus,GO:0035729,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
cellular response to high light intensity,GO:0071486,Epilepsy,MESH:D004827,6,Chloramphenicol|Dexamethasone|Ethosuximide|Gentamicins|Griseofulvin|Ketoconazole,0,
cellular response to high light intensity,GO:0071486,"Epilepsy, Absence",MESH:D004832,1,Ethosuximide,0,
cellular response to high light intensity,GO:0071486,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Bupropion|Ethosuximide|Tetracaine,0,
cellular response to histamine,GO:0071420,Epilepsy,MESH:D004827,0,,2,GABRB2|GABRB3
cellular response to histamine,GO:0071420,"Epilepsy, Absence",MESH:D004832,0,,1,GABRB3
cellular response to histamine,GO:0071420,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,GABRA1
cellular response to hormone stimulus,GO:0032870,Epilepsy,MESH:D004827,0,,3,ADRA2A|FOS|FOSB
cellular response to hormone stimulus,GO:0032870,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1H
cellular response to hormone stimulus,GO:0032870,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
cellular response to hydrogen peroxide,GO:0070301,Epilepsy,MESH:D004827,1,Cisplatin,1,ERN1
cellular response to hydrogen peroxide,GO:0070301,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cellular response to hydrogen sulfide,GO:1904881,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
cellular response to hydroperoxide,GO:0071447,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cellular response to hyperoxia,GO:0071455,Epilepsy,MESH:D004827,0,,1,TXNRD1
cellular response to hypoxia,GO:0071456,Epilepsy,MESH:D004827,1,Plant Extracts,6,AKT1|FOS|OPRD1|SCN2A|TGFB1|TSC1
cellular response to hypoxia,GO:0071456,"Epilepsy, Benign Neonatal, 3",MESH:C564274,0,,1,SCN2A
cellular response to hypoxia,GO:0071456,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
cellular response to hypoxia,GO:0071456,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,3,BDKRB2|SLIT2|VEGFA
cellular response to hypoxia,GO:0071456,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
cellular response to insulin-like growth factor stimulus,GO:1990314,Epilepsy,MESH:D004827,0,,1,TGFB1
cellular response to insulin stimulus,GO:0032869,Epilepsy,MESH:D004827,1,Plant Extracts,2,AKT1|TSC2
cellular response to insulin stimulus,GO:0032869,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
cellular response to insulin stimulus,GO:0032869,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
cellular response to interferon-beta,GO:0035458,Epilepsy,MESH:D004827,0,,1,HCN1
cellular response to ionizing radiation,GO:0071479,Epilepsy,MESH:D004827,1,Plant Extracts,1,TGFB1
cellular response to ionizing radiation,GO:0071479,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
cellular response to ionizing radiation,GO:0071479,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
cellular response to isoquinoline alkaloid,GO:0071317,Epilepsy,MESH:D004827,0,,1,MECP2
cellular response to lead ion,GO:0071284,Epilepsy,MESH:D004827,2,Calcium|Magnesium,0,
cellular response to leukemia inhibitory factor,GO:1990830,Epilepsy,MESH:D004827,0,,1,HNRNPU
cellular response to leukemia inhibitory factor,GO:1990830,"Epilepsy, Generalized",MESH:D004829,0,,1,CACNB4
cellular response to leukemia inhibitory factor,GO:1990830,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CACNB4
cellular response to leukemia inhibitory factor,GO:1990830,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,CACNB4
cellular response to light stimulus,GO:0071482,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chlorpromazine,0,
cellular response to lipid,GO:0071396,Epilepsy,MESH:D004827,0,,2,GRIN2A|GRIN2B
cellular response to lipid,GO:0071396,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
cellular response to lipid,GO:0071396,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
cellular response to lipopolysaccharide,GO:0071222,Epilepsy,MESH:D004827,1,Plant Extracts,2,MEF2C|SLC12A2
cellular response to lipopolysaccharide,GO:0071222,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,1,SLC12A2
cellular response to lipopolysaccharide,GO:0071222,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
cellular response to low-density lipoprotein particle stimulus,GO:0071404,Epilepsy,MESH:D004827,0,,1,TGFB1
cellular response to low-density lipoprotein particle stimulus,GO:0071404,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
cellular response to magnesium ion,GO:0071286,Epilepsy,MESH:D004827,0,,1,GRIN2A
cellular response to magnesium ion,GO:0071286,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
cellular response to magnesium ion,GO:0071286,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
cellular response to magnesium starvation,GO:0010350,Epilepsy,MESH:D004827,0,,1,GRIN2B
cellular response to manganese ion,GO:0071287,Epilepsy,MESH:D004827,0,,3,ERN1|GRIN2A|GRIN2B
cellular response to manganese ion,GO:0071287,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
cellular response to manganese ion,GO:0071287,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
cellular response to mechanical stimulus,GO:0071260,Epilepsy,MESH:D004827,0,,2,AKT1|TGFB1
cellular response to mechanical stimulus,GO:0071260,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,TEK|VEGFA
cellular response to mechanical stimulus,GO:0071260,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
cellular response to mercury ion,GO:0071288,Epilepsy,MESH:D004827,0,,1,SLC1A1
cellular response to mercury ion,GO:0071288,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
cellular response to methotrexate,GO:0071414,Epilepsy,MESH:D004827,1,Methotrexate,0,
cellular response to methotrexate,GO:0071414,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
cellular response to methotrexate,GO:0071414,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
cellular response to methotrexate,GO:0071414,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
cellular response to molecule of bacterial origin,GO:0071219,Epilepsy,MESH:D004827,1,Bicuculline,0,
cellular response to morphine,GO:0071315,Epilepsy,MESH:D004827,0,,1,OPRM1
cellular response to nerve growth factor stimulus,GO:1990090,Epilepsy,MESH:D004827,0,,2,AKT1|BDNF
cellular response to nerve growth factor stimulus,GO:1990090,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
cellular response to nerve growth factor stimulus,GO:1990090,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BDNF
cellular response to nicotine,GO:0071316,Epilepsy,MESH:D004827,2,Morphine|Naloxone,0,
cellular response to nicotine,GO:0071316,"Epilepsy, Absence",MESH:D004832,1,Naloxone,0,
cellular response to nicotine,GO:0071316,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,0,
cellular response to nicotine,GO:0071316,"Epilepsy, Nocturnal Frontal Lobe, Type 4",MESH:C563679,0,,1,CHRNA2
cellular response to nicotine,GO:0071316,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Morphine|Naloxone,0,
cellular response to nitrosative stress,GO:0071500,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
cellular response to norepinephrine stimulus,GO:0071874,Epilepsy,MESH:D004827,1,Norepinephrine,1,BDNF
cellular response to norepinephrine stimulus,GO:0071874,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BDNF
cellular response to organic cyclic compound,GO:0071407,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
cellular response to osmotic stress,GO:0071470,Epilepsy,MESH:D004827,0,,1,DDX3X
cellular response to oxidative stress,GO:0034599,Epilepsy,MESH:D004827,2,Carbamazepine|Plant Extracts,3,GPX1|SLC1A1|TXNRD1
cellular response to oxidative stress,GO:0034599,"Epilepsy, Absence",MESH:D004832,2,Carbamazepine|Doxorubicin,0,
cellular response to oxidative stress,GO:0034599,"Epilepsy, Complex Partial",MESH:D017029,1,Carbamazepine,0,
cellular response to oxidative stress,GO:0034599,"Epilepsy, Generalized",MESH:D004829,1,Carbamazepine,0,
cellular response to oxidative stress,GO:0034599,"Epilepsy, Rolandic",MESH:D019305,1,Carbamazepine,0,
cellular response to oxidative stress,GO:0034599,"Epilepsy, rolandic with paroxysmal exercise-induced dystonia and writer's cramp",MESH:C535499,0,,1,TBC1D24
cellular response to oxidative stress,GO:0034599,"Epilepsy, Temporal Lobe",MESH:D004833,2,Carbamazepine|Plant Extracts,1,SLC1A1
cellular response to oxidative stress,GO:0034599,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Carbamazepine|Ethanol|Plant Extracts,0,
cellular response to oxidative stress,GO:0034599,"MYOCLONIC EPILEPSY, FAMILIAL INFANTILE",OMIM:605021,0,,1,TBC1D24
cellular response to oxidised low-density lipoprotein particle stimulus,GO:0140052,Epilepsy,MESH:D004827,0,,1,AKT1
cellular response to parathyroid hormone stimulus,GO:0071374,Epilepsy,MESH:D004827,0,,2,FOS|MEF2C
cellular response to peptide,GO:1901653,Epilepsy,MESH:D004827,0,,1,AKT1
cellular response to peptide,GO:1901653,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
cellular response to phorbol 13-acetate 12-myristate,GO:1904628,Epilepsy,MESH:D004827,0,,1,FOS
cellular response to platelet-derived growth factor stimulus,GO:0036120,Epilepsy,MESH:D004827,0,,1,AKT1
cellular response to platelet-derived growth factor stimulus,GO:0036120,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
cellular response to potassium ion,GO:0035865,Epilepsy,MESH:D004827,0,,3,BDNF|MECP2|SLC12A2
cellular response to potassium ion,GO:0035865,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1H
cellular response to potassium ion,GO:0035865,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
cellular response to potassium ion,GO:0035865,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BDNF
cellular response to prolactin,GO:1990646,Epilepsy,MESH:D004827,0,,1,FOS
cellular response to prostaglandin E stimulus,GO:0071380,Epilepsy,MESH:D004827,0,,1,AKT1
cellular response to radiation,GO:0071478,Epilepsy,MESH:D004827,1,Folic Acid,0,
cellular response to rapamycin,GO:0072752,Epilepsy,MESH:D004827,0,,1,AKT1
cellular response to reactive oxygen species,GO:0034614,Epilepsy,MESH:D004827,0,,2,AKT1|FOS
cellular response to retinoic acid,GO:0071300,Epilepsy,MESH:D004827,0,,1,MEF2C
cellular response to sorbitol,GO:0072709,Epilepsy,MESH:D004827,0,,1,AKT1
cellular response to starvation,GO:0009267,Epilepsy,MESH:D004827,0,,4,ALB|TSC1|TSC2|WDR45
cellular response to starvation,GO:0009267,"Epilepsy, Partial, with Variable Foci",MESH:C565785,0,,2,NPRL2|NPRL3
cellular response to stimulus,GO:0051716,Epilepsy,MESH:D004827,0,,2,FOS|SLC1A2
cellular response to stimulus,GO:0051716,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
cellular response to stress,GO:0033554,Epilepsy,MESH:D004827,1,Cisplatin,1,AKT1
cellular response to stress,GO:0033554,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,GRM2|GRM3
cellular response to temperature stimulus,GO:0071502,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
cellular response to toxic substance,GO:0097237,Epilepsy,MESH:D004827,1,Dronabinol,1,OPRD1
cellular response to toxic substance,GO:0097237,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cellular response to transforming growth factor beta stimulus,GO:0071560,Epilepsy,MESH:D004827,0,,3,FOS|MEF2C|TGFB1
cellular response to trichostatin A,GO:0035984,Epilepsy,MESH:D004827,0,,1,MEF2C
cellular response to tumor necrosis factor,GO:0071356,Epilepsy,MESH:D004827,0,,3,AKT1|BDNF|FOS
cellular response to tumor necrosis factor,GO:0071356,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
cellular response to tumor necrosis factor,GO:0071356,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BDNF
cellular response to tumor necrosis factor,GO:0071356,SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY,OMIM:159950,0,,1,ASAH1
cellular response to type II interferon,GO:0071346,Epilepsy,MESH:D004827,0,,1,STXBP1
cellular response to unfolded protein,GO:0034620,Epilepsy,MESH:D004827,2,Gentamicins|Norepinephrine,1,ERN1
cellular response to UV,GO:0034644,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chlorpromazine,0,
cellular response to UV-A,GO:0071492,Epilepsy,MESH:D004827,1,Plant Extracts,0,
cellular response to UV-A,GO:0071492,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
cellular response to UV-A,GO:0071492,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
cellular response to UV-B,GO:0071493,Epilepsy,MESH:D004827,1,Ketoconazole,0,
cellular response to vascular endothelial growth factor stimulus,GO:0035924,Epilepsy,MESH:D004827,0,,2,AKT1|ERN1
cellular response to vascular endothelial growth factor stimulus,GO:0035924,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|VEGFA
cellular response to virus,GO:0098586,Epilepsy,MESH:D004827,0,,2,DDX3X|TGFB1
cellular response to vitamin D,GO:0071305,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
cellular response to vitamin D,GO:0071305,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VDR
cellular response to wortmannin,GO:1904568,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
cellular response to xenobiotic stimulus,GO:0071466,Epilepsy,MESH:D004827,2,Cisplatin|Ketoconazole,2,KCNQ2|MEF2C
cellular response to xenobiotic stimulus,GO:0071466,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cellular response to xenobiotic stimulus,GO:0071466,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
cellular response to xenobiotic stimulus,GO:0071466,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
cellular response to xenobiotic stimulus,GO:0071466,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
cellular response to X-ray,GO:0071481,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
cellular response to zinc ion,GO:0071294,Epilepsy,MESH:D004827,0,,3,GABRB3|GRIN2A|P2RX4
cellular response to zinc ion,GO:0071294,"Epilepsy, Absence",MESH:D004832,0,,1,GABRB3
cellular response to zinc ion,GO:0071294,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
cellular response to zinc ion,GO:0071294,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
cellular response to zinc ion,GO:0071294,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX4
cellular response to zinc ion starvation,GO:0034224,Epilepsy,MESH:D004827,0,,1,FOS
cellular senescence,GO:0090398,Epilepsy,MESH:D004827,6,Busulfan|Cisplatin|Etoposide|Folic Acid|Plant Extracts|Valproic Acid,0,
cellular senescence,GO:0090398,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
cellular senescence,GO:0090398,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
cellular senescence,GO:0090398,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
cellular senescence,GO:0090398,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cellular senescence,GO:0090398,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cellular senescence,GO:0090398,"Epilepsy, Temporal Lobe",MESH:D004833,2,Plant Extracts|Valproic Acid,0,
cellular senescence,GO:0090398,"Epilepsy, Tonic-Clonic",MESH:D004830,8,Busulfan|Caffeine|Chloroquine|Disulfiram|Melphalan|Methamphetamine|Plant Extracts|Valproic Acid,0,
cellular senescence,GO:0090398,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cellular sodium ion homeostasis,GO:0006883,Epilepsy,MESH:D004827,0,,2,SLC12A2|SLC1A3
cellular sodium ion homeostasis,GO:0006883,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
cellular stress response to acid chemical,GO:0097533,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
cellular triglyceride homeostasis,GO:0035356,Epilepsy,MESH:D004827,2,Erythromycin|Penicillin G,0,
cellular triglyceride homeostasis,GO:0035356,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Erythromycin|Penicillin G,0,
cellular zinc ion homeostasis,GO:0006882,Epilepsy,MESH:D004827,1,Calcium,1,SLC1A1
cellular zinc ion homeostasis,GO:0006882,"Epilepsy, Temporal Lobe",MESH:D004833,1,Clioquinol,1,SLC1A1
cellular zinc ion homeostasis,GO:0006882,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Disulfiram|Dizocilpine Maleate|Mefloquine,0,
cell volume homeostasis,GO:0006884,Epilepsy,MESH:D004827,1,Cisplatin,2,SLC12A2|SLC12A5
cell volume homeostasis,GO:0006884,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cell volume homeostasis,GO:0006884,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,SLC12A5
cell volume homeostasis,GO:0006884,"Epilepsy, Temporal Lobe",MESH:D004833,1,Chlorides,3,P2RX7|SLC12A2|SLC12A5
cell volume homeostasis,GO:0006884,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Sodium Chloride|Vincristine,0,
central nervous system development,GO:0007417,Epilepsy,MESH:D004827,1,Methotrexate,1,SMC1A
central nervous system development,GO:0007417,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
central nervous system development,GO:0007417,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
central nervous system development,GO:0007417,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
central nervous system development,GO:0007417,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
central nervous system development,GO:0007417,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
central nervous system development,GO:0007417,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,1,NES
central nervous system maturation,GO:0021626,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
central nervous system myelination,GO:0022010,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
central nervous system myelination,GO:0022010,Epilepsy,MESH:D004827,0,,1,CNTNAP2
central nervous system myelination,GO:0022010,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
central nervous system myelination,GO:0022010,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
central nervous system myelin maintenance,GO:0032286,Epilepsy,MESH:D004827,1,Lidocaine,0,
central nervous system myelin maintenance,GO:0032286,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Lidocaine|Methamphetamine,0,
central nervous system neuron axonogenesis,GO:0021955,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNB2
central nervous system neuron axonogenesis,GO:0021955,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
central nervous system neuron development,GO:0021954,Epilepsy,MESH:D004827,0,,2,FOXG1|NPY
central nervous system neuron development,GO:0021954,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,NPY
central nervous system neuron development,GO:0021954,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NTF3
central nervous system neuron differentiation,GO:0021953,Epilepsy,MESH:D004827,0,,1,FOXG1
central nervous system neuron differentiation,GO:0021953,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
central nervous system neuron differentiation,GO:0021953,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
central nervous system projection neuron axonogenesis,GO:0021952,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNB2
central nervous system projection neuron axonogenesis,GO:0021952,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
central nervous system projection neuron axonogenesis,GO:0021952,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
centrosome duplication,GO:0051298,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
centrosome separation,GO:0051299,Epilepsy,MESH:D004827,2,Griseofulvin|Oxcarbazepine,0,
centrosome separation,GO:0051299,"Epilepsy, Absence",MESH:D004832,1,Oxcarbazepine,0,
centrosome separation,GO:0051299,"Epilepsy, Complex Partial",MESH:D017029,1,Oxcarbazepine,0,
centrosome separation,GO:0051299,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Oxcarbazepine,0,
ceramide 1-phosphate transport,GO:1902389,Epilepsy,MESH:D004827,0,,1,CERT1
ceramide biosynthetic process,GO:0046513,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
ceramide biosynthetic process,GO:0046513,SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY,OMIM:159950,0,,1,ASAH1
ceramide catabolic process,GO:0046514,SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY,OMIM:159950,0,,1,ASAH1
ceramide metabolic process,GO:0006672,Epilepsy,MESH:D004827,0,,1,CERT1
ceramide translocation,GO:0099040,Epilepsy,MESH:D004827,0,,1,ABCB1
cerebellar granule cell precursor proliferation,GO:0021930,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
cerebellar molecular layer development,GO:0021679,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
cerebellar Purkinje cell differentiation,GO:0021702,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
cerebellar Purkinje cell layer development,GO:0021680,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
cerebellar Purkinje cell layer morphogenesis,GO:0021692,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
cerebellar Purkinje cell layer morphogenesis,GO:0021692,Epilepsy,MESH:D004827,0,,1,CNTNAP2
cerebellar Purkinje cell layer morphogenesis,GO:0021692,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
cerebellar Purkinje cell layer morphogenesis,GO:0021692,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
cerebellum development,GO:0021549,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
cerebellum development,GO:0021549,Epilepsy,MESH:D004827,1,Phenytoin,3,CNTNAP2|GABRB3|MECP2
cerebellum development,GO:0021549,"Epilepsy, Absence",MESH:D004832,1,Phenytoin,1,GABRB3
cerebellum development,GO:0021549,"Epilepsy, Complex Partial",MESH:D017029,1,Phenytoin,0,
cerebellum development,GO:0021549,"Epilepsy, Generalized",MESH:D004829,1,Phenytoin,0,
cerebellum development,GO:0021549,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenytoin,0,
cerebellum development,GO:0021549,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Phenytoin,0,
cerebellum maturation,GO:0021590,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
cerebral cortex cell migration,GO:0021795,"Epilepsy, Absence",MESH:D004832,0,,1,EFHC1
cerebral cortex cell migration,GO:0021795,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,EFHC1
cerebral cortex development,GO:0021987,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
cerebral cortex development,GO:0021987,Epilepsy,MESH:D004827,0,,10,CNTNAP2|FLNA|FOS|FOXG1|GRIN2A|GRIN2B|MECP2|NPY|SCN2A|TSC1
cerebral cortex development,GO:0021987,"Epilepsy, Benign Neonatal, 3",MESH:C564274,0,,1,SCN2A
cerebral cortex development,GO:0021987,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
cerebral cortex development,GO:0021987,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
cerebral cortex development,GO:0021987,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
cerebral cortex development,GO:0021987,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
cerebral cortex development,GO:0021987,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KCNC4|NPY
cerebral cortex GABAergic interneuron migration,GO:0021853,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
cerebral cortex neuron differentiation,GO:0021895,Epilepsy,MESH:D004827,1,Dronabinol,0,
cerebral cortex tangential migration,GO:0021800,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
cerebral cortex tangential migration,GO:0021800,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
cGMP biosynthetic process,GO:0006182,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
cGMP metabolic process,GO:0046068,Epilepsy,MESH:D004827,1,Pentylenetetrazole,0,
cGMP metabolic process,GO:0046068,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Pentylenetetrazole,0,
cGMP metabolic process,GO:0046068,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Aluminum|Pentylenetetrazole,0,
chemical synaptic transmission,GO:0007268,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
chemical synaptic transmission,GO:0007268,Epilepsy,MESH:D004827,23,"6-Cyano-7-nitroquinoxaline-2,3-dione|Acetazolamide|Amphetamine|Bicuculline|Calcium|Clonazepam|Clozapine|Diazepam|Dronabinol|gamma-Aminobutyric Acid|Ketamine|Lidocaine|Lithium|Magnesium|Morphine|Naloxone|Pentobarbital|Phenobarbital|Picrotoxin|Pilocarpine|Quetiapine Fumarate|Quisqualic Acid|Sevoflurane",19,CHRM1|CHRM2|CNTNAP2|GABRB2|GABRB3|GRIN2A|GRIN2B|GRM1|KCNQ2|MECP2|NPY|P2RX2|SLC12A5|SLC1A1|SLC1A2|SLC1A3|SLC6A1|SNAP25|VDAC1
chemical synaptic transmission,GO:0007268,"Epilepsy, Absence",MESH:D004832,7,Clonazepam|Diazepam|Naloxone|Phenobarbital|Picrotoxin|Pilocarpine|Riluzole,2,CACNA1A|GABRB3
chemical synaptic transmission,GO:0007268,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
chemical synaptic transmission,GO:0007268,"Epilepsy, Complex Partial",MESH:D017029,4,Clonazepam|Clozapine|Diazepam|Phenobarbital,0,
chemical synaptic transmission,GO:0007268,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
chemical synaptic transmission,GO:0007268,"Epilepsy, Frontal Lobe",MESH:D017034,0,,2,CHRNA4|CHRNB2
chemical synaptic transmission,GO:0007268,"Epilepsy, Generalized",MESH:D004829,4,Clozapine|Diazepam|Naloxone|Phenobarbital,2,CACNB4|CHRNA7
chemical synaptic transmission,GO:0007268,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,3,CACNB4|GABRD|SLC12A5
chemical synaptic transmission,GO:0007268,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
chemical synaptic transmission,GO:0007268,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
chemical synaptic transmission,GO:0007268,"Epilepsy, Nocturnal Frontal Lobe, Type 4",MESH:C563679,0,,1,CHRNA2
chemical synaptic transmission,GO:0007268,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
chemical synaptic transmission,GO:0007268,"Epilepsy, Temporal Lobe",MESH:D004833,5,Capsaicin|Clonazepam|Lithium|Phenobarbital|Pilocarpine,9,GRM1|GRM2|GRM3|GRM4|GRM5|KCNC4|NPY|SLC12A5|SLC1A1
chemical synaptic transmission,GO:0007268,"Epilepsy, Tonic-Clonic",MESH:D004830,17,Bupivacaine|Clonazepam|Clozapine|Cocaine|Diazepam|Ethanol|Fentanyl|Lidocaine|Lithium|Mefloquine|Meperidine|Morphine|Naloxone|Phenobarbital|Picrotoxin|Pilocarpine|Thiopental,0,
chemical synaptic transmission,GO:0007268,"Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders",MESH:C564505,0,,1,SYN1
chemical synaptic transmission,GO:0007268,Generalized Epilepsy and Paroxysmal Dyskinesia,MESH:C563719,0,,1,KCNMA1
chemical synaptic transmission,GO:0007268,MYOCLONIC-ATONIC EPILEPSY,OMIM:616421,0,,1,SLC6A1
chemical synaptic transmission,GO:0007268,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Acetazolamide,1,CACNB4
"chemical synaptic transmission, postsynaptic",GO:0099565,Epilepsy,MESH:D004827,1,Carbachol,0,
chemokine (C-C motif) ligand 11 production,GO:0071954,Epilepsy,MESH:D004827,1,Methimazole,0,
chemokine (C-C motif) ligand 17 production,GO:0044809,Epilepsy,MESH:D004827,1,Plant Extracts,0,
chemokine (C-C motif) ligand 17 production,GO:0044809,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
chemokine (C-C motif) ligand 17 production,GO:0044809,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
chemorepulsion involved in postnatal olfactory bulb interneuron migration,GO:0021836,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
chemosensory behavior,GO:0007635,Epilepsy,MESH:D004827,10,Bicuculline|Carbamazepine|Dronabinol|Fluoxetine|gamma-Aminobutyric Acid|Ketamine|Pentylenetetrazole|Picrotoxin|Topiramate|Valproic Acid,0,
chemosensory behavior,GO:0007635,"Epilepsy, Absence",MESH:D004832,4,Carbamazepine|Pentylenetetrazole|Picrotoxin|Valproic Acid,0,
chemosensory behavior,GO:0007635,"Epilepsy, Complex Partial",MESH:D017029,3,Carbamazepine|Topiramate|Valproic Acid,0,
chemosensory behavior,GO:0007635,"Epilepsy, Generalized",MESH:D004829,2,Carbamazepine|Valproic Acid,0,
chemosensory behavior,GO:0007635,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
chemosensory behavior,GO:0007635,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
chemosensory behavior,GO:0007635,"Epilepsy, Rolandic",MESH:D019305,3,Carbamazepine|Topiramate|Valproic Acid,0,
chemosensory behavior,GO:0007635,"Epilepsy, Temporal Lobe",MESH:D004833,4,"3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer|Carbamazepine|Topiramate|Valproic Acid",1,TRPV1
chemosensory behavior,GO:0007635,"Epilepsy, Tonic-Clonic",MESH:D004830,10,Caffeine|Carbamazepine|Chlormethiazole|Chloroquine|Cocaine|Methamphetamine|Pentylenetetrazole|Picrotoxin|Topiramate|Valproic Acid,0,
chemosensory behavior,GO:0007635,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
chemotaxis,GO:0006935,Epilepsy,MESH:D004827,1,Valproic Acid,0,
chemotaxis,GO:0006935,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
chemotaxis,GO:0006935,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
chemotaxis,GO:0006935,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
chemotaxis,GO:0006935,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
chemotaxis,GO:0006935,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
chemotaxis,GO:0006935,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
chemotaxis,GO:0006935,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,1,FGF2
chemotaxis,GO:0006935,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
chloride ion homeostasis,GO:0055064,Epilepsy,MESH:D004827,2,Ciprofloxacin|Dexamethasone,2,SLC12A2|SLC12A5
chloride ion homeostasis,GO:0055064,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,SLC12A5
chloride ion homeostasis,GO:0055064,"Epilepsy, Temporal Lobe",MESH:D004833,1,Chlorides,2,SLC12A2|SLC12A5
chloride ion homeostasis,GO:0055064,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ciprofloxacin,0,
chloride transmembrane transport,GO:1902476,Epilepsy,MESH:D004827,3,Carbachol|Phenobarbital|Picrotoxin,7,GABRB2|GABRB3|SLC12A2|SLC12A5|SLC1A1|SLC1A3|SLC6A1
chloride transmembrane transport,GO:1902476,"Epilepsy, Absence",MESH:D004832,2,Phenobarbital|Picrotoxin,1,GABRB3
chloride transmembrane transport,GO:1902476,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
chloride transmembrane transport,GO:1902476,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
chloride transmembrane transport,GO:1902476,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,4,CASR|CLCN2|GABRD|SLC12A5
chloride transmembrane transport,GO:1902476,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,3,SLC12A2|SLC12A5|SLC1A1
chloride transmembrane transport,GO:1902476,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Phenobarbital|Picrotoxin|Sodium Chloride,0,
chloride transmembrane transport,GO:1902476,MYOCLONIC-ATONIC EPILEPSY,OMIM:616421,0,,1,SLC6A1
chloride transmembrane transport,GO:1902476,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,GABRA1
chloride transport,GO:0006821,Epilepsy,MESH:D004827,0,,4,GABRB3|SLC12A2|SLC12A5|SLC4A10
chloride transport,GO:0006821,"Epilepsy, Absence",MESH:D004832,0,,1,GABRB3
chloride transport,GO:0006821,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,SLC4A10
chloride transport,GO:0006821,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,3,CLCN2|GABRD|SLC12A5
chloride transport,GO:0006821,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,SLC12A2|SLC12A5
chloride transport,GO:0006821,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,GABRA1
cholecystokinin signaling pathway,GO:0038188,Epilepsy,MESH:D004827,1,Plant Extracts,0,
cholecystokinin signaling pathway,GO:0038188,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
cholecystokinin signaling pathway,GO:0038188,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
cholesterol biosynthetic process,GO:0006695,Epilepsy,MESH:D004827,10,Bicuculline|Clozapine|Dexamethasone|gamma-Aminobutyric Acid|Haloperidol|Magnesium|Methimazole|Methylmercury Compounds|Muscimol|Plant Extracts,0,
cholesterol biosynthetic process,GO:0006695,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Haloperidol,0,
cholesterol biosynthetic process,GO:0006695,"Epilepsy, Complex Partial",MESH:D017029,1,Clozapine,0,
cholesterol biosynthetic process,GO:0006695,"Epilepsy, Generalized",MESH:D004829,2,Clozapine|Zidovudine,0,
cholesterol biosynthetic process,GO:0006695,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
cholesterol biosynthetic process,GO:0006695,"Epilepsy, Temporal Lobe",MESH:D004833,2,Capsaicin|Plant Extracts,0,
cholesterol biosynthetic process,GO:0006695,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Caffeine|Chloroquine|Clozapine|Ethanol|Haloperidol|Plant Extracts,0,
cholesterol efflux,GO:0033344,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Chloroquine|Ethanol|Sodium Chloride,0,
cholesterol homeostasis,GO:0042632,Epilepsy,MESH:D004827,5,Calcium|Estrogens|Folic Acid|Magnesium|Plant Extracts,1,TSC1
cholesterol homeostasis,GO:0042632,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
cholesterol homeostasis,GO:0042632,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
cholesterol homeostasis,GO:0042632,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Dizocilpine Maleate|Ethanol|Plant Extracts,0,
cholesterol metabolic process,GO:0008203,Epilepsy,MESH:D004827,9,Ampicillin|Cisplatin|Dexamethasone|Folic Acid|Lamotrigine|Methylmercury Compounds|Plant Extracts|Sevoflurane|Valproic Acid,0,
cholesterol metabolic process,GO:0008203,"Epilepsy, Absence",MESH:D004832,3,Doxorubicin|Lamotrigine|Valproic Acid,0,
cholesterol metabolic process,GO:0008203,"Epilepsy, Complex Partial",MESH:D017029,2,Lamotrigine|Valproic Acid,0,
cholesterol metabolic process,GO:0008203,"Epilepsy, Generalized",MESH:D004829,2,Lamotrigine|Valproic Acid,0,
cholesterol metabolic process,GO:0008203,"Epilepsy, Reflex",MESH:D020195,2,Polychlorinated Biphenyls|Valproic Acid,0,
cholesterol metabolic process,GO:0008203,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cholesterol metabolic process,GO:0008203,"Epilepsy, Temporal Lobe",MESH:D004833,3,Lamotrigine|Plant Extracts|Valproic Acid,0,
cholesterol metabolic process,GO:0008203,"Epilepsy, Tonic-Clonic",MESH:D004830,10,Acetaminophen|Caffeine|Chloroquine|Deferoxamine|Diclofenac|Ethanol|Lamotrigine|Metronidazole|Plant Extracts|Valproic Acid,1,CYP2D6
cholesterol metabolic process,GO:0008203,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cholesterol transport involved in cholesterol storage,GO:0010879,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Phenylpropanolamine,0,
choline catabolic process,GO:0042426,Pyridoxine-dependent epilepsy,MESH:C536254,0,,1,ALDH7A1
choline metabolic process,GO:0019695,Epilepsy,MESH:D004827,1,Cisplatin,0,
choline metabolic process,GO:0019695,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BCHE
choline transport,GO:0015871,Epilepsy,MESH:D004827,1,Clonidine,0,
choline transport,GO:0015871,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Clonidine,0,
chondroblast differentiation,GO:0060591,Epilepsy,MESH:D004827,1,Dexamethasone,0,
chondroblast differentiation,GO:0060591,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
chondrocyte development,GO:0002063,Epilepsy,MESH:D004827,1,Dexamethasone,0,
chondrocyte differentiation,GO:0002062,Epilepsy,MESH:D004827,0,,2,MEF2C|TGFB1
chondrocyte hypertrophy,GO:0003415,Epilepsy,MESH:D004827,1,Dexamethasone,0,
chondrocyte proliferation,GO:0035988,Epilepsy,MESH:D004827,1,Dexamethasone,0,
chondroitin sulfate metabolic process,GO:0030204,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,OXT
chondroitin sulfate proteoglycan biosynthetic process,GO:0050650,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,OXT
chordate embryonic development,GO:0043009,Epilepsy,MESH:D004827,0,,1,CHD2
chorionic trophoblast cell development,GO:0060719,Epilepsy,MESH:D004827,1,Dronabinol,0,
chromatin organization,GO:0006325,Epilepsy,MESH:D004827,0,,2,CHD2|HNRNPU
chromatin organization,GO:0006325,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1",OMIM:614231,0,,1,IER3IP1
chromatin remodeling,GO:0006338,Epilepsy,MESH:D004827,0,,5,AKT1|ARID1B|DYRK1A|ERN1|TXNRD1
chromatin remodeling,GO:0006338,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
chromosome condensation,GO:0030261,Epilepsy,MESH:D004827,1,Plant Extracts,0,
chromosome condensation,GO:0030261,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
chromosome condensation,GO:0030261,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
chromosome organization,GO:0051276,Epilepsy,MESH:D004827,2,Methotrexate|Oxcarbazepine,1,SMC1A
chromosome organization,GO:0051276,"Epilepsy, Absence",MESH:D004832,1,Oxcarbazepine,0,
chromosome organization,GO:0051276,"Epilepsy, Complex Partial",MESH:D017029,2,Methotrexate|Oxcarbazepine,0,
chromosome organization,GO:0051276,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
chromosome organization,GO:0051276,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Methamphetamine|Methotrexate|Oxcarbazepine,0,
chromosome segregation,GO:0007059,Epilepsy,MESH:D004827,1,Etoposide,1,DDX3X
chromosome segregation,GO:0007059,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Melphalan,0,
chronic inflammatory response,GO:0002544,Epilepsy,MESH:D004827,0,,1,BDNF
chronic inflammatory response,GO:0002544,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BDNF
cilium assembly,GO:0060271,Epilepsy,MESH:D004827,0,,1,FLNA
cilium assembly,GO:0060271,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
cilium-dependent cell motility,GO:0060285,"Epilepsy, Absence",MESH:D004832,0,,1,EFHC1
cilium-dependent cell motility,GO:0060285,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,EFHC1
cilium organization,GO:0044782,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
circadian behavior,GO:0048512,Epilepsy,MESH:D004827,0,,1,BDNF
circadian behavior,GO:0048512,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BDNF
circadian regulation of gene expression,GO:0032922,Epilepsy,MESH:D004827,2,Dexamethasone|Valproic Acid,1,HNRNPU
circadian regulation of gene expression,GO:0032922,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
circadian regulation of gene expression,GO:0032922,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
circadian regulation of gene expression,GO:0032922,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
circadian regulation of gene expression,GO:0032922,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
circadian regulation of gene expression,GO:0032922,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
circadian regulation of gene expression,GO:0032922,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
circadian regulation of gene expression,GO:0032922,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
circadian regulation of gene expression,GO:0032922,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
circadian rhythm,GO:0007623,Epilepsy,MESH:D004827,0,,3,BDNF|DYRK1A|UBE3A
circadian rhythm,GO:0007623,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,2,BDNF|NGF
circadian rhythm,GO:0007623,Generalized Epilepsy and Paroxysmal Dyskinesia,MESH:C563719,0,,1,KCNMA1
circadian sleep/wake cycle,GO:0042745,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
circadian sleep/wake cycle,GO:0042745,Epilepsy,MESH:D004827,0,,1,CNTNAP2
"circadian sleep/wake cycle, REM sleep",GO:0042747,Epilepsy,MESH:D004827,1,Carbachol,1,GABRB3
"circadian sleep/wake cycle, REM sleep",GO:0042747,"Epilepsy, Absence",MESH:D004832,0,,1,GABRB3
circulatory system development,GO:0072359,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 18, WITH OR WITHOUT EPILEPSY",OMIM:614249,0,,1,MED23
citrate metabolic process,GO:0006101,Epilepsy,MESH:D004827,1,"N-Methyl-3,4-methylenedioxyamphetamine",0,
citrate metabolic process,GO:0006101,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
citrate transport,GO:0015746,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
citrulline biosynthetic process,GO:0019240,Epilepsy,MESH:D004827,1,Phenobarbital,0,
citrulline biosynthetic process,GO:0019240,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
citrulline biosynthetic process,GO:0019240,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
citrulline biosynthetic process,GO:0019240,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
citrulline biosynthetic process,GO:0019240,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
citrulline biosynthetic process,GO:0019240,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
citrulline biosynthetic process,GO:0019240,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Phenobarbital,0,
clathrin coat assembly involved in endocytosis,GO:0099049,Epilepsy,MESH:D004827,0,,1,DNM1
clustering of voltage-gated potassium channels,GO:0045163,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
clustering of voltage-gated potassium channels,GO:0045163,Epilepsy,MESH:D004827,0,,1,CNTNAP2
clustering of voltage-gated potassium channels,GO:0045163,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
cobalamin metabolic process,GO:0009235,Epilepsy,MESH:D004827,1,Vitamin B 12,0,
cocaine metabolic process,GO:0050783,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BCHE
cochlea development,GO:0090102,Epilepsy,MESH:D004827,0,,2,GABRB2|GABRB3
cochlea development,GO:0090102,"Epilepsy, Absence",MESH:D004832,0,,1,GABRB3
coenzyme A metabolic process,GO:0015936,Epilepsy,MESH:D004827,1,Cisplatin,0,
cognition,GO:0050890,Epilepsy,MESH:D004827,5,Dronabinol|Ketamine|Methylmercury Compounds|rufinamide|Sevoflurane,4,ANKRD11|BDNF|CHRM1|KCNQ2
cognition,GO:0050890,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
cognition,GO:0050890,"Epilepsy, Frontal Lobe",MESH:D017034,0,,2,CHRNA4|CHRNB2
cognition,GO:0050890,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
cognition,GO:0050890,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
cognition,GO:0050890,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
cognition,GO:0050890,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
cognition,GO:0050890,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,GRM5
cognition,GO:0050890,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Acetaminophen|Aluminum|Dizocilpine Maleate|Ethanol|Methamphetamine,1,BDNF
collagen-activated tyrosine kinase receptor signaling pathway,GO:0038063,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|TEK
collagen biosynthetic process,GO:0032964,Epilepsy,MESH:D004827,1,Dexamethasone,0,
collagen biosynthetic process,GO:0032964,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
collagen biosynthetic process,GO:0032964,"Epilepsy, Generalized",MESH:D004829,1,Prednisolone,0,
collagen biosynthetic process,GO:0032964,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Ethanol,0,
collagen catabolic process,GO:0030574,Epilepsy,MESH:D004827,0,,1,SLC12A5
collagen catabolic process,GO:0030574,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,SLC12A5
collagen catabolic process,GO:0030574,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A5
collagen fibril organization,GO:0030199,Epilepsy,MESH:D004827,8,Cisplatin|Dexamethasone|Folic Acid|Lithium|Lithium Chloride|Phenobarbital|Sevoflurane|Valproic Acid,0,
collagen fibril organization,GO:0030199,"Epilepsy, Absence",MESH:D004832,4,Doxorubicin|Lithium Carbonate|Phenobarbital|Valproic Acid,0,
collagen fibril organization,GO:0030199,"Epilepsy, Complex Partial",MESH:D017029,2,Phenobarbital|Valproic Acid,0,
collagen fibril organization,GO:0030199,"Epilepsy, Generalized",MESH:D004829,3,Phenobarbital|Prednisolone|Valproic Acid,0,
collagen fibril organization,GO:0030199,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
collagen fibril organization,GO:0030199,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
collagen fibril organization,GO:0030199,"Epilepsy, Temporal Lobe",MESH:D004833,4,Lithium|Lithium Chloride|Phenobarbital|Valproic Acid,0,
collagen fibril organization,GO:0030199,"Epilepsy, Tonic-Clonic",MESH:D004830,11,Aluminum Hydroxide|Ethanol|Lithium|Lithium Carbonate|Lithium Chloride|Methamphetamine|Methylprednisolone|Phenobarbital|Prednisone|Valproic Acid|Vincristine,0,
collagen fibril organization,GO:0030199,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
collagen metabolic process,GO:0032963,Epilepsy,MESH:D004827,1,Dexamethasone,0,
collagen metabolic process,GO:0032963,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
collateral sprouting,GO:0048668,Epilepsy,MESH:D004827,0,,1,BDNF
collateral sprouting,GO:0048668,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BDNF
columnar/cuboidal epithelial cell maturation,GO:0002069,Epilepsy,MESH:D004827,0,,1,TGFB1
columnar/cuboidal epithelial cell maturation,GO:0002069,Generalized Epilepsy and Paroxysmal Dyskinesia,MESH:C563719,0,,1,KCNMA1
commissural neuron axon guidance,GO:0071679,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
complement activation,GO:0006956,"Epilepsy, Absence",MESH:D004832,1,Heparin,0,
complement activation,GO:0006956,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Heparin,0,
compound eye development,GO:0048749,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
conditioned place preference,GO:1990708,Epilepsy,MESH:D004827,3,Carbachol|Dronabinol|Morphine,3,BDNF|GRIN2A|SLC1A1
conditioned place preference,GO:1990708,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
conditioned place preference,GO:1990708,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
conditioned place preference,GO:1990708,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
conditioned place preference,GO:1990708,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Cocaine|Ethanol|Methamphetamine|Morphine,1,BDNF
conditioned taste aversion,GO:0001661,Epilepsy,MESH:D004827,1,Dronabinol,1,FOS
conditioned taste aversion,GO:0001661,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNB2
conditioned taste aversion,GO:0001661,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
connective tissue development,GO:0061448,Epilepsy,MESH:D004827,0,,1,TGFB1
connective tissue replacement involved in inflammatory response wound healing,GO:0002248,Epilepsy,MESH:D004827,0,,1,TGFB1
convergent extension involved in gastrulation,GO:0060027,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
copper ion homeostasis,GO:0055070,Epilepsy,MESH:D004827,2,Cisplatin|Penicillamine,0,
copper ion homeostasis,GO:0055070,"Epilepsy, Temporal Lobe",MESH:D004833,1,Clioquinol,0,
copper ion homeostasis,GO:0055070,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
cornea development in camera-type eye,GO:0061303,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
coronary artery morphogenesis,GO:0060982,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
coronary vasculature development,GO:0060976,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
coronary vein morphogenesis,GO:0003169,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
corpus callosum development,GO:0022038,Epilepsy,MESH:D004827,0,,1,SCN2A
corpus callosum development,GO:0022038,"Epilepsy, Benign Neonatal, 3",MESH:C564274,0,,1,SCN2A
corpus callosum development,GO:0022038,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KCNC4
corticospinal neuron axon guidance,GO:0021966,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",MESH:C565809,0,,1,SCN1B
corticospinal neuron axon guidance through spinal cord,GO:0021972,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
corticosteroid hormone secretion,GO:0035930,Epilepsy,MESH:D004827,1,Dexamethasone,0,
corticosterone secretion,GO:0035934,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
corticotropin hormone secreting cell development,GO:0060131,Epilepsy,MESH:D004827,1,Dexamethasone,0,
corticotropin hormone secreting cell differentiation,GO:0060128,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
cortisol biosynthetic process,GO:0034651,Epilepsy,MESH:D004827,1,Fluoxetine,0,
cortisol biosynthetic process,GO:0034651,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1H
cortisol biosynthetic process,GO:0034651,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
cortisol biosynthetic process,GO:0034651,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Venlafaxine Hydrochloride,0,
cortisol metabolic process,GO:0034650,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
cortisol secretion,GO:0043400,Epilepsy,MESH:D004827,0,,1,POMC
cortisol secretion,GO:0043400,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,POMC
coumarin metabolic process,GO:0009804,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,CYP2D6
cranial nerve development,GO:0021545,Epilepsy,MESH:D004827,0,,1,SLC1A3
cranial nerve development,GO:0021545,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NES
cranial skeletal system development,GO:1904888,Epilepsy,MESH:D004827,2,Folic Acid|Valproic Acid,0,
cranial skeletal system development,GO:1904888,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
cranial skeletal system development,GO:1904888,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
cranial skeletal system development,GO:1904888,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
cranial skeletal system development,GO:1904888,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
cranial skeletal system development,GO:1904888,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
cranial skeletal system development,GO:1904888,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
cranial skeletal system development,GO:1904888,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Valproic Acid,0,
cranial skeletal system development,GO:1904888,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
CRD-mediated mRNA stabilization,GO:0070934,Epilepsy,MESH:D004827,0,,1,HNRNPU
creatine biosynthetic process,GO:0006601,Epilepsy,MESH:D004827,2,Cisplatin|Plant Extracts,0,
creatine biosynthetic process,GO:0006601,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
creatine biosynthetic process,GO:0006601,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
creatine biosynthetic process,GO:0006601,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
creatine metabolic process,GO:0006600,Epilepsy,MESH:D004827,3,Dexamethasone|Gentamicins|Plant Extracts,0,
creatine metabolic process,GO:0006600,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
creatine metabolic process,GO:0006600,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
creatine metabolic process,GO:0006600,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
creatinine catabolic process,GO:0006602,Epilepsy,MESH:D004827,1,Cisplatin,0,
creatinine catabolic process,GO:0006602,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Deferoxamine,0,
creatinine metabolic process,GO:0046449,Epilepsy,MESH:D004827,11,"Cilastatin, Imipenem Drug Combination|Ciprofloxacin|Cisplatin|Dexamethasone|Estrogens|Folic Acid|Gentamicins|Methotrexate|Phenobarbital|Plant Extracts|Valproic Acid",0,
creatinine metabolic process,GO:0046449,"Epilepsy, Absence",MESH:D004832,5,"Cilastatin, Imipenem Drug Combination|Doxorubicin|Lithium Carbonate|Phenobarbital|Valproic Acid",0,
creatinine metabolic process,GO:0046449,"Epilepsy, Complex Partial",MESH:D017029,3,Methotrexate|Phenobarbital|Valproic Acid,0,
creatinine metabolic process,GO:0046449,"Epilepsy, Generalized",MESH:D004829,2,Phenobarbital|Valproic Acid,0,
creatinine metabolic process,GO:0046449,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
creatinine metabolic process,GO:0046449,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
creatinine metabolic process,GO:0046449,"Epilepsy, Temporal Lobe",MESH:D004833,5,Methotrexate|Phenobarbital|Plant Extracts|Tacrolimus|Valproic Acid,0,
creatinine metabolic process,GO:0046449,"Epilepsy, Tonic-Clonic",MESH:D004830,15,"Acetaminophen|Chloroquine|Cilastatin, Imipenem Drug Combination|Ciprofloxacin|Deferoxamine|Diclofenac|Lithium Carbonate|Methamphetamine|Methotrexate|Phenobarbital|Plant Extracts|pralidoxime|Tacrolimus|Valproic Acid|Venlafaxine Hydrochloride",0,
creatinine metabolic process,GO:0046449,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
cyclooxygenase pathway,GO:0019371,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,BDKRB1
cysteine transmembrane transport,GO:1903712,Epilepsy,MESH:D004827,0,,2,SLC1A1|SLC1A2
cysteine transmembrane transport,GO:1903712,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
cysteine transport,GO:0042883,Epilepsy,MESH:D004827,0,,1,SLC1A1
cysteine transport,GO:0042883,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
cytidine biosynthetic process,GO:0046088,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
cytokine-mediated signaling pathway,GO:0019221,Epilepsy,MESH:D004827,0,,2,AKT1|SLC1A1
cytokine-mediated signaling pathway,GO:0019221,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
cytokine production,GO:0001816,Epilepsy,MESH:D004827,0,,1,SLC1A1
cytokine production,GO:0001816,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
cytokine production,GO:0001816,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
cytokine production involved in inflammatory response,GO:0002534,Epilepsy,MESH:D004827,1,Cisplatin,0,
cytosine metabolic process,GO:0019858,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
cytoskeleton-dependent intracellular transport,GO:0030705,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
cytoskeleton organization,GO:0007010,Epilepsy,MESH:D004827,0,,1,AKT1
cytoskeleton organization,GO:0007010,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,MICAL1
cytoskeleton organization,GO:0007010,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
cytosolic pattern recognition receptor signaling pathway,GO:0002753,Epilepsy,MESH:D004827,0,,1,DDX3X
cytosolic ribosome assembly,GO:0042256,Epilepsy,MESH:D004827,0,,1,DDX3X
D-aspartate import across plasma membrane,GO:0070779,Epilepsy,MESH:D004827,0,,4,GFAP|SLC1A1|SLC1A2|SLC1A3
D-aspartate import across plasma membrane,GO:0070779,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
D-aspartate transport,GO:0070777,Epilepsy,MESH:D004827,0,,1,SLC1A1
D-aspartate transport,GO:0070777,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
decidualization,GO:0046697,Epilepsy,MESH:D004827,3,Dronabinol|Epinephrine|Estrogens,0,
decidualization,GO:0046697,"Epilepsy, Absence",MESH:D004832,1,Progesterone,0,
decidualization,GO:0046697,"Epilepsy, Temporal Lobe",MESH:D004833,1,Medroxyprogesterone Acetate,1,VDR
decidualization,GO:0046697,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Epinephrine,0,
defecation,GO:0030421,Epilepsy,MESH:D004827,2,Lithium Chloride|Pilocarpine,0,
defecation,GO:0030421,"Epilepsy, Absence",MESH:D004832,1,Pilocarpine,0,
defecation,GO:0030421,"Epilepsy, Temporal Lobe",MESH:D004833,2,Lithium Chloride|Pilocarpine,0,
defecation,GO:0030421,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Lithium Chloride|Methamphetamine|Pilocarpine,0,
defecation rhythm,GO:0035882,Epilepsy,MESH:D004827,3,Atropine|Clonidine|Morphine,0,
defecation rhythm,GO:0035882,"Epilepsy, Temporal Lobe",MESH:D004833,1,Capsaicin,0,
defecation rhythm,GO:0035882,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Atropine|Clonidine|Morphine,0,
defense response,GO:0006952,Epilepsy,MESH:D004827,0,,1,TGFB1
defense response to fungus,GO:0050832,Epilepsy,MESH:D004827,0,,1,TGFB1
defense response to Gram-negative bacterium,GO:0050829,Epilepsy,MESH:D004827,0,,1,NPY
defense response to Gram-negative bacterium,GO:0050829,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,NPY
defense response to Gram-positive bacterium,GO:0050830,Epilepsy,MESH:D004827,0,,1,NPY
defense response to Gram-positive bacterium,GO:0050830,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,NPY|P2RX7
definitive hemopoiesis,GO:0060216,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TEK
dendrite arborization,GO:0140059,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
dendrite arborization,GO:0140059,Epilepsy,MESH:D004827,5,Bicuculline|Dexamethasone|Dronabinol|Sevoflurane|Valproic Acid,1,CNTNAP2
dendrite arborization,GO:0140059,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
dendrite arborization,GO:0140059,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
dendrite arborization,GO:0140059,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,1,CHRNA7
dendrite arborization,GO:0140059,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
dendrite arborization,GO:0140059,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
dendrite arborization,GO:0140059,"Epilepsy, Temporal Lobe",MESH:D004833,2,Tacrolimus|Valproic Acid,0,
dendrite arborization,GO:0140059,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Tacrolimus|Valproic Acid,0,
dendrite arborization,GO:0140059,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
dendrite development,GO:0016358,Epilepsy,MESH:D004827,0,,3,BDNF|MECP2|SYNGAP1
dendrite development,GO:0016358,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
dendrite development,GO:0016358,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
dendrite development,GO:0016358,"Epilepsy, rolandic with paroxysmal exercise-induced dystonia and writer's cramp",MESH:C535499,0,,1,TBC1D24
dendrite development,GO:0016358,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Dizocilpine Maleate,1,BDNF
dendrite development,GO:0016358,"MYOCLONIC EPILEPSY, FAMILIAL INFANTILE",OMIM:605021,0,,1,TBC1D24
dendrite development,GO:0016358,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
dendrite extension,GO:0097484,Epilepsy,MESH:D004827,1,nimesulide,2,AUTS2|BDNF
dendrite extension,GO:0097484,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BDNF
dendrite morphogenesis,GO:0048813,Epilepsy,MESH:D004827,1,Methylmercury Compounds,1,UBE3A
dendrite morphogenesis,GO:0048813,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
dendritic cell dendrite assembly,GO:0097026,Epilepsy,MESH:D004827,0,,1,ARID1B
dendritic cell migration,GO:0036336,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
dendritic cell migration,GO:0036336,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
dendritic spine development,GO:0060996,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
dendritic spine development,GO:0060996,Epilepsy,MESH:D004827,4,Ketamine|Lithium|nimesulide|Picrotoxin,3,ARID1B|CNTNAP2|SLC12A5
dendritic spine development,GO:0060996,"Epilepsy, Absence",MESH:D004832,1,Picrotoxin,0,
dendritic spine development,GO:0060996,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,SLC12A5
dendritic spine development,GO:0060996,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium,1,SLC12A5
dendritic spine development,GO:0060996,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Lithium|Methamphetamine|Picrotoxin,0,
dendritic spine maintenance,GO:0097062,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
dendritic spine maintenance,GO:0097062,Epilepsy,MESH:D004827,0,,1,CNTNAP2
dendritic spine maintenance,GO:0097062,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
dendritic spine morphogenesis,GO:0060997,Epilepsy,MESH:D004827,2,Dronabinol|Sevoflurane,0,
dendritic spine organization,GO:0097061,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
dendritic spine organization,GO:0097061,Epilepsy,MESH:D004827,0,,2,CNTNAP2|GRIN2A
dendritic spine organization,GO:0097061,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
dendritic spine organization,GO:0097061,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
dendritic spine organization,GO:0097061,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
dendritic transport of messenger ribonucleoprotein complex,GO:0098963,Epilepsy,MESH:D004827,0,,2,HNRNPU|PURA
dentate gyrus development,GO:0021542,Epilepsy,MESH:D004827,1,Valproic Acid,3,KCNQ2|MEF2C|SCN2A
dentate gyrus development,GO:0021542,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
dentate gyrus development,GO:0021542,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
dentate gyrus development,GO:0021542,"Epilepsy, Benign Neonatal, 3",MESH:C564274,0,,1,SCN2A
dentate gyrus development,GO:0021542,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
dentate gyrus development,GO:0021542,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
dentate gyrus development,GO:0021542,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
dentate gyrus development,GO:0021542,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
dentate gyrus development,GO:0021542,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
dentate gyrus development,GO:0021542,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
dentate gyrus development,GO:0021542,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
dentate gyrus development,GO:0021542,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Valproic Acid,0,
dentate gyrus development,GO:0021542,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
desensitization of G protein-coupled receptor signaling pathway,GO:0002029,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,GRM5
desensitization of G protein-coupled receptor signaling pathway by arrestin,GO:0002032,Epilepsy,MESH:D004827,1,Dronabinol,0,
detection of calcium ion,GO:0005513,Epilepsy,MESH:D004827,1,Calcium,0,
detection of calcium ion,GO:0005513,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
detection of cAMP,GO:0031319,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
detection of chemical stimulus involved in sensory perception of pain,GO:0050968,"Epilepsy, Temporal Lobe",MESH:D004833,1,Capsaicin,1,TRPV1
detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,GO:0003029,Epilepsy,MESH:D004827,0,,1,P2RX2
detection of light stimulus involved in visual perception,GO:0050908,"Epilepsy, Generalized",MESH:D004829,0,,1,CACNB4
detection of light stimulus involved in visual perception,GO:0050908,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CACNB4
detection of light stimulus involved in visual perception,GO:0050908,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,CACNB4
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,Epilepsy,MESH:D004827,4,Dexamethasone|Ketoconazole|Morphine|Naloxone,2,GRIN2B|SCN1A
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,"Epilepsy, Absence",MESH:D004832,1,Naloxone,0,
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,1,SCN1A
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Morphine|Naloxone|Ropivacaine,0,
detection of mechanical stimulus involved in sensory perception of pain,GO:0050966,"Generalized Epilepsy With Febrile Seizures Plus, Type 2",MESH:C565810,0,,1,SCN1A
detection of mechanical stimulus involved in sensory perception of sound,GO:0050910,Epilepsy,MESH:D004827,0,,1,SLC12A2
detection of mechanical stimulus involved in sensory perception of sound,GO:0050910,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
detection of oxidative stress,GO:0070994,Epilepsy,MESH:D004827,34,"Amitriptyline|Busulfan|Carbamazepine|carbidopa, levodopa drug combination|Chloramphenicol|Cisplatin|Clonidine|Clozapine|Cytarabine|Dexamethasone|Dronabinol|Felbamate|Fluoxetine|Folic Acid|Ketamine|Ketoconazole|Lamotrigine|Lithium Chloride|Methotrexate|Methylmercury Compounds|Morphine|nimesulide|N-Methyl-3,4-methylenedioxyamphetamine|Penicillamine|Pentylenetetrazole|Phenobarbital|Phenytoin|Plant Extracts|Sevoflurane|Thiobarbituric Acid Reactive Substances|Topiramate|Valproic Acid|Vitamin B 12|Vitamin U",0,
detection of oxidative stress,GO:0070994,"Epilepsy, Absence",MESH:D004832,7,Carbamazepine|Doxorubicin|Lamotrigine|Pentylenetetrazole|Phenobarbital|Phenytoin|Valproic Acid,0,
detection of oxidative stress,GO:0070994,"Epilepsy, Complex Partial",MESH:D017029,8,Carbamazepine|Clozapine|Lamotrigine|Methotrexate|Phenobarbital|Phenytoin|Topiramate|Valproic Acid,0,
detection of oxidative stress,GO:0070994,"Epilepsy, Generalized",MESH:D004829,7,Carbamazepine|Clozapine|Lamotrigine|Phenobarbital|Phenytoin|Valproic Acid|Zidovudine,0,
detection of oxidative stress,GO:0070994,"Epilepsy, Reflex",MESH:D020195,2,Felbamate|Valproic Acid,0,
detection of oxidative stress,GO:0070994,"Epilepsy, Rolandic",MESH:D019305,3,Carbamazepine|Topiramate|Valproic Acid,0,
detection of oxidative stress,GO:0070994,"Epilepsy, Temporal Lobe",MESH:D004833,10,Capsaicin|Carbamazepine|Lamotrigine|Lithium Chloride|Methotrexate|Phenobarbital|Phenytoin|Plant Extracts|Topiramate|Valproic Acid,0,
detection of oxidative stress,GO:0070994,"Epilepsy, Tonic-Clonic",MESH:D004830,31,Acetaminophen|Aluminum|Amitriptyline|Bupivacaine|Buspirone|Busulfan|Carbamazepine|Chlormethiazole|Chloroquine|Chlorpromazine|Clonidine|Clozapine|Deferoxamine|Disulfiram|Ephedrine|Ethanol|Hexachlorocyclohexane|Lamotrigine|Lithium Chloride|Mechlorethamine|Methamphetamine|Methotrexate|Methylphenidate|Morphine|Pentylenetetrazole|Phenobarbital|Phenytoin|Plant Extracts|Topiramate|Valproic Acid|Vincristine,0,
detection of oxidative stress,GO:0070994,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
detection of renal blood flow,GO:0002000,Epilepsy,MESH:D004827,1,Folic Acid,0,
detection of symbiotic bacterium,GO:0009604,Epilepsy,MESH:D004827,1,Dexamethasone,0,
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,Epilepsy,MESH:D004827,3,Ketoconazole|Morphine|Naloxone,0,
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,"Epilepsy, Absence",MESH:D004832,1,Naloxone,0,
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,0,
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
detection of temperature stimulus involved in sensory perception of pain,GO:0050965,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Morphine|Naloxone|Vincristine,0,
detection of temperature stimulus involved in thermoception,GO:0050960,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
determination of adult lifespan,GO:0008340,Epilepsy,MESH:D004827,2,Ciprofloxacin|Plant Extracts,5,KCNQ2|POLG|SCN1A|SCN2A|TSC1
determination of adult lifespan,GO:0008340,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
determination of adult lifespan,GO:0008340,"Epilepsy, Benign Neonatal, 3",MESH:C564274,0,,1,SCN2A
determination of adult lifespan,GO:0008340,"Epilepsy, Generalized",MESH:D004829,0,,1,SCN1A
determination of adult lifespan,GO:0008340,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
determination of adult lifespan,GO:0008340,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ciprofloxacin|Plant Extracts,0,
determination of adult lifespan,GO:0008340,"Generalized Epilepsy With Febrile Seizures Plus, Type 2",MESH:C565810,0,,1,SCN1A
determination of affect,GO:0050894,Epilepsy,MESH:D004827,1,Dronabinol,0,
determination of heart left/right asymmetry,GO:0061371,Epilepsy,MESH:D004827,0,,1,FLNA
detoxification,GO:0098754,Epilepsy,MESH:D004827,1,Calcium,0,
detoxification of arsenic-containing substance,GO:0071722,Epilepsy,MESH:D004827,1,Folic Acid,0,
developmental growth,GO:0048589,Epilepsy,MESH:D004827,4,Atropine|Carbachol|Folic Acid|Methylmercury Compounds,1,SMC1A
developmental growth,GO:0048589,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
developmental growth,GO:0048589,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Atropine|Hexachlorocyclohexane,0,
developmental process,GO:0032502,Epilepsy,MESH:D004827,4,Carbachol|Ciprofloxacin|Cytarabine|Ketamine,0,
developmental process,GO:0032502,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ciprofloxacin,0,
developmental process involved in reproduction,GO:0003006,Epilepsy,MESH:D004827,1,Fluoxetine,1,STXBP1
diaphragm contraction,GO:0002086,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Soman,0,
dicarboxylic acid transport,GO:0006835,Epilepsy,MESH:D004827,0,,2,SLC1A2|SLC1A3
diestrus,GO:0060207,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
diet induced thermogenesis,GO:0002024,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
digestive tract development,GO:0048565,Epilepsy,MESH:D004827,0,,2,FLNA|TGFB1
dihydrofolate biosynthetic process,GO:0006761,Epilepsy,MESH:D004827,1,Methotrexate,0,
dihydrofolate biosynthetic process,GO:0006761,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
dihydrofolate biosynthetic process,GO:0006761,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
dihydrofolate biosynthetic process,GO:0006761,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
directional locomotion,GO:0033058,Epilepsy,MESH:D004827,0,,1,GRIN2A
directional locomotion,GO:0033058,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
directional locomotion,GO:0033058,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
DNA alkylation,GO:0006305,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Disulfiram|Mechlorethamine|Melphalan,0,
DNA amplification,GO:0006277,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Mebendazole,0,
DNA biosynthetic process,GO:0071897,Epilepsy,MESH:D004827,4,Dexamethasone|Folic Acid|Gentamicins|Phenobarbital,1,POLG
DNA biosynthetic process,GO:0071897,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Phenobarbital,0,
DNA biosynthetic process,GO:0071897,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
DNA biosynthetic process,GO:0071897,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
DNA biosynthetic process,GO:0071897,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
DNA biosynthetic process,GO:0071897,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Phenobarbital,0,
DNA catabolic process,GO:0006308,Epilepsy,MESH:D004827,7,Adenosine|Busulfan|Cisplatin|Cytarabine|Dexamethasone|Etoposide|Plant Extracts,0,
DNA catabolic process,GO:0006308,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
DNA catabolic process,GO:0006308,"Epilepsy, Generalized",MESH:D004829,1,Zidovudine,0,
DNA catabolic process,GO:0006308,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
DNA catabolic process,GO:0006308,"Epilepsy, Tonic-Clonic",MESH:D004830,7,Acetaminophen|Adenosine|Busulfan|Chlorpromazine|Deferoxamine|Paraoxon|Plant Extracts,0,
"DNA catabolic process, endonucleolytic",GO:0000737,Epilepsy,MESH:D004827,6,"Carbamazepine|carbidopa, levodopa drug combination|Cisplatin|N-Methyl-3,4-methylenedioxyamphetamine|Valproic Acid|Vitamin B 12",0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Epilepsy, Absence",MESH:D004832,3,Carbamazepine|Doxorubicin|Valproic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Epilepsy, Complex Partial",MESH:D017029,2,Carbamazepine|Valproic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Epilepsy, Generalized",MESH:D004829,2,Carbamazepine|Valproic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Epilepsy, Rolandic",MESH:D019305,2,Carbamazepine|Valproic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Epilepsy, Temporal Lobe",MESH:D004833,2,Carbamazepine|Valproic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Epilepsy, Tonic-Clonic",MESH:D004830,9,Acetaminophen|Caffeine|Carbamazepine|Chloroquine|Deferoxamine|Disulfiram|Ethanol|Methamphetamine|Valproic Acid,0,
"DNA catabolic process, endonucleolytic",GO:0000737,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
DNA damage checkpoint signaling,GO:0000077,Epilepsy,MESH:D004827,1,Plant Extracts,0,
DNA damage checkpoint signaling,GO:0000077,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
DNA damage checkpoint signaling,GO:0000077,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
"DNA damage response, signal transduction by p53 class mediator",GO:0030330,Epilepsy,MESH:D004827,1,Etoposide,0,
DNA hypermethylation,GO:0044026,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Soman,0,
DNA hypomethylation,GO:0044028,Epilepsy,MESH:D004827,2,Dexamethasone|Penicillamine,0,
DNA hypomethylation,GO:0044028,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Soman,0,
DNA integration,GO:0015074,Epilepsy,MESH:D004827,0,,1,CHD2
DNA integration,GO:0015074,"Epilepsy, Familial Adult Myoclonic, 3",MESH:C567098,0,,1,MARCHF6
DNA integration,GO:0015074,"EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS",OMIM:611726,0,,1,KCTD7
DNA integration,GO:0015074,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
DNA ligation,GO:0006266,Epilepsy,MESH:D004827,1,Etoposide,0,
DNA metabolic process,GO:0006259,Epilepsy,MESH:D004827,0,,1,POLG
DNA metabolic process,GO:0006259,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
DNA methylation,GO:0006306,Epilepsy,MESH:D004827,10,Adenosine|Amphetamine|Clozapine|Cytarabine|Dronabinol|Folic Acid|Haloperidol|Phenobarbital|Valproic Acid|Vitamin B 12,0,
DNA methylation,GO:0006306,"Epilepsy, Absence",MESH:D004832,4,Doxorubicin|Haloperidol|Phenobarbital|Valproic Acid,0,
DNA methylation,GO:0006306,"Epilepsy, Complex Partial",MESH:D017029,3,Clozapine|Phenobarbital|Valproic Acid,0,
DNA methylation,GO:0006306,"Epilepsy, Generalized",MESH:D004829,3,Clozapine|Phenobarbital|Valproic Acid,0,
DNA methylation,GO:0006306,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
DNA methylation,GO:0006306,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
DNA methylation,GO:0006306,"Epilepsy, Temporal Lobe",MESH:D004833,2,Phenobarbital|Valproic Acid,0,
DNA methylation,GO:0006306,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Adenosine|Clozapine|Cocaine|Haloperidol|Phenobarbital|Valproic Acid,0,
DNA methylation,GO:0006306,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
DNA methylation involved in embryo development,GO:0043045,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
DNA methylation on cytosine,GO:0032776,Epilepsy,MESH:D004827,1,Folic Acid,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,Epilepsy,MESH:D004827,4,Dronabinol|Folic Acid|Vitamin B 12|Vitamin B 6,0,
DNA methylation on cytosine within a CG sequence,GO:0010424,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
DNA modification,GO:0006304,Epilepsy,MESH:D004827,7,Cisplatin|Epinephrine|Folic Acid|Lithium|Methotrexate|Plant Extracts|Valproic Acid,0,
DNA modification,GO:0006304,"Epilepsy, Absence",MESH:D004832,3,Doxorubicin|Lithium Carbonate|Valproic Acid,0,
DNA modification,GO:0006304,"Epilepsy, Complex Partial",MESH:D017029,2,Methotrexate|Valproic Acid,0,
DNA modification,GO:0006304,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
DNA modification,GO:0006304,"Epilepsy, Reflex",MESH:D020195,2,Polychlorinated Biphenyls|Valproic Acid,0,
DNA modification,GO:0006304,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
DNA modification,GO:0006304,"Epilepsy, Temporal Lobe",MESH:D004833,4,Lithium|Methotrexate|Plant Extracts|Valproic Acid,0,
DNA modification,GO:0006304,"Epilepsy, Tonic-Clonic",MESH:D004830,9,Aluminum Hydroxide|Epinephrine|Lithium|Lithium Carbonate|Mechlorethamine|Melphalan|Methotrexate|Plant Extracts|Valproic Acid,0,
DNA modification,GO:0006304,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
DNA recombination,GO:0006310,"Epilepsy, Generalized",MESH:D004829,1,Zidovudine,0,
DNA repair,GO:0006281,Epilepsy,MESH:D004827,0,,2,SMC1A|TXNRD1
DNA repair,GO:0006281,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNA4
DNA repair,GO:0006281,"Epilepsy, Generalized",MESH:D004829,1,Zidovudine,0,
DNA repair,GO:0006281,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
DNA replication,GO:0006260,Epilepsy,MESH:D004827,1,Phenobarbital,3,ADRA2A|POLG|PURA
DNA replication,GO:0006260,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Phenobarbital,0,
DNA replication,GO:0006260,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
DNA replication,GO:0006260,"Epilepsy, Generalized",MESH:D004829,2,Phenobarbital|Zidovudine,0,
DNA replication,GO:0006260,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
DNA replication,GO:0006260,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Phenobarbital,0,
DNA replication initiation,GO:0006270,Epilepsy,MESH:D004827,0,,1,PURA
DNA replication proofreading,GO:0045004,Epilepsy,MESH:D004827,0,,1,POLG
DNA synthesis involved in DNA replication,GO:0090592,Epilepsy,MESH:D004827,1,Phenobarbital,0,
DNA synthesis involved in DNA replication,GO:0090592,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
DNA synthesis involved in DNA replication,GO:0090592,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
DNA synthesis involved in DNA replication,GO:0090592,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
DNA synthesis involved in DNA replication,GO:0090592,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
DNA synthesis involved in DNA replication,GO:0090592,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Phenobarbital,0,
DNA synthesis involved in mitotic DNA replication,GO:1904860,Epilepsy,MESH:D004827,1,Dexamethasone,0,
DNA synthesis involved in UV-damage excision repair,GO:1904161,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
DNA-templated DNA replication,GO:0006261,Epilepsy,MESH:D004827,0,,1,POLG
DNA topological change,GO:0006265,Epilepsy,MESH:D004827,1,Etoposide,0,
DNA unwinding involved in DNA replication,GO:0006268,Epilepsy,MESH:D004827,0,,1,PURA
dolichol-linked oligosaccharide biosynthetic process,GO:0006488,Epilepsy,MESH:D004827,0,,1,ALG13
dopamine biosynthetic process,GO:0042416,Epilepsy,MESH:D004827,4,Haloperidol|Morphine|Plant Extracts|Topiramate,0,
dopamine biosynthetic process,GO:0042416,"Epilepsy, Absence",MESH:D004832,2,4-Butyrolactone|Haloperidol,0,
dopamine biosynthetic process,GO:0042416,"Epilepsy, Complex Partial",MESH:D017029,1,Topiramate,0,
dopamine biosynthetic process,GO:0042416,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
dopamine biosynthetic process,GO:0042416,"Epilepsy, Rolandic",MESH:D019305,1,Topiramate,0,
dopamine biosynthetic process,GO:0042416,"Epilepsy, Temporal Lobe",MESH:D004833,2,Plant Extracts|Topiramate,0,
dopamine biosynthetic process,GO:0042416,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Cocaine|Haloperidol|Methamphetamine|Morphine|Plant Extracts|Topiramate,0,
dopamine metabolic process,GO:0042417,Epilepsy,MESH:D004827,6,"carbidopa, levodopa drug combination|daidzin|Fluoxetine|phosphinothricin|Plant Extracts|Valproic Acid",2,GRIN2A|SLC1A1
dopamine metabolic process,GO:0042417,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
dopamine metabolic process,GO:0042417,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
dopamine metabolic process,GO:0042417,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
dopamine metabolic process,GO:0042417,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
dopamine metabolic process,GO:0042417,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
dopamine metabolic process,GO:0042417,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,1,GRIN2A
dopamine metabolic process,GO:0042417,"Epilepsy, Temporal Lobe",MESH:D004833,2,Plant Extracts|Valproic Acid,1,SLC1A1
dopamine metabolic process,GO:0042417,"Epilepsy, Tonic-Clonic",MESH:D004830,8,Acetaminophen|Aluminum Hydroxide|Chloroquine|Ethanol|Methamphetamine|Plant Extracts|Valproic Acid|Venlafaxine Hydrochloride,0,
dopamine metabolic process,GO:0042417,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
dopamine receptor signaling pathway,GO:0007212,Epilepsy,MESH:D004827,0,,2,GNAO1|SLC1A1
dopamine receptor signaling pathway,GO:0007212,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
dopaminergic neuron differentiation,GO:0071542,Epilepsy,MESH:D004827,0,,1,BDNF
dopaminergic neuron differentiation,GO:0071542,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
dopaminergic neuron differentiation,GO:0071542,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methylphenidate,1,BDNF
dopamine secretion,GO:0014046,Epilepsy,MESH:D004827,5,Amphetamine|Atropine|Dextroamphetamine|Haloperidol|phosphinothricin,0,
dopamine secretion,GO:0014046,"Epilepsy, Absence",MESH:D004832,1,Haloperidol,0,
dopamine secretion,GO:0014046,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNB2
dopamine secretion,GO:0014046,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
dopamine secretion,GO:0014046,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Atropine|Haloperidol|Methamphetamine|Methylphenidate|Paraoxon,0,
"dopamine secretion, neurotransmission",GO:0061527,Epilepsy,MESH:D004827,1,Dronabinol,0,
dopamine transport,GO:0015872,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
dopamine uptake,GO:0090494,Epilepsy,MESH:D004827,1,Amphetamine,0,
dopamine uptake,GO:0090494,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Cocaine,0,
dorsal/ventral axon guidance,GO:0033563,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
dorsal/ventral pattern formation,GO:0009953,Epilepsy,MESH:D004827,0,,2,ALG13|FOXG1
dosage compensation by inactivation of X chromosome,GO:0009048,Epilepsy,MESH:D004827,0,,1,HNRNPU
double-strand break repair,GO:0006302,Epilepsy,MESH:D004827,0,,1,SMC1A
double-strand break repair via homologous recombination,GO:0000724,Epilepsy,MESH:D004827,2,Cisplatin|Valproic Acid,0,
double-strand break repair via homologous recombination,GO:0000724,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
double-strand break repair via homologous recombination,GO:0000724,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
double-strand break repair via homologous recombination,GO:0000724,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
double-strand break repair via homologous recombination,GO:0000724,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
double-strand break repair via homologous recombination,GO:0000724,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
double-strand break repair via homologous recombination,GO:0000724,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
double-strand break repair via homologous recombination,GO:0000724,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Mechlorethamine|Valproic Acid,0,
double-strand break repair via homologous recombination,GO:0000724,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
double-strand break repair via nonhomologous end joining,GO:0006303,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
doxorubicin transport,GO:1900753,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
doxorubicin transport,GO:1900753,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
drinking behavior,GO:0042756,Epilepsy,MESH:D004827,5,Cisplatin|Dronabinol|Gabapentin|Plant Extracts|Valproic Acid,0,
drinking behavior,GO:0042756,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
drinking behavior,GO:0042756,"Epilepsy, Complex Partial",MESH:D017029,2,Gabapentin|Valproic Acid,0,
drinking behavior,GO:0042756,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
drinking behavior,GO:0042756,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
drinking behavior,GO:0042756,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
drinking behavior,GO:0042756,"Epilepsy, Temporal Lobe",MESH:D004833,2,Plant Extracts|Valproic Acid,0,
drinking behavior,GO:0042756,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Ethanol|Gabapentin|Methamphetamine|Plant Extracts|Valproic Acid,1,OXT
drinking behavior,GO:0042756,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
ear development,GO:0043583,Epilepsy,MESH:D004827,1,Folic Acid,1,SLC12A2
ear development,GO:0043583,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
ear development,GO:0043583,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
early endosome to late endosome transport,GO:0045022,Epilepsy,MESH:D004827,0,,1,FLNA
eating behavior,GO:0042755,Epilepsy,MESH:D004827,1,Plant Extracts,2,OPRD1|OPRM1
eating behavior,GO:0042755,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
eating behavior,GO:0042755,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Ethanol|Paroxetine|Plant Extracts,1,OXT
electron transport chain,GO:0022900,Epilepsy,MESH:D004827,2,Morphine|nimesulide,0,
electron transport chain,GO:0022900,"Epilepsy, Temporal Lobe",MESH:D004833,1,Capsaicin,0,
electron transport chain,GO:0022900,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Cocaine|Morphine,0,
embryo development,GO:0009790,Epilepsy,MESH:D004827,11,Atropine|Carbachol|Dexamethasone|Dronabinol|Epinephrine|Folic Acid|gamma-Aminobutyric Acid|Ketamine|Methylmercury Compounds|Thalidomide|Valproic Acid,4,ANKRD11|GRIN2B|MECP2|TSC1
embryo development,GO:0009790,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
embryo development,GO:0009790,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
embryo development,GO:0009790,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
embryo development,GO:0009790,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
embryo development,GO:0009790,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
embryo development,GO:0009790,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
embryo development,GO:0009790,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Atropine|Caffeine|Diclofenac|Epinephrine|Ethanol|Valproic Acid,0,
embryo development,GO:0009790,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
embryo development ending in birth or egg hatching,GO:0009792,Epilepsy,MESH:D004827,1,Folic Acid,0,
embryo development ending in birth or egg hatching,GO:0009792,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
embryo implantation,GO:0007566,Epilepsy,MESH:D004827,2,Epinephrine|gamma-Aminobutyric Acid,0,
embryo implantation,GO:0007566,"Epilepsy, Absence",MESH:D004832,1,Progesterone,0,
embryo implantation,GO:0007566,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
embryo implantation,GO:0007566,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Epinephrine,0,
embryonic body morphogenesis,GO:0010172,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
embryonic brain development,GO:1990403,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
embryonic brain development,GO:1990403,Epilepsy,MESH:D004827,0,,1,CNTNAP2
embryonic brain development,GO:1990403,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
embryonic camera-type eye development,GO:0031076,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NES
embryonic cleavage,GO:0040016,Epilepsy,MESH:D004827,1,Dronabinol,0,
embryonic cranial skeleton morphogenesis,GO:0048701,Epilepsy,MESH:D004827,1,Ketamine,1,CDKL5
embryonic digit morphogenesis,GO:0042733,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
embryonic forelimb morphogenesis,GO:0035115,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
embryonic heart tube development,GO:0035050,Epilepsy,MESH:D004827,0,,1,MEF2C
embryonic heart tube development,GO:0035050,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
embryonic hemopoiesis,GO:0035162,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
embryonic hindlimb morphogenesis,GO:0035116,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
embryonic limb morphogenesis,GO:0030326,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
embryonic liver development,GO:1990402,Epilepsy,MESH:D004827,1,Dronabinol,1,TGFB1
embryonic morphogenesis,GO:0048598,Epilepsy,MESH:D004827,2,Dronabinol|Fluoxetine,0,
embryonic morphogenesis,GO:0048598,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
embryonic nail plate morphogenesis,GO:0035880,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
embryonic organ development,GO:0048568,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Buspirone,0,
embryonic skeletal system development,GO:0048706,Epilepsy,MESH:D004827,1,Dexamethasone,0,
embryonic skeletal system morphogenesis,GO:0048704,Epilepsy,MESH:D004827,0,,1,MEF2C
embryonic viscerocranium morphogenesis,GO:0048703,Epilepsy,MESH:D004827,0,,1,MEF2C
endocannabinoid signaling pathway,GO:0071926,Epilepsy,MESH:D004827,1,Dronabinol,0,
endocardial progenitor cell migration to the midline involved in heart field formation,GO:0003262,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
endocardium development,GO:0003157,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
endochondral bone growth,GO:0003416,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
endochondral ossification,GO:0001958,Epilepsy,MESH:D004827,1,Dexamethasone,1,MEF2C
endochondral ossification,GO:0001958,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TEK
endocytosis,GO:0006897,Epilepsy,MESH:D004827,2,"N-Methyl-3,4-methylenedioxyamphetamine|Plant Extracts",3,DNM1|KCNQ2|TSC2
endocytosis,GO:0006897,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
endocytosis,GO:0006897,"Epilepsy, Generalized",MESH:D004829,1,Prednisolone,1,CHRNA7
endocytosis,GO:0006897,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
endocytosis,GO:0006897,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
endoderm development,GO:0007492,Epilepsy,MESH:D004827,0,,1,TGFB1
endoplasmic reticulum calcium ion homeostasis,GO:0032469,Epilepsy,MESH:D004827,1,Calcium,0,
endoplasmic reticulum calcium ion homeostasis,GO:0032469,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Procaine,0,
endoplasmic reticulum disassembly,GO:1905692,Epilepsy,MESH:D004827,1,Ciprofloxacin,0,
endoplasmic reticulum disassembly,GO:1905692,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ciprofloxacin,0,
endoplasmic reticulum mannose trimming,GO:1904380,"Epilepsy, Familial Adult Myoclonic, 3",MESH:C567098,0,,1,MARCHF6
endoplasmic reticulum organization,GO:0007029,Epilepsy,MESH:D004827,0,,1,CERT1
endoplasmic reticulum organization,GO:0007029,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Caffeine|Dizocilpine Maleate|Ethanol,0,
endoplasmic reticulum organization,GO:0007029,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1",OMIM:614231,0,,1,IER3IP1
endoplasmic reticulum to Golgi vesicle-mediated transport,GO:0006888,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1",OMIM:614231,0,,1,IER3IP1
endoplasmic reticulum unfolded protein response,GO:0030968,Epilepsy,MESH:D004827,0,,1,ERN1
endosomal lumen acidification,GO:0048388,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
endosomal transport,GO:0016197,Epilepsy,MESH:D004827,0,,1,SNAP25
endosomal transport,GO:0016197,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
endosome lysis involved in viral entry into host cell,GO:0075514,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
endosome organization,GO:0007032,Epilepsy,MESH:D004827,0,,2,CERT1|DNM1
endosome organization,GO:0007032,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
endosome to plasma membrane protein transport,GO:0099638,"EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE",OMIM:254900,0,,1,SCARB2
endothelial cell activation,GO:0042118,Epilepsy,MESH:D004827,0,,1,P2RX4
endothelial cell activation,GO:0042118,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX4
endothelial cell chemotaxis,GO:0035767,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
endothelial cell development,GO:0001885,Epilepsy,MESH:D004827,0,,2,GPX1|ILK
endothelial cell differentiation,GO:0045446,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
endothelial cell migration,GO:0043542,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
endothelial cell migration,GO:0043542,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
endothelial cell proliferation,GO:0001935,Epilepsy,MESH:D004827,0,,1,ERN1
endothelial cell proliferation,GO:0001935,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,TEK|VEGFA
endothelial cell proliferation,GO:0001935,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
endothelial microparticle formation,GO:0072565,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Tranexamic Acid,0,
endothelial to hematopoietic transition,GO:0098508,Epilepsy,MESH:D004827,1,Thalidomide,0,
endothelial tube formation,GO:0120331,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
endothelial tube lumen extension,GO:0097498,Epilepsy,MESH:D004827,1,Dronabinol,0,
endothelial tube morphogenesis,GO:0061154,Epilepsy,MESH:D004827,1,Ketoconazole,0,
endothelial tube morphogenesis,GO:0061154,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
endothelial tube morphogenesis,GO:0061154,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Sodium Chloride,0,
endothelium development,GO:0003158,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
energy derivation by oxidation of organic compounds,GO:0015980,Epilepsy,MESH:D004827,1,Dexamethasone,0,
enteric nervous system development,GO:0048484,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NTF3
enteroendocrine cell differentiation,GO:0035883,Epilepsy,MESH:D004827,0,,1,TSC1
entrainment of circadian clock,GO:0009649,Epilepsy,MESH:D004827,0,,1,CHRM1
entry of bacterium into host cell,GO:0035635,Epilepsy,MESH:D004827,1,Ketoconazole,0,
eosinophil extravasation,GO:0072682,Epilepsy,MESH:D004827,1,Dexamethasone,0,
eosinophil migration,GO:0072677,Epilepsy,MESH:D004827,2,Dexamethasone|Methotrexate,0,
eosinophil migration,GO:0072677,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
eosinophil migration,GO:0072677,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
eosinophil migration,GO:0072677,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
ephrin receptor signaling pathway,GO:0048013,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|TEK
epidermal growth factor receptor signaling pathway,GO:0007173,Epilepsy,MESH:D004827,0,,1,AKT1
epidermal growth factor receptor signaling pathway,GO:0007173,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|TEK
epidermal growth factor receptor signaling pathway,GO:0007173,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,HBEGF
epidermal growth factor receptor signaling pathway,GO:0007173,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
epidermis development,GO:0008544,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NTF3
epidermis morphogenesis,GO:0048730,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
epigenetic regulation of gene expression,GO:0040029,Epilepsy,MESH:D004827,2,Dexamethasone|Sevoflurane,2,GPX1|MECP2
epinephrine metabolic process,GO:0042414,Epilepsy,MESH:D004827,1,Epinephrine,0,
epinephrine metabolic process,GO:0042414,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Epinephrine,0,
epithelial cell differentiation,GO:0030855,Epilepsy,MESH:D004827,0,,1,VDAC1
epithelial cell differentiation,GO:0030855,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
epithelial cell maturation,GO:0002070,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|VEGFA
epithelial cell proliferation,GO:0050673,Epilepsy,MESH:D004827,0,,2,PURA|TGFB1
epithelial cell proliferation,GO:0050673,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|VEGFA
epithelial cell proliferation,GO:0050673,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
epithelial cell proliferation involved in renal tubule morphogenesis,GO:2001013,Epilepsy,MESH:D004827,0,,1,MEF2C
epithelial fluid transport,GO:0042045,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Sodium Chloride,0,
epithelial structure maintenance,GO:0010669,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Deferoxamine,0,
epithelial to mesenchymal transition,GO:0001837,Epilepsy,MESH:D004827,0,,2,FLNA|TGFB1
ERAD pathway,GO:0036503,"Epilepsy, Familial Adult Myoclonic, 3",MESH:C567098,0,,1,MARCHF6
ERBB2-EGFR signaling pathway,GO:0038134,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,HBEGF
ERBB2-ERBB4 signaling pathway,GO:0038135,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,HBEGF
ERK1 and ERK2 cascade,GO:0070371,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
ERK1 and ERK2 cascade,GO:0070371,Epilepsy,MESH:D004827,1,Plant Extracts,1,CNTNAP2
ERK1 and ERK2 cascade,GO:0070371,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
ERK1 and ERK2 cascade,GO:0070371,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Plant Extracts|Sertraline,1,FGF2
ER overload response,GO:0006983,"Epilepsy, Temporal Lobe",MESH:D004833,1,Sialic Acids,0,
ER to Golgi ceramide transport,GO:0035621,Epilepsy,MESH:D004827,1,Dronabinol,1,CERT1
erythrocyte differentiation,GO:0030218,Epilepsy,MESH:D004827,1,Folic Acid,2,HNRNPU|SELENOW
erythrocyte homeostasis,GO:0034101,Epilepsy,MESH:D004827,1,Calcium,0,
erythrocyte homeostasis,GO:0034101,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
erythrocyte homeostasis,GO:0034101,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Deferoxamine,0,
erythromycin metabolic process,GO:1901113,Epilepsy,MESH:D004827,4,Dexamethasone|Erythromycin|Ketoconazole|Phenobarbital,0,
erythromycin metabolic process,GO:1901113,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
erythromycin metabolic process,GO:1901113,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
erythromycin metabolic process,GO:1901113,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
erythromycin metabolic process,GO:1901113,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
erythromycin metabolic process,GO:1901113,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Erythromycin|Phenobarbital,0,
establishment of bipolar cell polarity involved in cell morphogenesis,GO:0061159,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
establishment of blood-brain barrier,GO:0060856,Epilepsy,MESH:D004827,3,daidzin|Diazepam|Pentylenetetrazole,0,
establishment of blood-brain barrier,GO:0060856,"Epilepsy, Absence",MESH:D004832,2,Diazepam|Pentylenetetrazole,0,
establishment of blood-brain barrier,GO:0060856,"Epilepsy, Complex Partial",MESH:D017029,1,Diazepam,0,
establishment of blood-brain barrier,GO:0060856,"Epilepsy, Generalized",MESH:D004829,1,Diazepam,0,
establishment of blood-brain barrier,GO:0060856,"Epilepsy, Temporal Lobe",MESH:D004833,1,Clioquinol,0,
establishment of blood-brain barrier,GO:0060856,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Diazepam|Pentylenetetrazole,0,
establishment of body hair or bristle planar orientation,GO:0048104,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
establishment of cell polarity,GO:0030010,Epilepsy,MESH:D004827,0,,2,KCNQ2|TSC2
establishment of cell polarity,GO:0030010,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
establishment of cell polarity,GO:0030010,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
establishment of endothelial barrier,GO:0061028,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Procaine,0,
establishment of endothelial blood-brain barrier,GO:0014045,Epilepsy,MESH:D004827,1,Valproic Acid,0,
establishment of endothelial blood-brain barrier,GO:0014045,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
establishment of endothelial blood-brain barrier,GO:0014045,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
establishment of endothelial blood-brain barrier,GO:0014045,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
establishment of endothelial blood-brain barrier,GO:0014045,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
establishment of endothelial blood-brain barrier,GO:0014045,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
establishment of endothelial blood-brain barrier,GO:0014045,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
establishment of endothelial blood-brain barrier,GO:0014045,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
establishment of endothelial blood-brain barrier,GO:0014045,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,Epilepsy,MESH:D004827,2,Ampicillin|Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Methamphetamine|Metronidazole|Valproic Acid,0,
establishment of endothelial intestinal barrier,GO:0090557,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
establishment of imaginal disc-derived wing hair orientation,GO:0001737,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
establishment of localization in cell,GO:0051649,Epilepsy,MESH:D004827,1,Dexamethasone,3,SCN1A|SNAP25|STXBP1
establishment of localization in cell,GO:0051649,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
establishment of localization in cell,GO:0051649,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
establishment of localization in cell,GO:0051649,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNB2
establishment of localization in cell,GO:0051649,"Epilepsy, Generalized",MESH:D004829,0,,2,CHRNA7|SCN1A
establishment of localization in cell,GO:0051649,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
establishment of localization in cell,GO:0051649,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
establishment of localization in cell,GO:0051649,"Generalized Epilepsy With Febrile Seizures Plus, Type 2",MESH:C565810,0,,1,SCN1A
establishment of meiotic sister chromatid cohesion,GO:0034089,Epilepsy,MESH:D004827,0,,1,SMC1A
establishment of mitotic sister chromatid cohesion,GO:0034087,Epilepsy,MESH:D004827,0,,1,SMC1A
establishment of planar polarity,GO:0001736,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
establishment of planar polarity,GO:0001736,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
establishment of protein localization,GO:0045184,Epilepsy,MESH:D004827,0,,2,FLNA|SLC1A1
establishment of protein localization,GO:0045184,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
establishment of protein localization,GO:0045184,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
establishment of protein localization to chromatin,GO:0071169,Epilepsy,MESH:D004827,2,Cisplatin|Methotrexate,0,
establishment of protein localization to chromatin,GO:0071169,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
establishment of protein localization to chromatin,GO:0071169,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
establishment of protein localization to chromatin,GO:0071169,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
establishment of protein localization to juxtaparanode region of axon,GO:0071206,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
establishment of protein localization to mitochondrion,GO:0072655,Epilepsy,MESH:D004827,0,,1,AKT1
establishment of protein localization to plasma membrane,GO:0061951,Epilepsy,MESH:D004827,6,Dexamethasone|Epinephrine|Haloperidol|Imipramine|Maprotiline|Protriptyline,0,
establishment of protein localization to plasma membrane,GO:0061951,"Epilepsy, Absence",MESH:D004832,2,Haloperidol|Promazine,0,
establishment of protein localization to plasma membrane,GO:0061951,"Epilepsy, Tonic-Clonic",MESH:D004830,11,Chloroquine|Disulfiram|Epinephrine|Haloperidol|Imipramine|Maprotiline|Methylprednisolone|Nortriptyline|Paroxetine|Prednisone|Proguanil,0,
establishment of Sertoli cell barrier,GO:0097368,Epilepsy,MESH:D004827,1,Busulfan,1,FLNA
establishment of Sertoli cell barrier,GO:0097368,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Busulfan,0,
establishment of skin barrier,GO:0061436,Epilepsy,MESH:D004827,1,Ketoconazole,0,
establishment of skin barrier,GO:0061436,"Epilepsy, Myoclonic, Benign Adult Familial, Type 2",MESH:C564313,0,,1,STARD7
establishment of skin barrier,GO:0061436,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
establishment or maintenance of cell polarity,GO:0007163,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
establishment or maintenance of epithelial cell apical/basal polarity,GO:0045197,Epilepsy,MESH:D004827,0,,1,ILK
estradiol secretion,GO:0035938,Epilepsy,MESH:D004827,1,Dronabinol,0,
estradiol secretion,GO:0035938,"Epilepsy, Temporal Lobe",MESH:D004833,1,Medroxyprogesterone Acetate,0,
estradiol secretion,GO:0035938,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
estrogen biosynthetic process,GO:0006703,Epilepsy,MESH:D004827,4,gamma-Aminobutyric Acid|Ketamine|Ketoconazole|Methylmercury Compounds,0,
estrogen catabolic process,GO:0006711,Epilepsy,MESH:D004827,1,Plant Extracts,0,
estrogen catabolic process,GO:0006711,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
estrogen catabolic process,GO:0006711,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
estrogen metabolic process,GO:0008210,Epilepsy,MESH:D004827,5,Cisplatin|Estrogens|Lamotrigine|Methotrexate|Plant Extracts,0,
estrogen metabolic process,GO:0008210,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Lamotrigine,0,
estrogen metabolic process,GO:0008210,"Epilepsy, Complex Partial",MESH:D017029,2,Lamotrigine|Methotrexate,0,
estrogen metabolic process,GO:0008210,"Epilepsy, Generalized",MESH:D004829,1,Lamotrigine,0,
estrogen metabolic process,GO:0008210,"Epilepsy, Temporal Lobe",MESH:D004833,3,Lamotrigine|Methotrexate|Plant Extracts,0,
estrogen metabolic process,GO:0008210,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Acetaminophen|Lamotrigine|Methotrexate|Plant Extracts,1,CYP2D6
estrogen secretion,GO:0035937,Epilepsy,MESH:D004827,2,Adenosine|Plant Extracts,0,
estrogen secretion,GO:0035937,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
estrogen secretion,GO:0035937,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Adenosine|Plant Extracts,0,
estrous cycle,GO:0044849,Epilepsy,MESH:D004827,1,Cisplatin,1,OPRM1
estrous cycle,GO:0044849,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Acetaminophen|Caffeine|Dinoprost|Vincristine,0,
estrus,GO:0060209,Epilepsy,MESH:D004827,1,daidzin,0,
estrus,GO:0060209,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
ethanolamine metabolic process,GO:0006580,Epilepsy,MESH:D004827,1,Methotrexate,0,
ethanolamine metabolic process,GO:0006580,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
ethanolamine metabolic process,GO:0006580,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
ethanolamine metabolic process,GO:0006580,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
ethanol metabolic process,GO:0006067,Epilepsy,MESH:D004827,1,Propofol,0,
ethanol metabolic process,GO:0006067,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
ethanol metabolic process,GO:0006067,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Propofol,0,
ether lipid biosynthetic process,GO:0008611,Epilepsy,MESH:D004827,1,Valproic Acid,0,
ether lipid biosynthetic process,GO:0008611,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
ether lipid biosynthetic process,GO:0008611,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
ether lipid biosynthetic process,GO:0008611,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
ether lipid biosynthetic process,GO:0008611,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
ether lipid biosynthetic process,GO:0008611,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
ether lipid biosynthetic process,GO:0008611,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
ether lipid biosynthetic process,GO:0008611,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
ether lipid biosynthetic process,GO:0008611,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
evoked excitatory postsynaptic potential,GO:0098817,Epilepsy,MESH:D004827,11,"4-Aminopyridine|6-Cyano-7-nitroquinoxaline-2,3-dione|Calcium|Dronabinol|Kainic Acid|Penicillin G|Pentylenetetrazole|Picrotoxin|Pilocarpine|Pregabalin|Strychnine",0,
evoked excitatory postsynaptic potential,GO:0098817,"Epilepsy, Absence",MESH:D004832,3,Pentylenetetrazole|Picrotoxin|Pilocarpine,0,
evoked excitatory postsynaptic potential,GO:0098817,"Epilepsy, Generalized",MESH:D004829,1,Pregabalin,0,
evoked excitatory postsynaptic potential,GO:0098817,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
evoked excitatory postsynaptic potential,GO:0098817,"Epilepsy, Temporal Lobe",MESH:D004833,2,Kainic Acid|Pilocarpine,0,
evoked excitatory postsynaptic potential,GO:0098817,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Bupropion|Caffeine|Penicillin G|Pentylenetetrazole|Picrotoxin|Pilocarpine,0,
evoked neurotransmitter secretion,GO:0061670,Epilepsy,MESH:D004827,1,Propofol,0,
evoked neurotransmitter secretion,GO:0061670,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
evoked neurotransmitter secretion,GO:0061670,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
excitatory chemical synaptic transmission,GO:0098976,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
excitatory chemical synaptic transmission,GO:0098976,Epilepsy,MESH:D004827,0,,5,CNTNAP2|GRIN2A|GRIN2B|KCNQ2|TSC2
excitatory chemical synaptic transmission,GO:0098976,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
excitatory chemical synaptic transmission,GO:0098976,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
excitatory chemical synaptic transmission,GO:0098976,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
excitatory chemical synaptic transmission,GO:0098976,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
excitatory postsynaptic potential,GO:0060079,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
excitatory postsynaptic potential,GO:0060079,Epilepsy,MESH:D004827,22,"2-(2,3-dicarboxycyclopropyl)glycine|4-Aminopyridine|6-Cyano-7-nitroquinoxaline-2,3-dione|Amphetamine|Atropine|Calcium|Carbachol|Carbamazepine|Enkephalin, Ala(2)-MePhe(4)-Gly(5)-|Excitatory Amino Acid Agents|Haloperidol|Imipramine|Ketamine|Lamotrigine|Levetiracetam|Magnesium|Morphine|Naloxone|Norepinephrine|Phenytoin|Picrotoxin|Topiramate",11,AKT1|BDNF|CNTNAP2|GRIN2A|GRIN2B|MECP2|MEF2C|OPRM1|P2RX2|P2RX4|PCDH19
excitatory postsynaptic potential,GO:0060079,"Epilepsy, Absence",MESH:D004832,8,Carbamazepine|CGP 35348|Haloperidol|Lamotrigine|Levetiracetam|Naloxone|Phenytoin|Picrotoxin,0,
excitatory postsynaptic potential,GO:0060079,"Epilepsy, Complex Partial",MESH:D017029,5,Carbamazepine|Lamotrigine|Levetiracetam|Phenytoin|Topiramate,0,
excitatory postsynaptic potential,GO:0060079,"Epilepsy, Female-Restricted, with Mental Retardation",MESH:C564715,0,,1,PCDH19
excitatory postsynaptic potential,GO:0060079,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
excitatory postsynaptic potential,GO:0060079,"Epilepsy, Frontal Lobe",MESH:D017034,0,,2,CHRNA4|CHRNB2
excitatory postsynaptic potential,GO:0060079,"Epilepsy, Generalized",MESH:D004829,4,Carbamazepine|Lamotrigine|Naloxone|Phenytoin,1,CHRNA7
excitatory postsynaptic potential,GO:0060079,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
excitatory postsynaptic potential,GO:0060079,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
excitatory postsynaptic potential,GO:0060079,"Epilepsy, Nocturnal Frontal Lobe, Type 4",MESH:C563679,0,,1,CHRNA2
excitatory postsynaptic potential,GO:0060079,"Epilepsy, Rolandic",MESH:D019305,2,Carbamazepine|Topiramate,1,GRIN2A
excitatory postsynaptic potential,GO:0060079,"Epilepsy, Temporal Lobe",MESH:D004833,7,Capsaicin|Carbamazepine|Lamotrigine|Levetiracetam|Phenytoin|Tacrolimus|Topiramate,3,P2RX4|P2RX7|TRPV1
excitatory postsynaptic potential,GO:0060079,"Epilepsy, Tonic-Clonic",MESH:D004830,15,Atropine|Carbamazepine|Cocaine|Haloperidol|Imipramine|Lamotrigine|Levetiracetam|Morphine|Naloxone|Paraoxon|Phenytoin|Picrotoxin|Quinine|Tacrolimus|Topiramate,1,BDNF
excitatory postsynaptic potential,GO:0060079,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Levetiracetam,0,
excitatory synapse assembly,GO:1904861,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
excitatory synapse assembly,GO:1904861,Epilepsy,MESH:D004827,0,,1,CNTNAP2
excretion,GO:0007588,Epilepsy,MESH:D004827,1,Cisplatin,0,
execution phase of apoptosis,GO:0097194,Epilepsy,MESH:D004827,0,,1,AKT1
exocytic insertion of neurotransmitter receptor to postsynaptic membrane,GO:0098967,Epilepsy,MESH:D004827,0,,1,STX1B
exocytic insertion of neurotransmitter receptor to postsynaptic membrane,GO:0098967,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9",OMIM:616172,0,,1,STX1B
exocytosis,GO:0006887,Epilepsy,MESH:D004827,1,Propofol,3,KCNQ2|SNAP25|STXBP1
exocytosis,GO:0006887,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
exocytosis,GO:0006887,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
exocytosis,GO:0006887,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
exosomal secretion,GO:1990182,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
exploration behavior,GO:0035640,Epilepsy,MESH:D004827,9,Cisplatin|Dexamethasone|Diazepam|Dronabinol|Flumazenil|Fluoxetine|Haloperidol|Morphine|Valproic Acid,2,GABRB3|KCNQ2
exploration behavior,GO:0035640,"Epilepsy, Absence",MESH:D004832,3,Diazepam|Haloperidol|Valproic Acid,1,GABRB3
exploration behavior,GO:0035640,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
exploration behavior,GO:0035640,"Epilepsy, Complex Partial",MESH:D017029,2,Diazepam|Valproic Acid,0,
exploration behavior,GO:0035640,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNA4
exploration behavior,GO:0035640,"Epilepsy, Generalized",MESH:D004829,2,Diazepam|Valproic Acid,0,
exploration behavior,GO:0035640,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
exploration behavior,GO:0035640,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
exploration behavior,GO:0035640,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
exploration behavior,GO:0035640,"Epilepsy, Temporal Lobe",MESH:D004833,2,Tacrolimus|Valproic Acid,0,
exploration behavior,GO:0035640,"Epilepsy, Tonic-Clonic",MESH:D004830,8,Diazepam|Ethanol|Haloperidol|Methamphetamine|Morphine|Tacrolimus|Valproic Acid|Venlafaxine Hydrochloride,0,
exploration behavior,GO:0035640,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
export across plasma membrane,GO:0140115,Epilepsy,MESH:D004827,1,Dexamethasone,1,ABCB1
external genitalia morphogenesis,GO:0035261,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
extracellular exosome assembly,GO:0071971,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
extracellular exosome biogenesis,GO:0097734,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
extracellular matrix assembly,GO:0085029,Epilepsy,MESH:D004827,0,,1,TGFB1
extracellular matrix assembly,GO:0085029,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
extracellular matrix organization,GO:0030198,Epilepsy,MESH:D004827,0,,2,GFAP|SLC12A5
extracellular matrix organization,GO:0030198,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,SLC12A5
extracellular matrix organization,GO:0030198,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A5
extracellular vesicle biogenesis,GO:0140112,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Ethanol,0,
extraembryonic membrane development,GO:1903867,Epilepsy,MESH:D004827,1,phosphinothricin,0,
extrinsic apoptotic signaling pathway,GO:0097191,Epilepsy,MESH:D004827,0,,1,TGFB1
extrinsic apoptotic signaling pathway,GO:0097191,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
extrinsic apoptotic signaling pathway,GO:0097191,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Sertraline,0,
extrinsic apoptotic signaling pathway in absence of ligand,GO:0097192,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NGF
extrinsic apoptotic signaling pathway via death domain receptors,GO:0008625,Epilepsy,MESH:D004827,1,Plant Extracts,1,DDX3X
extrinsic apoptotic signaling pathway via death domain receptors,GO:0008625,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
extrinsic apoptotic signaling pathway via death domain receptors,GO:0008625,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,1,NGF
eye blink reflex,GO:0060082,Epilepsy,MESH:D004827,1,Dronabinol,0,
eye blink reflex,GO:0060082,Generalized Epilepsy and Paroxysmal Dyskinesia,MESH:C563719,0,,1,KCNMA1
eye development,GO:0001654,Epilepsy,MESH:D004827,1,Dronabinol,0,
eye development,GO:0001654,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
eyelid development in camera-type eye,GO:0061029,Epilepsy,MESH:D004827,1,Valproic Acid,0,
eyelid development in camera-type eye,GO:0061029,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
eyelid development in camera-type eye,GO:0061029,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
eyelid development in camera-type eye,GO:0061029,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
eyelid development in camera-type eye,GO:0061029,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
eyelid development in camera-type eye,GO:0061029,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
eyelid development in camera-type eye,GO:0061029,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
eyelid development in camera-type eye,GO:0061029,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
eyelid development in camera-type eye,GO:0061029,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
eyelid development in camera-type eye,GO:0061029,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
eye photoreceptor cell development,GO:0042462,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
eye pigmentation,GO:0048069,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
face development,GO:0060324,Epilepsy,MESH:D004827,0,,1,ANKRD11
face morphogenesis,GO:0060325,Epilepsy,MESH:D004827,0,,2,ANKRD11|TGFB1
face morphogenesis,GO:0060325,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
fat cell differentiation,GO:0045444,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
fat cell differentiation,GO:0045444,Epilepsy,MESH:D004827,5,Dexamethasone|Estrogens|Lithium Chloride|Methylmercury Compounds|Thiobarbituric Acid Reactive Substances,2,CNTNAP2|GPX1
fat cell differentiation,GO:0045444,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
fat cell differentiation,GO:0045444,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium Chloride,0,
fat cell differentiation,GO:0045444,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Chloroquine|Lithium Chloride|Paraoxon,0,
fat cell proliferation,GO:0070341,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methylprednisolone,0,
fat pad development,GO:0060613,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
fat pad development,GO:0060613,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
fatty acid beta-oxidation,GO:0006635,Epilepsy,MESH:D004827,1,Dexamethasone,0,
fatty acid biosynthetic process,GO:0006633,Epilepsy,MESH:D004827,1,Plant Extracts,0,
fatty acid biosynthetic process,GO:0006633,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
fatty acid biosynthetic process,GO:0006633,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Acetaminophen|Ethanol|Plant Extracts,0,
fatty acid catabolic process,GO:0009062,Epilepsy,MESH:D004827,1,Epinephrine,0,
fatty acid catabolic process,GO:0009062,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Epinephrine,0,
fatty acid derivative biosynthetic process,GO:1901570,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Dinoprost,0,
fatty acid derivative metabolic process,GO:1901568,Epilepsy,MESH:D004827,2,Haloperidol|Morphine,0,
fatty acid derivative metabolic process,GO:1901568,"Epilepsy, Absence",MESH:D004832,1,Haloperidol,0,
fatty acid derivative metabolic process,GO:1901568,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Haloperidol|Morphine,0,
"fatty acid elongation, unsaturated fatty acid",GO:0019368,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
fatty acid homeostasis,GO:0055089,Epilepsy,MESH:D004827,2,Estrogens|Plant Extracts,0,
fatty acid homeostasis,GO:0055089,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
fatty acid homeostasis,GO:0055089,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
fatty acid metabolic process,GO:0006631,Epilepsy,MESH:D004827,4,Cisplatin|Folic Acid|Propofol|Vitamin B 12,0,
fatty acid metabolic process,GO:0006631,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
fatty acid metabolic process,GO:0006631,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
fatty acid metabolic process,GO:0006631,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
fatty acid metabolic process,GO:0006631,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Acetaminophen|Ethanol|Propofol,0,
fatty acid metabolic process,GO:0006631,SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY,OMIM:159950,0,,1,ASAH1
fatty acid oxidation,GO:0019395,Epilepsy,MESH:D004827,3,Cisplatin|Dexamethasone|Methotrexate,0,
fatty acid oxidation,GO:0019395,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
fatty acid oxidation,GO:0019395,"Epilepsy, Generalized",MESH:D004829,1,Zidovudine,0,
fatty acid oxidation,GO:0019395,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
fatty acid oxidation,GO:0019395,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Acetaminophen|Chloroquine|Diclofenac|Methotrexate,0,
fatty acid transport,GO:0015908,Epilepsy,MESH:D004827,1,Dexamethasone,0,
fear response,GO:0042596,Epilepsy,MESH:D004827,1,Folic Acid,3,ADRA2A|BDNF|GRIN2B
fear response,GO:0042596,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BDNF
feeding behavior,GO:0007631,Epilepsy,MESH:D004827,4,Cisplatin|Cytarabine|Methylmercury Compounds|Valproic Acid,2,BDNF|NPY
feeding behavior,GO:0007631,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
feeding behavior,GO:0007631,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
feeding behavior,GO:0007631,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 8",OMIM:616461,0,,1,GAL
feeding behavior,GO:0007631,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
feeding behavior,GO:0007631,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
feeding behavior,GO:0007631,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
feeding behavior,GO:0007631,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,1,NPY
feeding behavior,GO:0007631,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Ethanol|Methamphetamine|tetramethylenedisulfotetramine|Valproic Acid,1,BDNF
feeding behavior,GO:0007631,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
female genitalia morphogenesis,GO:0048807,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
female germ-line cyst formation,GO:0048135,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
female pregnancy,GO:0007565,Epilepsy,MESH:D004827,0,,4,ADRA2A|FOS|FOSB|TGFB1
female pregnancy,GO:0007565,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
female pregnancy,GO:0007565,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
female pregnancy,GO:0007565,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,1,OXT
ferroptosis,GO:0097707,Epilepsy,MESH:D004827,3,Busulfan|Cisplatin|Sevoflurane,0,
ferroptosis,GO:0097707,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
ferroptosis,GO:0097707,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Acetaminophen|Busulfan|Chloroquine|Deferoxamine|Ethanol|Ropivacaine,0,
fertilization,GO:0009566,Epilepsy,MESH:D004827,1,Cisplatin,0,
fertilization,GO:0009566,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
fever generation,GO:0001660,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TRPV1
fibroblast activation,GO:0072537,Epilepsy,MESH:D004827,1,Folic Acid,0,
fibroblast growth factor receptor signaling pathway,GO:0008543,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|TEK
fibroblast growth factor receptor signaling pathway,GO:0008543,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
fibroblast migration,GO:0010761,Epilepsy,MESH:D004827,0,,2,AKT1|ILK
fibroblast proliferation,GO:0048144,Epilepsy,MESH:D004827,1,Norepinephrine,1,GPX1
filopodium assembly,GO:0046847,Epilepsy,MESH:D004827,3,Citalopram|Clozapine|Haloperidol,0,
filopodium assembly,GO:0046847,"Epilepsy, Absence",MESH:D004832,1,Haloperidol,0,
filopodium assembly,GO:0046847,"Epilepsy, Complex Partial",MESH:D017029,1,Clozapine,0,
filopodium assembly,GO:0046847,"Epilepsy, Generalized",MESH:D004829,1,Clozapine,0,
filopodium assembly,GO:0046847,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Citalopram|Clozapine|Ethanol|Haloperidol,0,
fin regeneration,GO:0031101,Epilepsy,MESH:D004827,0,,1,VDAC2
flagellated sperm motility,GO:0030317,Epilepsy,MESH:D004827,3,Dexamethasone|Dronabinol|Plant Extracts,0,
flagellated sperm motility,GO:0030317,"Epilepsy, Absence",MESH:D004832,0,,1,EFHC1
flagellated sperm motility,GO:0030317,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
flagellated sperm motility,GO:0030317,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,1,TRPV1
flagellated sperm motility,GO:0030317,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
flagellated sperm motility,GO:0030317,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,EFHC1
flight behavior,GO:0007629,Epilepsy,MESH:D004827,1,Ketamine,0,
focal adhesion assembly,GO:0048041,Epilepsy,MESH:D004827,1,Dronabinol,0,
focal adhesion disassembly,GO:0120181,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
folate import across plasma membrane,GO:1904447,Epilepsy,MESH:D004827,1,Valproic Acid,0,
folate import across plasma membrane,GO:1904447,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
folate import across plasma membrane,GO:1904447,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
folate import across plasma membrane,GO:1904447,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
folate import across plasma membrane,GO:1904447,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
folate import across plasma membrane,GO:1904447,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
folate import across plasma membrane,GO:1904447,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
folate import across plasma membrane,GO:1904447,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
folate import across plasma membrane,GO:1904447,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
folic acid metabolic process,GO:0046655,Epilepsy,MESH:D004827,3,Dexamethasone|Folic Acid|Methotrexate,1,FOLR1
folic acid metabolic process,GO:0046655,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
folic acid metabolic process,GO:0046655,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
folic acid metabolic process,GO:0046655,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
folic acid transport,GO:0015884,Epilepsy,MESH:D004827,2,Folic Acid|Methotrexate,1,FOLR1
folic acid transport,GO:0015884,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
folic acid transport,GO:0015884,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
folic acid transport,GO:0015884,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
follicle-stimulating hormone signaling pathway,GO:0042699,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
forebrain development,GO:0030900,Epilepsy,MESH:D004827,1,Folic Acid,2,FOXG1|GNAO1
forebrain development,GO:0030900,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
forebrain development,GO:0030900,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
forebrain development,GO:0030900,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KCNC4
forebrain development,GO:0030900,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
forebrain generation of neurons,GO:0021872,Epilepsy,MESH:D004827,1,Dronabinol,0,
forebrain neuron differentiation,GO:0021879,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
formaldehyde metabolic process,GO:0046292,Epilepsy,MESH:D004827,1,"N-Methyl-3,4-methylenedioxyamphetamine",0,
formation of radial glial scaffolds,GO:0021943,Epilepsy,MESH:D004827,0,,1,FLNA
frontal suture morphogenesis,GO:0060364,Epilepsy,MESH:D004827,0,,1,TGFB1
fumarate metabolic process,GO:0006106,Epilepsy,MESH:D004827,2,"Cisplatin|N-Methyl-3,4-methylenedioxyamphetamine",0,
fumarate metabolic process,GO:0006106,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
fusion of sperm to egg plasma membrane involved in single fertilization,GO:0007342,Epilepsy,MESH:D004827,0,,1,FOLR1
G0 to G1 transition,GO:0045023,Epilepsy,MESH:D004827,4,Cisplatin|Dexamethasone|Folic Acid|Plant Extracts,0,
G0 to G1 transition,GO:0045023,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
G0 to G1 transition,GO:0045023,"Epilepsy, Temporal Lobe",MESH:D004833,2,Clioquinol|Plant Extracts,0,
G0 to G1 transition,GO:0045023,"Epilepsy, Tonic-Clonic",MESH:D004830,9,Acetaminophen|Aluminum|Caffeine|Chloroquine|Deferoxamine|Disulfiram|Mebendazole|Plant Extracts|Tetracaine,0,
G1/S transition of mitotic cell cycle,GO:0000082,Epilepsy,MESH:D004827,1,Cytarabine,0,
G1 to G0 transition,GO:0070314,"Polyhydramnios, Megalencephaly, And Symptomatic Epilepsy",MESH:C567020,0,,1,STRADA
G2/M transition of mitotic cell cycle,GO:0000086,Epilepsy,MESH:D004827,7,Ciprofloxacin|Cisplatin|Dexamethasone|Dronabinol|Etoposide|Folic Acid|Plant Extracts,1,ABCB1
G2/M transition of mitotic cell cycle,GO:0000086,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
G2/M transition of mitotic cell cycle,GO:0000086,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
G2/M transition of mitotic cell cycle,GO:0000086,"Epilepsy, Tonic-Clonic",MESH:D004830,9,Aluminum|Caffeine|Ciprofloxacin|Diclofenac|Disulfiram|Mebendazole|Methamphetamine|Plant Extracts|Tetracaine,1,NES
GABAergic neuron differentiation,GO:0097154,Epilepsy,MESH:D004827,1,Dexamethasone,0,
galactose metabolic process,GO:0006012,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
galactose metabolic process,GO:0006012,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 8",OMIM:616461,0,,1,GAL
galactose metabolic process,GO:0006012,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
gamete generation,GO:0007276,Epilepsy,MESH:D004827,0,,1,DDX3X
gamma-aminobutyric acid biosynthetic process,GO:0009449,Epilepsy,MESH:D004827,3,4-Aminopyridine|Ciprofloxacin|Topiramate,1,SLC1A3
gamma-aminobutyric acid biosynthetic process,GO:0009449,"Epilepsy, Complex Partial",MESH:D017029,1,Topiramate,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,"Epilepsy, Rolandic",MESH:D019305,1,Topiramate,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,"Epilepsy, Temporal Lobe",MESH:D004833,2,bacoside A|Topiramate,0,
gamma-aminobutyric acid biosynthetic process,GO:0009449,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Ciprofloxacin|Etomidate|Methylprednisolone|Topiramate,0,
gamma-aminobutyric acid import,GO:0051939,Epilepsy,MESH:D004827,1,Norepinephrine,1,SLC6A1
gamma-aminobutyric acid import,GO:0051939,MYOCLONIC-ATONIC EPILEPSY,OMIM:616421,0,,1,SLC6A1
gamma-aminobutyric acid metabolic process,GO:0009448,Epilepsy,MESH:D004827,6,Dexamethasone|gamma-Aminobutyric Acid|Muscimol|Pentylenetetrazole|Plant Extracts|Valproic Acid,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Epilepsy, Absence",MESH:D004832,2,Pentylenetetrazole|Valproic Acid,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Epilepsy, Temporal Lobe",MESH:D004833,2,Plant Extracts|Valproic Acid,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Pentylenetetrazole|Plant Extracts|Valproic Acid,0,
gamma-aminobutyric acid metabolic process,GO:0009448,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
gamma-aminobutyric acid reuptake,GO:0051936,Epilepsy,MESH:D004827,0,,1,SLC6A1
gamma-aminobutyric acid reuptake,GO:0051936,"Epilepsy, Complex Partial",MESH:D017029,1,Tiagabine,0,
gamma-aminobutyric acid reuptake,GO:0051936,MYOCLONIC-ATONIC EPILEPSY,OMIM:616421,0,,1,SLC6A1
gamma-aminobutyric acid secretion,GO:0014051,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
gamma-aminobutyric acid secretion,GO:0014051,"Epilepsy, Generalized",MESH:D004829,0,,1,CACNB4
gamma-aminobutyric acid secretion,GO:0014051,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CACNB4
gamma-aminobutyric acid secretion,GO:0014051,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,GRM4|P2RX7
gamma-aminobutyric acid secretion,GO:0014051,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,CACNB4
gamma-aminobutyric acid signaling pathway,GO:0007214,Epilepsy,MESH:D004827,3,Bicuculline|gamma-Aminobutyric Acid|Picrotoxin,4,BDNF|GABRB2|GABRB3|SLC12A2
gamma-aminobutyric acid signaling pathway,GO:0007214,"Epilepsy, Absence",MESH:D004832,1,Picrotoxin,2,CACNA1A|GABRB3
gamma-aminobutyric acid signaling pathway,GO:0007214,"Epilepsy, Generalized",MESH:D004829,0,,1,CACNB4
gamma-aminobutyric acid signaling pathway,GO:0007214,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,2,CACNB4|GABRD
gamma-aminobutyric acid signaling pathway,GO:0007214,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
gamma-aminobutyric acid signaling pathway,GO:0007214,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
gamma-aminobutyric acid signaling pathway,GO:0007214,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Picrotoxin,1,BDNF
gamma-aminobutyric acid signaling pathway,GO:0007214,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,2,CACNB4|GABRA1
ganglioside biosynthetic process,GO:0001574,Amish Infantile Epilepsy Syndrome,MESH:C563799,0,,1,ST3GAL5
gap junction-mediated intercellular transport,GO:1990349,Epilepsy,MESH:D004827,2,Cisplatin|Dronabinol,0,
gap junction-mediated intercellular transport,GO:1990349,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Hexachlorocyclohexane,0,
gastric motility,GO:0035482,Epilepsy,MESH:D004827,1,Fluoxetine,0,
gastrulation,GO:0007369,Epilepsy,MESH:D004827,0,,1,TXNRD1
gastrulation,GO:0007369,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
gene expression,GO:0010467,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
gene expression,GO:0010467,Epilepsy,MESH:D004827,0,,10,AKT1|ANKRD11|CHD2|CNTNAP2|GFAP|KCNQ2|MECP2|MEF2C|SLC1A1|TGFB1
gene expression,GO:0010467,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
gene expression,GO:0010467,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
gene expression,GO:0010467,"Epilepsy, Temporal Lobe",MESH:D004833,0,,4,GRM2|GRM3|P2RX7|SLC1A1
gene expression,GO:0010467,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1",OMIM:614231,0,,1,IER3IP1
gene expression,GO:0010467,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
"general adaptation syndrome, behavioral process",GO:0051867,Epilepsy,MESH:D004827,0,,1,HCN1
generation of neurons,GO:0048699,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NTF3
generation of ovulation cycle rhythm,GO:0060112,Epilepsy,MESH:D004827,1,Cisplatin,0,
generation of ovulation cycle rhythm,GO:0060112,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
generation of precursor metabolites and energy,GO:0006091,Epilepsy,MESH:D004827,0,,1,POMC
generation of precursor metabolites and energy,GO:0006091,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,POMC
genomic imprinting,GO:0071514,Epilepsy,MESH:D004827,0,,1,MECP2
germarium-derived egg chamber formation,GO:0007293,"Epilepsy, Partial, with Variable Foci",MESH:C565785,0,,2,NPRL2|NPRL3
germ cell development,GO:0007281,Epilepsy,MESH:D004827,0,,1,AKT1
germ cell development,GO:0007281,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
germ cell migration,GO:0008354,Epilepsy,MESH:D004827,0,,1,TGFB1
germ cell migration,GO:0008354,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NES
germinal center formation,GO:0002467,Epilepsy,MESH:D004827,0,,1,MEF2C
"germline cell cycle switching, mitotic to meiotic cell cycle",GO:0051729,"Epilepsy, Partial, with Variable Foci",MESH:C565785,0,,1,NPRL2
germ-line stem cell division,GO:0042078,Epilepsy,MESH:D004827,2,Cisplatin|Etoposide,0,
glial cell-derived neurotrophic factor receptor signaling pathway,GO:0035860,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
glial cell differentiation,GO:0010001,Epilepsy,MESH:D004827,2,Dronabinol|Lithium Chloride,0,
glial cell differentiation,GO:0010001,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
glial cell differentiation,GO:0010001,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
glial cell differentiation,GO:0010001,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium Chloride,0,
glial cell differentiation,GO:0010001,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Lithium Chloride,1,FGF2
glial cell fate commitment,GO:0021781,Epilepsy,MESH:D004827,1,Dexamethasone,0,
glial cell fate determination,GO:0007403,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NTF3
glial cell migration,GO:0008347,Epilepsy,MESH:D004827,1,Cisplatin,0,
glial cell proliferation,GO:0014009,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
glial cell proliferation,GO:0014009,Epilepsy,MESH:D004827,1,Kainic Acid,2,CNTNAP2|MECP2
glial cell proliferation,GO:0014009,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
glial cell proliferation,GO:0014009,"Epilepsy, Temporal Lobe",MESH:D004833,1,Kainic Acid,0,
glomerular basement membrane development,GO:0032836,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
glomerular filtration,GO:0003094,Epilepsy,MESH:D004827,12,Acetazolamide|Calcium|Carbachol|Cisplatin|Clonidine|Gentamicins|Lidocaine|Morphine|Naloxone|Norepinephrine|Pentobarbital|Phentolamine,0,
glomerular filtration,GO:0003094,"Epilepsy, Absence",MESH:D004832,1,Naloxone,0,
glomerular filtration,GO:0003094,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,0,
glomerular filtration,GO:0003094,"Epilepsy, Temporal Lobe",MESH:D004833,1,Tacrolimus,0,
glomerular filtration,GO:0003094,"Epilepsy, Tonic-Clonic",MESH:D004830,10,Acetaminophen|Chloroquine|Clonidine|Deferoxamine|Diclofenac|Domperidone|Lidocaine|Morphine|Naloxone|Tacrolimus,0,
glomerular filtration,GO:0003094,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Acetazolamide,0,
glomerulus morphogenesis,GO:0072102,Epilepsy,MESH:D004827,0,,1,MEF2C
glomerulus vasculature development,GO:0072012,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TEK
glucocorticoid metabolic process,GO:0008211,Epilepsy,MESH:D004827,1,Dronabinol,1,MECP2
glucocorticoid metabolic process,GO:0008211,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
gluconeogenesis,GO:0006094,Epilepsy,MESH:D004827,11,Calcium|Dexamethasone|Epinephrine|Ketamine|Lithium Chloride|malic acid|Methimazole|Norepinephrine|Pentobarbital|Phenobarbital|Phentolamine,0,
gluconeogenesis,GO:0006094,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
gluconeogenesis,GO:0006094,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
gluconeogenesis,GO:0006094,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
gluconeogenesis,GO:0006094,"Epilepsy, Temporal Lobe",MESH:D004833,2,Lithium Chloride|Phenobarbital,0,
gluconeogenesis,GO:0006094,"Epilepsy, Tonic-Clonic",MESH:D004830,7,Aminophylline|Clomipramine|Epinephrine|Ethanol|Lithium Chloride|Phenobarbital|Prednisone,0,
glucose 6-phosphate metabolic process,GO:0051156,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
glucose catabolic process,GO:0006007,Epilepsy,MESH:D004827,1,Ketoconazole,0,
glucose homeostasis,GO:0042593,Epilepsy,MESH:D004827,5,Carbamazepine|Dexamethasone|Estrogens|Folic Acid|Plant Extracts,3,ADRA2A|AKT1|POMC
glucose homeostasis,GO:0042593,"Epilepsy, Absence",MESH:D004832,1,Carbamazepine,1,CACNA1A
glucose homeostasis,GO:0042593,"Epilepsy, Complex Partial",MESH:D017029,1,Carbamazepine,0,
glucose homeostasis,GO:0042593,"Epilepsy, Generalized",MESH:D004829,1,Carbamazepine,0,
glucose homeostasis,GO:0042593,"Epilepsy, Rolandic",MESH:D019305,1,Carbamazepine,0,
glucose homeostasis,GO:0042593,"Epilepsy, Temporal Lobe",MESH:D004833,2,Carbamazepine|Plant Extracts,1,CNR1
glucose homeostasis,GO:0042593,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Carbamazepine|Dizocilpine Maleate|Ethanol|Plant Extracts|Tetracaine,1,POMC
glucose homeostasis,GO:0042593,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1",OMIM:614231,0,,1,IER3IP1
glucose import,GO:0046323,Epilepsy,MESH:D004827,5,Cisplatin|Dronabinol|Norepinephrine|Plant Extracts|Valproic Acid,2,TSC1|TSC2
glucose import,GO:0046323,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
glucose import,GO:0046323,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
glucose import,GO:0046323,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
glucose import,GO:0046323,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
glucose import,GO:0046323,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
glucose import,GO:0046323,"Epilepsy, Temporal Lobe",MESH:D004833,3,Plant Extracts|Tacrolimus|Valproic Acid,0,
glucose import,GO:0046323,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Bupivacaine|Hexachlorocyclohexane|Plant Extracts|Tacrolimus|Valproic Acid,0,
glucose import,GO:0046323,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
glucose import across plasma membrane,GO:0098708,Epilepsy,MESH:D004827,1,Calcium,0,
glucose import across plasma membrane,GO:0098708,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
glucose metabolic process,GO:0006006,Epilepsy,MESH:D004827,6,Calcium|Dexamethasone|Folic Acid|Propofol|Sevoflurane|Vitamin B 12,1,AKT1
glucose metabolic process,GO:0006006,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
glucose metabolic process,GO:0006006,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
glucose metabolic process,GO:0006006,"Epilepsy, Tonic-Clonic",MESH:D004830,7,Acetaminophen|Bupivacaine|Diclofenac|Ethanol|Methylprednisolone|Procaine|Propofol,0,
glucose transmembrane transport,GO:1904659,Epilepsy,MESH:D004827,1,Plant Extracts,0,
glucose transmembrane transport,GO:1904659,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
glucose transmembrane transport,GO:1904659,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
glutamate biosynthetic process,GO:0006537,Epilepsy,MESH:D004827,5,"Aminooxyacetic Acid|Kainic Acid|N-Methyl-3,4-methylenedioxyamphetamine|Topiramate|trimethyltin chloride",0,
glutamate biosynthetic process,GO:0006537,"Epilepsy, Complex Partial",MESH:D017029,1,Topiramate,0,
glutamate biosynthetic process,GO:0006537,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
glutamate biosynthetic process,GO:0006537,"Epilepsy, Rolandic",MESH:D019305,1,Topiramate,0,
glutamate biosynthetic process,GO:0006537,"Epilepsy, Temporal Lobe",MESH:D004833,2,Kainic Acid|Topiramate,0,
glutamate biosynthetic process,GO:0006537,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Methylprednisolone|Topiramate,0,
glutamate metabolic process,GO:0006536,Epilepsy,MESH:D004827,8,Cisplatin|Dexamethasone|Dronabinol|Lithium Chloride|Naloxone|Pentylenetetrazole|Pilocarpine|Valproic Acid,0,
glutamate metabolic process,GO:0006536,"Epilepsy, Absence",MESH:D004832,5,Doxorubicin|Naloxone|Pentylenetetrazole|Pilocarpine|Valproic Acid,0,
glutamate metabolic process,GO:0006536,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
glutamate metabolic process,GO:0006536,"Epilepsy, Generalized",MESH:D004829,2,Naloxone|Valproic Acid,0,
glutamate metabolic process,GO:0006536,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
glutamate metabolic process,GO:0006536,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
glutamate metabolic process,GO:0006536,"Epilepsy, Temporal Lobe",MESH:D004833,3,Lithium Chloride|Pilocarpine|Valproic Acid,0,
glutamate metabolic process,GO:0006536,"Epilepsy, Tonic-Clonic",MESH:D004830,8,Caffeine|Ethanol|Lithium Chloride|Methamphetamine|Naloxone|Pentylenetetrazole|Pilocarpine|Valproic Acid,0,
glutamate metabolic process,GO:0006536,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
glutamate receptor signaling pathway,GO:0007215,Epilepsy,MESH:D004827,0,,3,GRIN2A|GRIN2B|SLC1A1
glutamate receptor signaling pathway,GO:0007215,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
glutamate receptor signaling pathway,GO:0007215,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
glutamate receptor signaling pathway,GO:0007215,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,GRM2|SLC1A1
glutamatergic neuron differentiation,GO:1905962,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
glutamatergic neuron differentiation,GO:1905962,Epilepsy,MESH:D004827,1,Dexamethasone,1,CNTNAP2
glutamate secretion,GO:0014047,Epilepsy,MESH:D004827,6,"4-Aminopyridine|6-Cyano-7-nitroquinoxaline-2,3-dione|Calcium|Enkephalin, Ala(2)-MePhe(4)-Gly(5)-|Kainic Acid|Lidocaine",1,BDNF
glutamate secretion,GO:0014047,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
glutamate secretion,GO:0014047,"Epilepsy, Temporal Lobe",MESH:D004833,1,Kainic Acid,3,GRM2|P2RX7|TRPV1
glutamate secretion,GO:0014047,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Dizocilpine Maleate|Lidocaine,1,BDNF
glutamine biosynthetic process,GO:0006542,Epilepsy,MESH:D004827,1,Kainic Acid,0,
glutamine biosynthetic process,GO:0006542,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
glutamine biosynthetic process,GO:0006542,"Epilepsy, Temporal Lobe",MESH:D004833,1,Kainic Acid,0,
glutamine biosynthetic process,GO:0006542,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
glutamine metabolic process,GO:0006541,Epilepsy,MESH:D004827,2,Propofol|Sevoflurane,1,MECP2
glutamine metabolic process,GO:0006541,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
glutamine metabolic process,GO:0006541,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
glutathione biosynthetic process,GO:0006750,Epilepsy,MESH:D004827,24,"Azathioprine|Chondroitin Sulfates|Cimetidine|Ciprofloxacin|Cisplatin|Clozapine|Dexamethasone|Folic Acid|Gentamicins|Ifosfamide|Kainic Acid|Ketoconazole|Lithium Chloride|Methimazole|Methotrexate|Methylmercury Compounds|N-Methyl-3,4-methylenedioxyamphetamine|Phenobarbital|Phenytoin|Pilocarpine|Plant Extracts|Topiramate|Valproic Acid|Vitamin B 12",2,SLC1A1|SLC1A2
glutathione biosynthetic process,GO:0006750,"Epilepsy, Absence",MESH:D004832,7,Doxorubicin|Lithium Carbonate|Phenobarbital|Phenytoin|Pilocarpine|Riluzole|Valproic Acid,0,
glutathione biosynthetic process,GO:0006750,"Epilepsy, Complex Partial",MESH:D017029,6,Clozapine|Methotrexate|Phenobarbital|Phenytoin|Topiramate|Valproic Acid,0,
glutathione biosynthetic process,GO:0006750,"Epilepsy, Generalized",MESH:D004829,4,Clozapine|Phenobarbital|Phenytoin|Valproic Acid,0,
glutathione biosynthetic process,GO:0006750,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
glutathione biosynthetic process,GO:0006750,"Epilepsy, Reflex",MESH:D020195,2,Polychlorinated Biphenyls|Valproic Acid,0,
glutathione biosynthetic process,GO:0006750,"Epilepsy, Rolandic",MESH:D019305,2,Topiramate|Valproic Acid,0,
glutathione biosynthetic process,GO:0006750,"Epilepsy, Temporal Lobe",MESH:D004833,10,Kainic Acid|Lithium Chloride|Methotrexate|Phenobarbital|Phenytoin|Pilocarpine|Plant Extracts|Tacrolimus|Topiramate|Valproic Acid,1,SLC1A1
glutathione biosynthetic process,GO:0006750,"Epilepsy, Tonic-Clonic",MESH:D004830,27,Acetaminophen|Aluminum|Caffeine|Chlormethiazole|Chloroquine|Chlorpromazine|Cimetidine|Ciprofloxacin|Clozapine|Cocaine|Deferoxamine|Diclofenac|Dizocilpine Maleate|Ethanol|Hexachlorocyclohexane|Lithium Carbonate|Lithium Chloride|Methamphetamine|Methotrexate|Phenobarbital|Phenytoin|Pilocarpine|Plant Extracts|Tacrolimus|Topiramate|Valproic Acid|Venlafaxine Hydrochloride,0,
glutathione biosynthetic process,GO:0006750,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
glutathione catabolic process,GO:0006751,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
glutathione derivative biosynthetic process,GO:1901687,Epilepsy,MESH:D004827,6,Cisplatin|Fluoxetine|Ketoconazole|Methotrexate|Penicillamine|Plant Extracts,0,
glutathione derivative biosynthetic process,GO:1901687,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
glutathione derivative biosynthetic process,GO:1901687,"Epilepsy, Temporal Lobe",MESH:D004833,2,Methotrexate|Plant Extracts,0,
glutathione derivative biosynthetic process,GO:1901687,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Acetaminophen|Diclofenac|Ethanol|Methotrexate|Plant Extracts,0,
glutathione metabolic process,GO:0006749,Epilepsy,MESH:D004827,31,"Amitriptyline|Atropine|Carbamazepine|carbidopa, levodopa drug combination|Ciprofloxacin|Cisplatin|Dexamethasone|Dronabinol|Epinephrine|Etoposide|Felbamate|Fluoxetine|Folic Acid|Gentamicins|Imipramine|Kainic Acid|Ketamine|Ketoconazole|Methotrexate|Methylmercury Compounds|nimesulide|Pentylenetetrazole|Phenobarbital|Plant Extracts|Pregabalin|Strychnine|Topiramate|Valproic Acid|Vitamin B 12|Vitamin B 6|Vitamin U",3,GPX1|SLC1A1|TXNRD1
glutathione metabolic process,GO:0006749,"Epilepsy, Absence",MESH:D004832,5,Carbamazepine|Doxorubicin|Pentylenetetrazole|Phenobarbital|Valproic Acid,0,
glutathione metabolic process,GO:0006749,"Epilepsy, Complex Partial",MESH:D017029,6,Carbamazepine|Methotrexate|Phenobarbital|Topiramate|Trazodone|Valproic Acid,0,
glutathione metabolic process,GO:0006749,"Epilepsy, Generalized",MESH:D004829,5,Carbamazepine|Phenobarbital|Pregabalin|Trazodone|Valproic Acid,0,
glutathione metabolic process,GO:0006749,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
glutathione metabolic process,GO:0006749,"Epilepsy, Reflex",MESH:D020195,2,Felbamate|Valproic Acid,0,
glutathione metabolic process,GO:0006749,"Epilepsy, Rolandic",MESH:D019305,3,Carbamazepine|Topiramate|Valproic Acid,0,
glutathione metabolic process,GO:0006749,"Epilepsy, Temporal Lobe",MESH:D004833,9,Capsaicin|Carbamazepine|Clioquinol|Kainic Acid|Methotrexate|Phenobarbital|Plant Extracts|Topiramate|Valproic Acid,1,SLC1A1
glutathione metabolic process,GO:0006749,"Epilepsy, Tonic-Clonic",MESH:D004830,31,Acetaminophen|Aluminum|Aluminum Hydroxide|Amitriptyline|Atropine|Caffeine|Carbamazepine|Chlormethiazole|Chloroquine|Ciprofloxacin|Deferoxamine|Diclofenac|Disulfiram|Dizocilpine Maleate|Epinephrine|Ethanol|Etomidate|Imipramine|Methotrexate|Methylprednisolone|Paraoxon|Paroxetine|Pentylenetetrazole|Phenobarbital|Plant Extracts|Ropivacaine|Sertraline|Theophylline|Topiramate|Valproic Acid|Vincristine,0,
glutathione metabolic process,GO:0006749,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
glycerol-3-phosphate metabolic process,GO:0006072,Epilepsy,MESH:D004827,1,Aminooxyacetic Acid,0,
glycerol-3-phosphate metabolic process,GO:0006072,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
glycerol-3-phosphate metabolic process,GO:0006072,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
glycerol biosynthetic process,GO:0006114,Epilepsy,MESH:D004827,1,Epinephrine,0,
glycerol biosynthetic process,GO:0006114,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Epinephrine,0,
glycerol metabolic process,GO:0006071,Epilepsy,MESH:D004827,2,Dexamethasone|Propofol,0,
glycerol metabolic process,GO:0006071,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
glycerol metabolic process,GO:0006071,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
glycerol transmembrane transport,GO:0015793,Epilepsy,MESH:D004827,2,Norepinephrine|Plant Extracts,0,
glycerol transmembrane transport,GO:0015793,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
glycerol transmembrane transport,GO:0015793,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Caffeine|Ephedrine|Plant Extracts,0,
glycerophospholipid metabolic process,GO:0006650,Epilepsy,MESH:D004827,2,Folic Acid|Vitamin B 12,0,
glycerophospholipid metabolic process,GO:0006650,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
glycerophospholipid metabolic process,GO:0006650,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Etomidate,0,
glycine betaine biosynthetic process from choline,GO:0019285,Pyridoxine-dependent epilepsy,MESH:C536254,0,,1,ALDH7A1
glycine biosynthetic process,GO:0006545,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Methylprednisolone,0,
glycogen biosynthetic process,GO:0005978,Epilepsy,MESH:D004827,2,Folic Acid|Plant Extracts,1,AKT1
glycogen biosynthetic process,GO:0005978,"Epilepsy, Absence",MESH:D004832,1,Lithium Carbonate,0,
glycogen biosynthetic process,GO:0005978,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
glycogen biosynthetic process,GO:0005978,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Diclofenac|Lithium Carbonate|Plant Extracts,0,
glycogen catabolic process,GO:0005980,Epilepsy,MESH:D004827,8,Adenosine|Calcium|Dexamethasone|Epinephrine|Methotrexate|Norepinephrine|Pentobarbital|Phentolamine,0,
glycogen catabolic process,GO:0005980,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
glycogen catabolic process,GO:0005980,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
glycogen catabolic process,GO:0005980,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Acetaminophen|Adenosine|Caffeine|Epinephrine|Methotrexate|Theophylline,0,
glycogen cell differentiation involved in embryonic placenta development,GO:0060709,Epilepsy,MESH:D004827,0,,1,AKT1
glycogen metabolic process,GO:0005977,Epilepsy,MESH:D004827,2,Cisplatin|Plant Extracts,1,AKT1
glycogen metabolic process,GO:0005977,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
glycogen metabolic process,GO:0005977,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Diclofenac|Plant Extracts|Sodium Chloride,0,
glycolytic process,GO:0006096,Epilepsy,MESH:D004827,5,Calcium|Dexamethasone|Epinephrine|Lidocaine|Pentobarbital,0,
glycolytic process,GO:0006096,"Epilepsy, Absence",MESH:D004832,3,Doxorubicin|Heparin|Progesterone,0,
glycolytic process,GO:0006096,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Bupivacaine|Epinephrine|Heparin|Lidocaine,0,
glycoprotein biosynthetic process,GO:0009101,Epilepsy,MESH:D004827,1,Cimetidine,0,
glycoprotein biosynthetic process,GO:0009101,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Cimetidine|Ethanol,0,
glycoprotein catabolic process,GO:0006516,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 8",OMIM:616461,0,,1,GAL
glycoprotein metabolic process,GO:0009100,Epilepsy,MESH:D004827,1,Valproic Acid,0,
glycoprotein metabolic process,GO:0009100,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
glycoprotein metabolic process,GO:0009100,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
glycoprotein metabolic process,GO:0009100,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
glycoprotein metabolic process,GO:0009100,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
glycoprotein metabolic process,GO:0009100,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
glycoprotein metabolic process,GO:0009100,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
glycoprotein metabolic process,GO:0009100,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
glycoprotein metabolic process,GO:0009100,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
glycosaminoglycan metabolic process,GO:0030203,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
glycosphingolipid biosynthetic process,GO:0006688,Amish Infantile Epilepsy Syndrome,MESH:C563799,0,,1,ST3GAL5
glycosphingolipid biosynthetic process,GO:0006688,Epilepsy,MESH:D004827,1,Ketoconazole,0,
glycosylation,GO:0070085,Epilepsy,MESH:D004827,2,Dexamethasone|Haloperidol,0,
glycosylation,GO:0070085,"Epilepsy, Absence",MESH:D004832,2,Haloperidol|Promazine,0,
glycosylation,GO:0070085,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Haloperidol|Pimozide,0,
glyoxal metabolic process,GO:1903189,Epilepsy,MESH:D004827,1,"N-Methyl-3,4-methylenedioxyamphetamine",0,
Golgi disassembly,GO:0090166,Epilepsy,MESH:D004827,1,Griseofulvin,0,
Golgi lumen acidification,GO:0061795,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
Golgi organization,GO:0007030,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Chloroquine|Dizocilpine Maleate,0,
GPI anchor biosynthetic process,GO:0006506,Epilepsy,MESH:D004827,1,Cisplatin,0,
GPI anchor biosynthetic process,GO:0006506,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Chlorambucil|Melphalan,0,
G protein-coupled acetylcholine receptor signaling pathway,GO:0007213,Epilepsy,MESH:D004827,3,Atropine|Carbachol|Pilocarpine,2,CHRM1|CHRM2
G protein-coupled acetylcholine receptor signaling pathway,GO:0007213,"Epilepsy, Absence",MESH:D004832,1,Pilocarpine,0,
G protein-coupled acetylcholine receptor signaling pathway,GO:0007213,"Epilepsy, Temporal Lobe",MESH:D004833,1,Pilocarpine,0,
G protein-coupled acetylcholine receptor signaling pathway,GO:0007213,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Atropine|Paraoxon|Pilocarpine,0,
G protein-coupled adenosine receptor signaling pathway,GO:0001973,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
G protein-coupled glutamate receptor signaling pathway,GO:0007216,Epilepsy,MESH:D004827,0,,2,GRIN2B|GRM1
G protein-coupled glutamate receptor signaling pathway,GO:0007216,"Epilepsy, Temporal Lobe",MESH:D004833,0,,5,GRM1|GRM2|GRM3|GRM4|GRM5
G protein-coupled opioid receptor signaling pathway,GO:0038003,Epilepsy,MESH:D004827,0,,2,OPRD1|OPRM1
G protein-coupled receptor internalization,GO:0002031,Epilepsy,MESH:D004827,0,,1,DNM1
G protein-coupled receptor signaling pathway,GO:0007186,Epilepsy,MESH:D004827,0,,9,ADRA2A|AKT1|CHRM1|CHRM2|GNAO1|GRM1|NPY2R|OPRD1|OPRM1
G protein-coupled receptor signaling pathway,GO:0007186,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
G protein-coupled receptor signaling pathway,GO:0007186,"Epilepsy, Temporal Lobe",MESH:D004833,0,,10,BDKRB1|BDKRB2|CNR1|GRM1|GRM2|GRM3|GRM4|GRM5|NPY2R|SLIT2
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",GO:0007187,Epilepsy,MESH:D004827,0,,5,CHRM1|CHRM2|NPY|OPRD1|OPRM1
"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger",GO:0007187,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,CNR1|NPY
granulocyte differentiation,GO:0030851,Epilepsy,MESH:D004827,1,Dronabinol,0,
grooming behavior,GO:0007625,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
grooming behavior,GO:0007625,Epilepsy,MESH:D004827,7,Cisplatin|Diazepam|Dronabinol|Flumazenil|Ketamine|Morphine|Valproic Acid,3,CNTNAP2|KCNQ2|SLC1A1
grooming behavior,GO:0007625,"Epilepsy, Absence",MESH:D004832,2,Diazepam|Valproic Acid,0,
grooming behavior,GO:0007625,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
grooming behavior,GO:0007625,"Epilepsy, Complex Partial",MESH:D017029,2,Diazepam|Valproic Acid,0,
grooming behavior,GO:0007625,"Epilepsy, Generalized",MESH:D004829,2,Diazepam|Valproic Acid,0,
grooming behavior,GO:0007625,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
grooming behavior,GO:0007625,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
grooming behavior,GO:0007625,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,1,SLC1A1
grooming behavior,GO:0007625,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Diazepam|Ethanol|Morphine|Valproic Acid,1,OXT
grooming behavior,GO:0007625,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
growth,GO:0040007,Epilepsy,MESH:D004827,3,Methylmercury Compounds|Propofol|Sevoflurane,0,
growth,GO:0040007,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
growth,GO:0040007,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
growth factor dependent regulation of skeletal muscle satellite cell proliferation,GO:0014843,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
growth plate cartilage development,GO:0003417,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Disulfiram,0,
GTP biosynthetic process,GO:0006183,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
guanosine metabolic process,GO:0008617,Epilepsy,MESH:D004827,1,Cisplatin,0,
habituation,GO:0046959,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
halogen metabolic process,GO:0070276,Epilepsy,MESH:D004827,0,,1,TXNRD1
hard palate development,GO:0060022,Epilepsy,MESH:D004827,0,,1,GABRB3
hard palate development,GO:0060022,"Epilepsy, Absence",MESH:D004832,0,,1,GABRB3
hatching,GO:0035188,Epilepsy,MESH:D004827,7,Carbamazepine|Ciprofloxacin|Dronabinol|Folic Acid|Plant Extracts|Propofol|Valproic Acid,0,
hatching,GO:0035188,"Epilepsy, Absence",MESH:D004832,3,Carbamazepine|Doxorubicin|Valproic Acid,0,
hatching,GO:0035188,"Epilepsy, Complex Partial",MESH:D017029,2,Carbamazepine|Valproic Acid,0,
hatching,GO:0035188,"Epilepsy, Generalized",MESH:D004829,3,Carbamazepine|Propofol|Valproic Acid,0,
hatching,GO:0035188,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
hatching,GO:0035188,"Epilepsy, Rolandic",MESH:D019305,2,Carbamazepine|Valproic Acid,0,
hatching,GO:0035188,"Epilepsy, Temporal Lobe",MESH:D004833,3,Carbamazepine|Plant Extracts|Valproic Acid,0,
hatching,GO:0035188,"Epilepsy, Tonic-Clonic",MESH:D004830,7,Caffeine|Carbamazepine|Ciprofloxacin|Hexachlorocyclohexane|Plant Extracts|Propofol|Valproic Acid,0,
hatching,GO:0035188,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
head development,GO:0060322,Epilepsy,MESH:D004827,4,Atropine|Dexamethasone|Methylmercury Compounds|Valproic Acid,1,ANKRD11
head development,GO:0060322,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
head development,GO:0060322,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
head development,GO:0060322,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
head development,GO:0060322,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
head development,GO:0060322,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
head development,GO:0060322,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
head development,GO:0060322,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Atropine|Dizocilpine Maleate|Ethanol|pralidoxime|Valproic Acid,0,
head development,GO:0060322,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
head morphogenesis,GO:0060323,Epilepsy,MESH:D004827,1,Atropine,1,ANKRD11
head morphogenesis,GO:0060323,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Atropine|Ethanol,0,
head morphogenesis,GO:0060323,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
heart contraction,GO:0060047,Epilepsy,MESH:D004827,0,,4,ANKRD11|GPX1|ILK|SLC1A1
heart contraction,GO:0060047,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Progesterone,0,
heart contraction,GO:0060047,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
heart contraction,GO:0060047,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Bupivacaine|Caffeine|Diclofenac,0,
heart development,GO:0007507,Epilepsy,MESH:D004827,4,Epinephrine|Folic Acid|Methotrexate|Thalidomide,5,ANKRD11|ILK|MEF2C|TGFB1|TSC2
heart development,GO:0007507,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
heart development,GO:0007507,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,2,TEK|VDR
heart development,GO:0007507,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Caffeine|Diclofenac|Epinephrine|Ethanol|Methotrexate,1,OXT
heart development,GO:0007507,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
heart formation,GO:0060914,Epilepsy,MESH:D004827,2,Folic Acid|Lithium Chloride,0,
heart formation,GO:0060914,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium Chloride,0,
heart formation,GO:0060914,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Lithium Chloride,0,
heart looping,GO:0001947,Epilepsy,MESH:D004827,0,,2,FOLR1|MEF2C
heart morphogenesis,GO:0003007,Epilepsy,MESH:D004827,1,Atropine,2,CERT1|FLNA
heart morphogenesis,GO:0003007,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
heart morphogenesis,GO:0003007,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Atropine,0,
heart process,GO:0003015,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
heart trabecula formation,GO:0060347,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,TEK
heart valve morphogenesis,GO:0003179,Epilepsy,MESH:D004827,0,,1,TGFB1
heat acclimation,GO:0010286,Epilepsy,MESH:D004827,1,Morphine,0,
heat acclimation,GO:0010286,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Morphine,0,
heat dissipation,GO:0031653,Epilepsy,MESH:D004827,1,Dronabinol,0,
heat dissipation,GO:0031653,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Soman,0,
heat generation,GO:0031649,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
helper T cell enhancement of B cell mediated immune response,GO:0035399,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Sarin,0,
hematopoietic progenitor cell differentiation,GO:0002244,Epilepsy,MESH:D004827,0,,2,KCNAB2|TGFB1
hematopoietic stem cell differentiation,GO:0060218,Epilepsy,MESH:D004827,0,,1,CHD2
hematopoietic stem cell differentiation,GO:0060218,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Deferoxamine,0,
hematopoietic stem cell proliferation,GO:0071425,Epilepsy,MESH:D004827,1,Cytarabine,0,
heme metabolic process,GO:0042168,Epilepsy,MESH:D004827,1,Phenobarbital,0,
heme metabolic process,GO:0042168,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
heme metabolic process,GO:0042168,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
heme metabolic process,GO:0042168,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
heme metabolic process,GO:0042168,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
heme metabolic process,GO:0042168,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Phenobarbital,0,
heme oxidation,GO:0006788,Epilepsy,MESH:D004827,2,Chloramphenicol|Cimetidine,0,
heme oxidation,GO:0006788,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Cimetidine,0,
hemoglobin biosynthetic process,GO:0042541,Epilepsy,MESH:D004827,2,Folic Acid|Plant Extracts,0,
hemoglobin biosynthetic process,GO:0042541,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Lithium Carbonate,0,
hemoglobin biosynthetic process,GO:0042541,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
hemoglobin biosynthetic process,GO:0042541,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Ethanol|Lithium Carbonate|Plant Extracts,0,
hemoglobin metabolic process,GO:0020027,Epilepsy,MESH:D004827,2,Calcium|Folic Acid,0,
hemoglobin metabolic process,GO:0020027,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
hemopoiesis,GO:0030097,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|TEK
hemopoiesis,GO:0030097,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Diclofenac,0,
heparan sulfate proteoglycan biosynthetic process,GO:0015012,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,OXT
heparan sulfate proteoglycan metabolic process,GO:0030201,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,OXT
hepatic stellate cell activation,GO:0035733,Epilepsy,MESH:D004827,1,Valproic Acid,0,
hepatic stellate cell activation,GO:0035733,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
hepatic stellate cell activation,GO:0035733,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
hepatic stellate cell activation,GO:0035733,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
hepatic stellate cell activation,GO:0035733,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
hepatic stellate cell activation,GO:0035733,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
hepatic stellate cell activation,GO:0035733,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
hepatic stellate cell activation,GO:0035733,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Valproic Acid,0,
hepatic stellate cell activation,GO:0035733,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
hepatocyte differentiation,GO:0070365,Epilepsy,MESH:D004827,1,Dexamethasone,0,
hepatocyte differentiation,GO:0070365,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Diclofenac,0,
hepatocyte growth factor receptor signaling pathway,GO:0048012,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|TEK
hepatocyte homeostasis,GO:0036333,Epilepsy,MESH:D004827,1,Folic Acid,0,
hepatocyte homeostasis,GO:0036333,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
heterochromatin formation,GO:0031507,Epilepsy,MESH:D004827,0,,1,MECP2
heterocycle metabolic process,GO:0046483,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Methotrimeprazine,0,
heterotypic cell-cell adhesion,GO:0034113,Epilepsy,MESH:D004827,1,Dronabinol,0,
heterotypic cell-cell adhesion,GO:0034113,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
high-density lipoprotein particle clearance,GO:0034384,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
hindbrain development,GO:0030902,Epilepsy,MESH:D004827,1,Folic Acid,0,
hindbrain development,GO:0030902,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
hippocampal interneuron differentiation,GO:0097410,Epilepsy,MESH:D004827,1,Dronabinol,0,
hippocampal neuron apoptotic process,GO:0110088,Epilepsy,MESH:D004827,1,Sevoflurane,1,STAMBP
hippocampal pyramidal neuron differentiation,GO:0097432,Epilepsy,MESH:D004827,0,,1,KCNQ2
hippocampal pyramidal neuron differentiation,GO:0097432,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
hippocampus development,GO:0021766,Epilepsy,MESH:D004827,1,Sevoflurane,5,GRIN2A|GRIN2B|KCNQ2|MECP2|TSC1
hippocampus development,GO:0021766,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
hippocampus development,GO:0021766,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
hippocampus development,GO:0021766,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
hippocampus development,GO:0021766,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
hippocampus development,GO:0021766,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
hippocampus development,GO:0021766,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
histamine biosynthetic process,GO:0001694,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
histamine secretion,GO:0001821,Epilepsy,MESH:D004827,2,Calcium|Plant Extracts,0,
histamine secretion,GO:0001821,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
histamine secretion,GO:0001821,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
histamine secretion by mast cell,GO:0002553,Epilepsy,MESH:D004827,1,Plant Extracts,0,
histamine secretion by mast cell,GO:0002553,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
histamine secretion by mast cell,GO:0002553,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
histamine secretion involved in inflammatory response,GO:0002441,Epilepsy,MESH:D004827,2,Calcium|Dexamethasone,0,
histamine secretion mediated by immunoglobulin,GO:0097280,Epilepsy,MESH:D004827,16,Adenosine|Calcium|Carbachol|Cimetidine|Clonidine|Dexamethasone|Epinephrine|Iopamidol|Lidocaine|Lithium|Morphine|Naloxone|nimesulide|Norepinephrine|Perphenazine|Phentolamine,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Epilepsy, Absence",MESH:D004832,3,Doxorubicin|Heparin|Naloxone,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Epilepsy, Generalized",MESH:D004829,3,Naloxone|Prednisolone|Thiamylal,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Epilepsy, Temporal Lobe",MESH:D004833,4,Capsaicin|Lithium|Sialic Acids|Tacrolimus,0,
histamine secretion mediated by immunoglobulin,GO:0097280,"Epilepsy, Tonic-Clonic",MESH:D004830,20,Adenosine|Aminophylline|Cimetidine|Clonidine|Deferoxamine|Dizocilpine Maleate|Epinephrine|Ethanol|Fentanyl|Heparin|Lidocaine|Lithium|Methylphenidate|Morphine|Naloxone|Succinylcholine|Tacrolimus|Theophylline|Thiamylal|Thiopental,0,
histone acetylation,GO:0016573,Epilepsy,MESH:D004827,1,Gentamicins,0,
histone H2A-K5 acetylation,GO:0043977,Epilepsy,MESH:D004827,1,Dronabinol,0,
histone H3 acetylation,GO:0043966,Epilepsy,MESH:D004827,5,Aminooxyacetic Acid|Dexamethasone|Fluoxetine|Morphine|Valproic Acid,0,
histone H3 acetylation,GO:0043966,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
histone H3 acetylation,GO:0043966,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
histone H3 acetylation,GO:0043966,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
histone H3 acetylation,GO:0043966,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
histone H3 acetylation,GO:0043966,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
histone H3 acetylation,GO:0043966,"Epilepsy, Temporal Lobe",MESH:D004833,2,Clioquinol|Valproic Acid,0,
histone H3 acetylation,GO:0043966,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Chloroquine|Morphine|Valproic Acid|Venlafaxine Hydrochloride,0,
histone H3 acetylation,GO:0043966,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
histone H3 deacetylation,GO:0070932,Epilepsy,MESH:D004827,1,Valproic Acid,0,
histone H3 deacetylation,GO:0070932,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
histone H3 deacetylation,GO:0070932,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
histone H3 deacetylation,GO:0070932,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
histone H3 deacetylation,GO:0070932,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
histone H3 deacetylation,GO:0070932,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
histone H3 deacetylation,GO:0070932,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
histone H3 deacetylation,GO:0070932,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Valproic Acid,0,
histone H3 deacetylation,GO:0070932,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
histone H3-K14 acetylation,GO:0044154,Epilepsy,MESH:D004827,2,Dexamethasone|Dronabinol,0,
histone H3-K14 acetylation,GO:0044154,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
histone H3-K14 acetylation,GO:0044154,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
histone H3-K18 acetylation,GO:0043971,Epilepsy,MESH:D004827,1,Phenobarbital,0,
histone H3-K18 acetylation,GO:0043971,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
histone H3-K18 acetylation,GO:0043971,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
histone H3-K18 acetylation,GO:0043971,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
histone H3-K18 acetylation,GO:0043971,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
histone H3-K18 acetylation,GO:0043971,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Phenobarbital,0,
histone H3-K27 acetylation,GO:0043974,Epilepsy,MESH:D004827,1,Dexamethasone,0,
histone H3-K27 acetylation,GO:0043974,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Caffeine|Ethanol,0,
histone H3-K27 trimethylation,GO:0098532,Epilepsy,MESH:D004827,3,Dronabinol|Morphine|phosphinothricin,0,
histone H3-K27 trimethylation,GO:0098532,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Morphine,0,
histone H3-K36 dimethylation,GO:0097676,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Mechlorethamine,0,
histone H3-K36 methylation,GO:0010452,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
histone H3-K36 trimethylation,GO:0097198,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Deferoxamine|Ethanol,0,
histone H3-K4 demethylation,GO:0034720,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Phenelzine,0,
histone H3-K4 dimethylation,GO:0044648,Epilepsy,MESH:D004827,2,Folic Acid|Morphine,0,
histone H3-K4 dimethylation,GO:0044648,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Deferoxamine|Ethanol|Morphine,0,
histone H3-K4 methylation,GO:0051568,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
histone H3-K4 monomethylation,GO:0097692,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Mechlorethamine,0,
histone H3-K4 trimethylation,GO:0080182,Epilepsy,MESH:D004827,2,Morphine|Phenobarbital,0,
histone H3-K4 trimethylation,GO:0080182,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
histone H3-K4 trimethylation,GO:0080182,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
histone H3-K4 trimethylation,GO:0080182,"Epilepsy, Generalized",MESH:D004829,2,Phenobarbital|Zidovudine,0,
histone H3-K4 trimethylation,GO:0080182,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
histone H3-K4 trimethylation,GO:0080182,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Acetaminophen|Deferoxamine|Ethanol|Mechlorethamine|Morphine|Phenobarbital,0,
histone H3-K56 acetylation,GO:0097043,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
histone H3-K9 acetylation,GO:0043970,Epilepsy,MESH:D004827,4,Dexamethasone|Dronabinol|Etoposide|Plant Extracts,0,
histone H3-K9 acetylation,GO:0043970,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
histone H3-K9 acetylation,GO:0043970,"Epilepsy, Generalized",MESH:D004829,1,Zidovudine,0,
histone H3-K9 acetylation,GO:0043970,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
histone H3-K9 acetylation,GO:0043970,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Acetaminophen|Caffeine|Deferoxamine|Ethanol|Mechlorethamine|Plant Extracts,0,
histone H3-K9 dimethylation,GO:0036123,Epilepsy,MESH:D004827,5,Amphetamine|Cisplatin|Dronabinol|Folic Acid|Morphine,0,
histone H3-K9 dimethylation,GO:0036123,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Deferoxamine|Ethanol|Morphine,0,
histone H3-K9 trimethylation,GO:0036124,Epilepsy,MESH:D004827,1,Dronabinol,0,
histone H3-K9 trimethylation,GO:0036124,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Deferoxamine|Ethanol|Mechlorethamine,0,
histone H3-R2 methylation,GO:0034970,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Cocaine,0,
histone H4 acetylation,GO:0043967,Epilepsy,MESH:D004827,5,Amphetamine|Dexamethasone|Methylmercury Compounds|Morphine|Valproic Acid,0,
histone H4 acetylation,GO:0043967,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
histone H4 acetylation,GO:0043967,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
histone H4 acetylation,GO:0043967,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
histone H4 acetylation,GO:0043967,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
histone H4 acetylation,GO:0043967,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
histone H4 acetylation,GO:0043967,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
histone H4 acetylation,GO:0043967,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Morphine|Valproic Acid,0,
histone H4 acetylation,GO:0043967,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
histone H4 deacetylation,GO:0070933,Epilepsy,MESH:D004827,1,Valproic Acid,0,
histone H4 deacetylation,GO:0070933,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
histone H4 deacetylation,GO:0070933,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
histone H4 deacetylation,GO:0070933,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
histone H4 deacetylation,GO:0070933,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
histone H4 deacetylation,GO:0070933,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
histone H4 deacetylation,GO:0070933,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
histone H4 deacetylation,GO:0070933,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
histone H4 deacetylation,GO:0070933,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
histone H4-K12 acetylation,GO:0043983,Epilepsy,MESH:D004827,1,Dronabinol,0,
histone H4-K16 acetylation,GO:0043984,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
histone H4-K20 trimethylation,GO:0034773,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
histone H4-K5 acetylation,GO:0043981,Epilepsy,MESH:D004827,1,Etoposide,0,
homeostasis of number of cells,GO:0048872,Epilepsy,MESH:D004827,3,Ampicillin|Lithium Chloride|Valproic Acid,0,
homeostasis of number of cells,GO:0048872,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
homeostasis of number of cells,GO:0048872,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
homeostasis of number of cells,GO:0048872,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
homeostasis of number of cells,GO:0048872,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
homeostasis of number of cells,GO:0048872,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
homeostasis of number of cells,GO:0048872,"Epilepsy, Temporal Lobe",MESH:D004833,2,Lithium Chloride|Valproic Acid,0,
homeostasis of number of cells,GO:0048872,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Deferoxamine|Lithium Chloride|Methamphetamine|Metronidazole|Valproic Acid,0,
homeostasis of number of cells,GO:0048872,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
homeostasis of number of cells within a tissue,GO:0048873,Epilepsy,MESH:D004827,1,Methotrexate,0,
homeostasis of number of cells within a tissue,GO:0048873,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
homeostasis of number of cells within a tissue,GO:0048873,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,2,P2RX7|VEGFA
homeostasis of number of cells within a tissue,GO:0048873,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
homocysteine metabolic process,GO:0050667,Epilepsy,MESH:D004827,2,Folic Acid|Vitamin B 12,0,
homologous recombination,GO:0035825,Epilepsy,MESH:D004827,1,Cisplatin,0,
homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007156,Epilepsy,MESH:D004827,0,,1,PCDH19
homophilic cell adhesion via plasma membrane adhesion molecules,GO:0007156,"Epilepsy, Female-Restricted, with Mental Retardation",MESH:C564715,0,,1,PCDH19
homotypic cell-cell adhesion,GO:0034109,Epilepsy,MESH:D004827,3,Cisplatin|Dronabinol|Etoposide,0,
homotypic cell-cell adhesion,GO:0034109,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ropivacaine,0,
hormone biosynthetic process,GO:0042446,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1A
hormone metabolic process,GO:0042445,Epilepsy,MESH:D004827,2,Dexamethasone|Epinephrine,0,
hormone metabolic process,GO:0042445,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
hormone metabolic process,GO:0042445,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Epinephrine,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,Epilepsy,MESH:D004827,4,Ampicillin|Carbamazepine|Dronabinol|Gentamicins,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Epilepsy, Absence",MESH:D004832,2,Carbamazepine|Doxorubicin,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Epilepsy, Complex Partial",MESH:D017029,1,Carbamazepine,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Epilepsy, Generalized",MESH:D004829,1,Carbamazepine,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Epilepsy, Rolandic",MESH:D019305,1,Carbamazepine,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Epilepsy, Temporal Lobe",MESH:D004833,1,Carbamazepine,0,
host-mediated regulation of intestinal microbiota composition,GO:0048874,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Carbamazepine|Ethanol|Methamphetamine|Metronidazole,0,
humoral immune response,GO:0006959,Epilepsy,MESH:D004827,0,,1,MEF2C
humoral immune response,GO:0006959,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
humoral immune response,GO:0006959,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Hexachlorocyclohexane,0,
humoral immune response mediated by circulating immunoglobulin,GO:0002455,Epilepsy,MESH:D004827,1,Methylmercury Compounds,0,
hyaluronan biosynthetic process,GO:0030213,Epilepsy,MESH:D004827,1,Methylmercury Compounds,0,
hyaluronan catabolic process,GO:0030214,Epilepsy,MESH:D004827,0,,1,TGFB1
hyaluronan catabolic process,GO:0030214,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
hydrocarbon metabolic process,GO:0120252,Epilepsy,MESH:D004827,1,Ketamine,0,
hydrogen peroxide biosynthetic process,GO:0050665,Epilepsy,MESH:D004827,6,Calcium|Cisplatin|Folic Acid|malic acid|Plant Extracts|Propofol,0,
hydrogen peroxide biosynthetic process,GO:0050665,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
hydrogen peroxide biosynthetic process,GO:0050665,"Epilepsy, Generalized",MESH:D004829,2,Prednisolone|Propofol,0,
hydrogen peroxide biosynthetic process,GO:0050665,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
hydrogen peroxide biosynthetic process,GO:0050665,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Ethanol|Plant Extracts|Propofol,0,
hydrogen peroxide catabolic process,GO:0042744,Epilepsy,MESH:D004827,1,Calcium,2,GPX1|TXNRD1
hydrogen peroxide metabolic process,GO:0042743,Epilepsy,MESH:D004827,1,Cisplatin,0,
hydrogen peroxide metabolic process,GO:0042743,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
hydrogen peroxide metabolic process,GO:0042743,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Ethanol,0,
hydrogen sulfide biosynthetic process,GO:0070814,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Caffeine,0,
hypermethylation of CpG island,GO:0044027,Epilepsy,MESH:D004827,0,,1,MECP2
hypermethylation of CpG island,GO:0044027,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
hyperosmotic response,GO:0006972,Epilepsy,MESH:D004827,0,,1,SLC12A2
hyperosmotic response,GO:0006972,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
hypothalamus development,GO:0021854,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
hypothalamus development,GO:0021854,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
hypotonic response,GO:0006971,Epilepsy,MESH:D004827,1,gamma-Aminobutyric Acid,1,SLC12A5
hypotonic response,GO:0006971,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,SLC12A5
hypotonic response,GO:0006971,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A5
hypotonic response,GO:0006971,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Sodium Chloride,0,
I-kappaB kinase/NF-kappaB signaling,GO:0007249,Epilepsy,MESH:D004827,1,Plant Extracts,1,AKT1
I-kappaB kinase/NF-kappaB signaling,GO:0007249,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
I-kappaB kinase/NF-kappaB signaling,GO:0007249,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
imaginal disc-derived leg morphogenesis,GO:0007480,Epilepsy,MESH:D004827,0,,1,PURA
imaginal disc-derived wing hair organization,GO:0035317,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
immune response,GO:0006955,Epilepsy,MESH:D004827,0,,3,CERT1|OPRD1|OPRM1
immune response,GO:0006955,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,BDKRB1|BDKRB2
immunoglobulin production,GO:0002377,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
immunoglobulin production,GO:0002377,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Hexachlorocyclohexane,0,
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,Epilepsy,MESH:D004827,2,Dexamethasone|Plant Extracts,0,
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
immunoglobulin production involved in immunoglobulin-mediated immune response,GO:0002381,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
import across plasma membrane,GO:0098739,Epilepsy,MESH:D004827,2,Adenosine|Ketoconazole,0,
import across plasma membrane,GO:0098739,"Epilepsy, Absence",MESH:D004832,1,Heparin,0,
import across plasma membrane,GO:0098739,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Adenosine|Heparin|Quinine,0,
import into cell,GO:0098657,Epilepsy,MESH:D004827,4,Calcium|Cisplatin|Methotrexate|Phenobarbital,0,
import into cell,GO:0098657,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
import into cell,GO:0098657,"Epilepsy, Complex Partial",MESH:D017029,2,Methotrexate|Phenobarbital,0,
import into cell,GO:0098657,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
import into cell,GO:0098657,"Epilepsy, Temporal Lobe",MESH:D004833,2,Methotrexate|Phenobarbital,0,
import into cell,GO:0098657,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Chloroquine|Chlorpromazine|Methamphetamine|Methotrexate|Phenobarbital,0,
indole-containing compound metabolic process,GO:0042430,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acyclovir,0,
indole metabolic process,GO:0042431,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
induction of negative chemotaxis,GO:0050929,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
induction of positive chemotaxis,GO:0050930,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
induction of positive chemotaxis,GO:0050930,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NTF3
inflammatory response,GO:0006954,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
inflammatory response,GO:0006954,Epilepsy,MESH:D004827,14,Chondroitin Sulfates|Cisplatin|Dexamethasone|Dronabinol|Epinephrine|Erythromycin|Gentamicins|Methotrexate|Methylmercury Compounds|Morphine|Penicillin G|Plant Extracts|Sevoflurane|Valproic Acid,6,AKT1|CNTNAP2|DDX3X|FOS|MECP2|TGFB1
inflammatory response,GO:0006954,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
inflammatory response,GO:0006954,"Epilepsy, Complex Partial",MESH:D017029,3,Methotrexate|Trazodone|Valproic Acid,0,
inflammatory response,GO:0006954,"Epilepsy, Generalized",MESH:D004829,2,Trazodone|Valproic Acid,0,
inflammatory response,GO:0006954,"Epilepsy, Myoclonic, Benign Adult Familial, Type 2",MESH:C564313,0,,1,STARD7
inflammatory response,GO:0006954,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
inflammatory response,GO:0006954,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
inflammatory response,GO:0006954,"Epilepsy, Temporal Lobe",MESH:D004833,3,Methotrexate|Plant Extracts|Valproic Acid,3,BDKRB1|BDKRB2|P2RX7
inflammatory response,GO:0006954,"Epilepsy, Tonic-Clonic",MESH:D004830,22,Acetaminophen|Aluminum|Buspirone|Caffeine|Diclofenac|Disulfiram|Ephedrine|Epinephrine|Erythromycin|Ethanol|Hexachlorocyclohexane|Methamphetamine|Methotrexate|Methylprednisolone|Morphine|Paroxetine|Penicillin G|Plant Extracts|Prednisone|Sarin|Valproic Acid|Vincristine,0,
inflammatory response,GO:0006954,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
inflammatory response to antigenic stimulus,GO:0002437,Epilepsy,MESH:D004827,1,Dexamethasone,0,
inhibitory chemical synaptic transmission,GO:0098977,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
inhibitory chemical synaptic transmission,GO:0098977,Epilepsy,MESH:D004827,2,Atropine|Picrotoxin,3,CNTNAP2|KCNQ2|TSC2
inhibitory chemical synaptic transmission,GO:0098977,"Epilepsy, Absence",MESH:D004832,1,Picrotoxin,0,
inhibitory chemical synaptic transmission,GO:0098977,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
inhibitory chemical synaptic transmission,GO:0098977,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Atropine|Picrotoxin,0,
inhibitory postsynaptic potential,GO:0060080,Epilepsy,MESH:D004827,17,"Amphetamine|Atropine|Bicuculline|Calcium|Carbachol|Clonidine|Clozapine|Diazepam|Enkephalin, Ala(2)-MePhe(4)-Gly(5)-|Fluoxetine|Haloperidol|Kainic Acid|perampanel|Picrotoxin|Propofol|Strychnine|Topiramate",2,BDNF|GABRB3
inhibitory postsynaptic potential,GO:0060080,"Epilepsy, Absence",MESH:D004832,5,CGP 35348|Diazepam|Haloperidol|Picrotoxin|Riluzole,1,GABRB3
inhibitory postsynaptic potential,GO:0060080,"Epilepsy, Complex Partial",MESH:D017029,3,Clozapine|Diazepam|Topiramate,0,
inhibitory postsynaptic potential,GO:0060080,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNA4
inhibitory postsynaptic potential,GO:0060080,"Epilepsy, Generalized",MESH:D004829,3,Clozapine|Diazepam|Propofol,0,
inhibitory postsynaptic potential,GO:0060080,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
inhibitory postsynaptic potential,GO:0060080,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
inhibitory postsynaptic potential,GO:0060080,"Epilepsy, Rolandic",MESH:D019305,1,Topiramate,0,
inhibitory postsynaptic potential,GO:0060080,"Epilepsy, Temporal Lobe",MESH:D004833,3,Capsaicin|Kainic Acid|Topiramate,0,
inhibitory postsynaptic potential,GO:0060080,"Epilepsy, Tonic-Clonic",MESH:D004830,12,Atropine|Chlorpromazine|Clonidine|Clozapine|Cocaine|Diazepam|Haloperidol|Picrotoxin|Propofol|Quinine|Thiopental|Topiramate,1,BDNF
inhibitory synapse assembly,GO:1904862,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
inhibitory synapse assembly,GO:1904862,Epilepsy,MESH:D004827,0,,3,CNTNAP2|GABRB2|GABRB3
inhibitory synapse assembly,GO:1904862,"Epilepsy, Absence",MESH:D004832,0,,1,GABRB3
inhibitory synapse assembly,GO:1904862,"Myoclonic Epilepsy, Juvenile",MESH:D020190,0,,1,GABRA1
initiation of primordial ovarian follicle growth,GO:0001544,Epilepsy,MESH:D004827,2,Dexamethasone|Dronabinol,0,
innate immune response,GO:0045087,Epilepsy,MESH:D004827,0,,2,DDX3X|NPY
innate immune response,GO:0045087,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,NPY
innate vocalization behavior,GO:0098582,Epilepsy,MESH:D004827,0,,1,AUTS2
inner dynein arm assembly,GO:0036159,"Epilepsy, Partial, with Variable Foci",MESH:C565785,0,,1,NPRL2
inner ear auditory receptor cell differentiation,GO:0042491,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
inner ear auditory receptor cell differentiation,GO:0042491,Generalized Epilepsy and Paroxysmal Dyskinesia,MESH:C563719,0,,1,KCNMA1
inner ear development,GO:0048839,Epilepsy,MESH:D004827,0,,2,BDNF|TGFB1
inner ear development,GO:0048839,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,BDNF
inner ear morphogenesis,GO:0042472,Epilepsy,MESH:D004827,0,,2,FOXG1|SLC12A2
inner ear morphogenesis,GO:0042472,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
inner ear receptor cell development,GO:0060119,Epilepsy,MESH:D004827,0,,2,GABRB2|GABRB3
inner ear receptor cell development,GO:0060119,"Epilepsy, Absence",MESH:D004832,0,,1,GABRB3
innervation,GO:0060384,Epilepsy,MESH:D004827,0,,2,GABRB2|GABRB3
innervation,GO:0060384,"Epilepsy, Absence",MESH:D004832,0,,1,GABRB3
inorganic anion import across plasma membrane,GO:0098658,Epilepsy,MESH:D004827,0,,2,SLC12A2|SLC6A1
inorganic anion import across plasma membrane,GO:0098658,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
inorganic anion import across plasma membrane,GO:0098658,MYOCLONIC-ATONIC EPILEPSY,OMIM:616421,0,,1,SLC6A1
inorganic anion transport,GO:0015698,Epilepsy,MESH:D004827,0,,1,SLC4A10
inorganic anion transport,GO:0015698,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,SLC4A10
inorganic cation import across plasma membrane,GO:0098659,Epilepsy,MESH:D004827,1,4-Aminopyridine,1,SLC12A2
inorganic cation import across plasma membrane,GO:0098659,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A2
inorganic cation transmembrane transport,GO:0098662,Epilepsy,MESH:D004827,1,Ketoconazole,1,P2RX4
inorganic cation transmembrane transport,GO:0098662,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1H
inorganic cation transmembrane transport,GO:0098662,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX4
inositol metabolic process,GO:0006020,Epilepsy,MESH:D004827,1,Methotrexate,1,MECP2
inositol metabolic process,GO:0006020,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
inositol metabolic process,GO:0006020,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
inositol metabolic process,GO:0006020,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
insulin-like growth factor receptor signaling pathway,GO:0048009,Epilepsy,MESH:D004827,0,,2,AKT1|TSC2
insulin-like growth factor receptor signaling pathway,GO:0048009,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|TEK
insulin-like growth factor receptor signaling pathway,GO:0048009,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
insulin metabolic process,GO:1901142,Epilepsy,MESH:D004827,2,Calcium|Plant Extracts,1,ERN1
insulin metabolic process,GO:1901142,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
insulin metabolic process,GO:1901142,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
insulin metabolic process,GO:1901142,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 1",OMIM:614231,0,,1,IER3IP1
insulin receptor signaling pathway,GO:0008286,Epilepsy,MESH:D004827,0,,1,AKT1
insulin receptor signaling pathway,GO:0008286,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|TEK
insulin secretion,GO:0030073,Epilepsy,MESH:D004827,1,Fluoxetine,1,SNAP25
insulin secretion,GO:0030073,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 8",OMIM:616461,0,,1,GAL
insulin secretion,GO:0030073,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
insulin secretion,GO:0030073,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Clomipramine|Paroxetine,0,
integrated stress response signaling,GO:0140467,Epilepsy,MESH:D004827,0,,1,FOS
integrin-mediated signaling pathway,GO:0007229,Epilepsy,MESH:D004827,0,,1,ILK
intein-mediated protein splicing,GO:0016539,Epilepsy,MESH:D004827,1,Cisplatin,0,
interleukin-10 production,GO:0032613,Epilepsy,MESH:D004827,1,Methylmercury Compounds,0,
interleukin-10 production,GO:0032613,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
interleukin-18-mediated signaling pathway,GO:0035655,Epilepsy,MESH:D004827,0,,1,AKT1
interleukin-1 alpha production,GO:0032610,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
interleukin-1 beta production,GO:0032611,Epilepsy,MESH:D004827,1,Methylmercury Compounds,1,ERN1
interleukin-1 beta production,GO:0032611,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
interleukin-1 beta production,GO:0032611,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
interleukin-4 production,GO:0032633,Epilepsy,MESH:D004827,1,Methylmercury Compounds,0,
interleukin-6 production,GO:0032635,Epilepsy,MESH:D004827,2,Ketamine|Methylmercury Compounds,0,
interleukin-6 production,GO:0032635,"Epilepsy, Generalized",MESH:D004829,0,,1,CHRNA7
interleukin-6 production,GO:0032635,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
interleukin-6 production,GO:0032635,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Chloroquine,0,
inter-male aggressive behavior,GO:0002121,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
intermediate filament-based process,GO:0045103,Epilepsy,MESH:D004827,0,,1,GFAP
intermediate filament organization,GO:0045109,Epilepsy,MESH:D004827,0,,1,GFAP
intermembrane lipid transfer,GO:0120009,Epilepsy,MESH:D004827,0,,1,CERT1
intermembrane lipid transfer,GO:0120009,"Epilepsy, Myoclonic, Benign Adult Familial, Type 2",MESH:C564313,0,,1,STARD7
intermembrane sphingolipid transfer,GO:0120012,Epilepsy,MESH:D004827,0,,1,CERT1
interneuron migration,GO:1904936,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
interneuron migration,GO:1904936,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
intestinal absorption,GO:0050892,Epilepsy,MESH:D004827,1,Dronabinol,2,ADRA2A|SLCO1A5
intestinal absorption,GO:0050892,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VDR
intestinal epithelial cell development,GO:0060576,Epilepsy,MESH:D004827,2,Folic Acid|Vitamin B 12,0,
intestinal epithelial cell differentiation,GO:0060575,Epilepsy,MESH:D004827,0,,2,NPY|TSC2
intestinal epithelial cell differentiation,GO:0060575,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,NPY
intestinal epithelial structure maintenance,GO:0060729,Epilepsy,MESH:D004827,1,Ampicillin,0,
intestinal epithelial structure maintenance,GO:0060729,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Ethanol|Methamphetamine|Metronidazole,0,
intestinal motility,GO:0120054,Epilepsy,MESH:D004827,2,Fluoxetine|Morphine,1,FLNA
intestinal motility,GO:0120054,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Morphine,0,
intestinal stem cell homeostasis,GO:0036335,Epilepsy,MESH:D004827,0,,1,TSC1
intestine smooth muscle contraction,GO:0014827,Epilepsy,MESH:D004827,3,Atropine|Calcium|Phentolamine,0,
intestine smooth muscle contraction,GO:0014827,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Atropine,0,
intracellular bile acid receptor signaling pathway,GO:0038185,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VDR
intracellular distribution of mitochondria,GO:0048312,Epilepsy,MESH:D004827,1,Valproic Acid,0,
intracellular distribution of mitochondria,GO:0048312,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
intracellular distribution of mitochondria,GO:0048312,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
intracellular distribution of mitochondria,GO:0048312,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
intracellular distribution of mitochondria,GO:0048312,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
intracellular distribution of mitochondria,GO:0048312,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
intracellular distribution of mitochondria,GO:0048312,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
intracellular distribution of mitochondria,GO:0048312,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Valproic Acid|Vincristine,0,
intracellular distribution of mitochondria,GO:0048312,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
intracellular pH elevation,GO:0051454,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
intracellular pH reduction,GO:0051452,Epilepsy,MESH:D004827,1,Etoposide,1,SLC12A5
intracellular pH reduction,GO:0051452,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,SLC12A5
intracellular pH reduction,GO:0051452,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC12A5
intracellular pH reduction,GO:0051452,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Theophylline,0,
intracellular pH reduction,GO:0051452,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
intracellular protein transport,GO:0006886,Epilepsy,MESH:D004827,0,,3,GFAP|STX1B|STXBP1
intracellular protein transport,GO:0006886,"GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9",OMIM:616172,0,,1,STX1B
intracellular sequestering of iron ion,GO:0006880,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
intracellular signal transduction,GO:0035556,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
intracellular signal transduction,GO:0035556,Epilepsy,MESH:D004827,0,,4,AKT1|CDKL5|CNTNAP2|DDX3X
intracellular signal transduction,GO:0035556,"Epilepsy, Partial, with Variable Foci",MESH:C565785,0,,1,DEPDC5
intracellular signal transduction,GO:0035556,Hyperekplexia and Epilepsy,MESH:C564474,0,,1,ARHGEF9
intracellular steroid hormone receptor signaling pathway,GO:0030518,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VDR
intracellular transport of virus,GO:0075733,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
intrahepatic bile duct development,GO:0035622,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
intrinsic apoptotic signaling pathway,GO:0097193,Epilepsy,MESH:D004827,1,Plant Extracts,1,DDX3X
intrinsic apoptotic signaling pathway,GO:0097193,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
intrinsic apoptotic signaling pathway,GO:0097193,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Plant Extracts|Sertraline,0,
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,GO:0070059,Epilepsy,MESH:D004827,0,,1,ERN1
intrinsic apoptotic signaling pathway in response to osmotic stress,GO:0008627,Epilepsy,MESH:D004827,0,,1,SCN2A
intrinsic apoptotic signaling pathway in response to osmotic stress,GO:0008627,"Epilepsy, Benign Neonatal, 3",MESH:C564274,0,,1,SCN2A
intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,GO:1990127,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,BDKRB2
intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008631,Epilepsy,MESH:D004827,1,Lithium Chloride,1,GPX1
intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008631,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium Chloride,0,
intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008631,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Lithium Chloride,0,
in utero embryonic development,GO:0001701,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
in utero embryonic development,GO:0001701,Epilepsy,MESH:D004827,0,,4,ANKRD11|CERT1|CNTNAP2|GRIN2B
in utero embryonic development,GO:0001701,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,SLIT2|VEGFA
ionotropic glutamate receptor signaling pathway,GO:0035235,Epilepsy,MESH:D004827,0,,2,GRIN2A|GRIN2B
ionotropic glutamate receptor signaling pathway,GO:0035235,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
ionotropic glutamate receptor signaling pathway,GO:0035235,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
IRE1-mediated unfolded protein response,GO:0036498,Epilepsy,MESH:D004827,0,,1,ERN1
iron ion export across plasma membrane,GO:1903988,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Chloroquine|Deferoxamine,0,
iron ion homeostasis,GO:0055072,Epilepsy,MESH:D004827,4,Cisplatin|Etoposide|Folic Acid|Valproic Acid,0,
iron ion homeostasis,GO:0055072,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
iron ion homeostasis,GO:0055072,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
iron ion homeostasis,GO:0055072,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
iron ion homeostasis,GO:0055072,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
iron ion homeostasis,GO:0055072,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
iron ion homeostasis,GO:0055072,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
iron ion homeostasis,GO:0055072,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Acetaminophen|Chloroquine|Deferoxamine|Ethanol|Valproic Acid,0,
iron ion homeostasis,GO:0055072,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
iron ion import across cell outer membrane,GO:0098706,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
iron ion transport,GO:0006826,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Deferoxamine,0,
isoleucine biosynthetic process,GO:0009097,Epilepsy,MESH:D004827,1,Phenobarbital,0,
isoleucine biosynthetic process,GO:0009097,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
isoleucine biosynthetic process,GO:0009097,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
isoleucine biosynthetic process,GO:0009097,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
isoleucine biosynthetic process,GO:0009097,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
isoleucine biosynthetic process,GO:0009097,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
isoleucine biosynthetic process,GO:0009097,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Phenobarbital,0,
isoleucine metabolic process,GO:0006549,Epilepsy,MESH:D004827,1,Propofol,0,
isoleucine metabolic process,GO:0006549,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
isoleucine metabolic process,GO:0006549,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
isoquinoline alkaloid metabolic process,GO:0033076,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,CYP2D6
JNK cascade,GO:0007254,Epilepsy,MESH:D004827,2,Cisplatin|Plant Extracts,0,
JNK cascade,GO:0007254,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
JNK cascade,GO:0007254,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CASR
JNK cascade,GO:0007254,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
JNK cascade,GO:0007254,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Plant Extracts|Sertraline,0,
kainate selective glutamate receptor signaling pathway,GO:0098991,Epilepsy,MESH:D004827,1,Methylmercury Compounds,0,
keratinocyte differentiation,GO:0030216,Epilepsy,MESH:D004827,1,Calcium,0,
keratinocyte differentiation,GO:0030216,SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY,OMIM:159950,0,,1,ASAH1
kidney development,GO:0001822,Epilepsy,MESH:D004827,0,,1,TSC1
kidney development,GO:0001822,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,SLIT2|VEGFA
killing of cells of another organism,GO:0031640,Epilepsy,MESH:D004827,0,,1,POMC
killing of cells of another organism,GO:0031640,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,POMC
Kit signaling pathway,GO:0038109,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|TEK
Kupffer's vesicle development,GO:0070121,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
kynurenic acid metabolic process,GO:0034275,Epilepsy,MESH:D004827,1,Dronabinol,0,
kynurenic acid metabolic process,GO:0034275,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
labyrinthine layer blood vessel development,GO:0060716,Epilepsy,MESH:D004827,0,,1,AKT1
lactate biosynthetic process,GO:0019249,Epilepsy,MESH:D004827,4,Cisplatin|Clozapine|Folic Acid|Haloperidol,0,
lactate biosynthetic process,GO:0019249,"Epilepsy, Absence",MESH:D004832,1,Haloperidol,0,
lactate biosynthetic process,GO:0019249,"Epilepsy, Complex Partial",MESH:D017029,1,Clozapine,0,
lactate biosynthetic process,GO:0019249,"Epilepsy, Generalized",MESH:D004829,1,Clozapine,0,
lactate biosynthetic process,GO:0019249,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Acetaminophen|Bupropion|Chlorpromazine|Clozapine|Haloperidol,0,
lactate biosynthetic process from pyruvate,GO:0019244,Epilepsy,MESH:D004827,1,Aminooxyacetic Acid,0,
lactate metabolic process,GO:0006089,Epilepsy,MESH:D004827,2,Propofol|Sevoflurane,0,
lactate metabolic process,GO:0006089,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
lactate metabolic process,GO:0006089,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
lactate metabolic process,GO:0006089,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Acetaminophen|Clomipramine|Ethanol|Propofol,0,
lactation,GO:0007595,Epilepsy,MESH:D004827,1,Folic Acid,0,
lactation,GO:0007595,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,VDR|VEGFA
lactation,GO:0007595,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,OXT
lactic acid secretion,GO:0046722,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
lactose metabolic process,GO:0005988,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Diclofenac,0,
L-alanine catabolic process,GO:0042853,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
"L-alanine catabolic process, by transamination",GO:0019481,Epilepsy,MESH:D004827,1,Plant Extracts,0,
"L-alanine catabolic process, by transamination",GO:0019481,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
"L-alanine catabolic process, by transamination",GO:0019481,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
L-alpha-amino acid transmembrane transport,GO:1902475,Epilepsy,MESH:D004827,0,,2,SLC1A2|SLC1A3
lamellipodium assembly,GO:0030032,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
Langerhans cell differentiation,GO:0061520,Epilepsy,MESH:D004827,0,,1,TGFB1
larval behavior,GO:0030537,Epilepsy,MESH:D004827,1,Dronabinol,0,
larval development,GO:0002164,Epilepsy,MESH:D004827,4,Methotrexate|Pentylenetetrazole|Picrotoxin|Valproic Acid,0,
larval development,GO:0002164,"Epilepsy, Absence",MESH:D004832,3,Pentylenetetrazole|Picrotoxin|Valproic Acid,0,
larval development,GO:0002164,"Epilepsy, Complex Partial",MESH:D017029,2,Methotrexate|Valproic Acid,0,
larval development,GO:0002164,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
larval development,GO:0002164,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
larval development,GO:0002164,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
larval development,GO:0002164,"Epilepsy, Temporal Lobe",MESH:D004833,2,Methotrexate|Valproic Acid,0,
larval development,GO:0002164,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Methotrexate|Pentylenetetrazole|Picrotoxin|tetramethylenedisulfotetramine|Valproic Acid,0,
larval development,GO:0002164,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
larval feeding behavior,GO:0030536,Epilepsy,MESH:D004827,1,Fluoxetine,0,
larval locomotory behavior,GO:0008345,Epilepsy,MESH:D004827,2,Picrotoxin|Valproic Acid,0,
larval locomotory behavior,GO:0008345,"Epilepsy, Absence",MESH:D004832,2,Picrotoxin|Valproic Acid,0,
larval locomotory behavior,GO:0008345,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
larval locomotory behavior,GO:0008345,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
larval locomotory behavior,GO:0008345,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
larval locomotory behavior,GO:0008345,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
larval locomotory behavior,GO:0008345,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
larval locomotory behavior,GO:0008345,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Hexachlorocyclohexane|Picrotoxin|tetramethylenedisulfotetramine|Valproic Acid,0,
larval locomotory behavior,GO:0008345,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,1,GABRA1
larval midgut histolysis,GO:0035069,Epilepsy,MESH:D004827,0,,1,TSC1
L-ascorbic acid biosynthetic process,GO:0019853,Epilepsy,MESH:D004827,1,Cisplatin,0,
L-ascorbic acid biosynthetic process,GO:0019853,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
L-ascorbic acid metabolic process,GO:0019852,Epilepsy,MESH:D004827,2,Cisplatin|Dronabinol,0,
L-ascorbic acid metabolic process,GO:0019852,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Vincristine,0,
L-aspartate import across plasma membrane,GO:0140009,Epilepsy,MESH:D004827,0,,3,SLC1A1|SLC1A2|SLC1A3
L-aspartate import across plasma membrane,GO:0140009,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
L-aspartate transmembrane transport,GO:0070778,Epilepsy,MESH:D004827,0,,2,SLC1A1|SLC1A2
L-aspartate transmembrane transport,GO:0070778,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
lateral geniculate nucleus development,GO:0021771,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNB2
lateral geniculate nucleus development,GO:0021771,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
lateral motor column neuron migration,GO:0097477,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
lateral motor column neuron migration,GO:0097477,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
layer formation in cerebral cortex,GO:0021819,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
layer formation in cerebral cortex,GO:0021819,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
learning,GO:0007612,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
learning,GO:0007612,Epilepsy,MESH:D004827,8,Folic Acid|Ketamine|Lithium Chloride|Pentylenetetrazole|Plant Extracts|Propofol|Sevoflurane|trimethyltin chloride,10,BDNF|CNTNAP2|GABRB3|GRIN2A|GRIN2B|KCNQ2|MECP2|SLC12A5|SLC6A1|VDAC1
learning,GO:0007612,"Epilepsy, Absence",MESH:D004832,1,Pentylenetetrazole,1,GABRB3
learning,GO:0007612,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
learning,GO:0007612,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
learning,GO:0007612,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
learning,GO:0007612,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
learning,GO:0007612,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
learning,GO:0007612,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNB2
learning,GO:0007612,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
learning,GO:0007612,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,SLC12A5
learning,GO:0007612,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
learning,GO:0007612,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
learning,GO:0007612,"Epilepsy, Temporal Lobe",MESH:D004833,2,Lithium Chloride|Plant Extracts,3,GRM4|GRM5|SLC12A5
learning,GO:0007612,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Acetaminophen|Lithium Chloride|Pentylenetetrazole|Plant Extracts|Propofol|Soman,2,BCHE|BDNF
learning,GO:0007612,MYOCLONIC-ATONIC EPILEPSY,OMIM:616421,0,,1,SLC6A1
learning or memory,GO:0007611,Epilepsy,MESH:D004827,3,Methylmercury Compounds|Propofol|Sevoflurane,5,BDNF|GRIN2A|GRIN2B|MEF2C|SLC1A1
learning or memory,GO:0007611,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
learning or memory,GO:0007611,"Epilepsy, Generalized",MESH:D004829,1,Propofol,1,CHRNA7
learning or memory,GO:0007611,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
learning or memory,GO:0007611,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
learning or memory,GO:0007611,"Epilepsy, Temporal Lobe",MESH:D004833,0,,3,CNR1|GRM5|SLC1A1
learning or memory,GO:0007611,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,1,BDNF
lens fiber cell differentiation,GO:0070306,Epilepsy,MESH:D004827,0,,1,TGFB1
leucine metabolic process,GO:0006551,Epilepsy,MESH:D004827,2,Propofol|Sevoflurane,0,
leucine metabolic process,GO:0006551,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
leucine metabolic process,GO:0006551,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Propofol,0,
leukocyte activation,GO:0045321,Epilepsy,MESH:D004827,1,Dexamethasone,0,
leukocyte adhesion to vascular endothelial cell,GO:0061756,Epilepsy,MESH:D004827,1,Dexamethasone,0,
leukocyte chemotaxis,GO:0030595,Epilepsy,MESH:D004827,13,Adenosine|Chloramphenicol|Epinephrine|Erythromycin|Gentamicins|Griseofulvin|Ketoconazole|Lidocaine|Morphine|Naloxone|nimesulide|Norepinephrine|Phenobarbital,0,
leukocyte chemotaxis,GO:0030595,"Epilepsy, Absence",MESH:D004832,3,Doxorubicin|Naloxone|Phenobarbital,0,
leukocyte chemotaxis,GO:0030595,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
leukocyte chemotaxis,GO:0030595,"Epilepsy, Generalized",MESH:D004829,3,Naloxone|Phenobarbital|Prednisolone,0,
leukocyte chemotaxis,GO:0030595,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
leukocyte chemotaxis,GO:0030595,"Epilepsy, Tonic-Clonic",MESH:D004830,15,Acetaminophen|Adenosine|Chlorpromazine|Diclofenac|Epinephrine|Erythromycin|Lidocaine|Methylprednisolone|Morphine|Naloxone|Phenobarbital|Procaine|Tetracaine|Theophylline|Vincristine,0,
leukocyte chemotaxis involved in inflammatory response,GO:0002232,Epilepsy,MESH:D004827,2,Dexamethasone|Sevoflurane,0,
leukocyte chemotaxis involved in inflammatory response,GO:0002232,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Diclofenac|Ethanol,0,
leukocyte degranulation,GO:0043299,Epilepsy,MESH:D004827,3,Dexamethasone|Morphine|Thalidomide,0,
leukocyte degranulation,GO:0043299,"Epilepsy, Absence",MESH:D004832,1,Heparin,0,
leukocyte degranulation,GO:0043299,"Epilepsy, Temporal Lobe",MESH:D004833,1,Tacrolimus,0,
leukocyte degranulation,GO:0043299,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Heparin|Morphine|Sodium Chloride|Tacrolimus,0,
leukocyte homeostasis,GO:0001776,Epilepsy,MESH:D004827,1,Plant Extracts,0,
leukocyte homeostasis,GO:0001776,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Lithium Carbonate,0,
leukocyte homeostasis,GO:0001776,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
leukocyte homeostasis,GO:0001776,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
leukocyte homeostasis,GO:0001776,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Lithium Carbonate|Plant Extracts,0,
leukocyte mediated cytotoxicity,GO:0001909,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
leukocyte mediated cytotoxicity,GO:0001909,"Epilepsy, Temporal Lobe",MESH:D004833,1,Tacrolimus,0,
leukocyte mediated cytotoxicity,GO:0001909,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Tacrolimus,0,
leukocyte migration,GO:0050900,Epilepsy,MESH:D004827,1,Dexamethasone,0,
leukocyte migration,GO:0050900,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Hexachlorocyclohexane,0,
leukocyte migration involved in inflammatory response,GO:0002523,Epilepsy,MESH:D004827,17,Cimetidine|Cisplatin|Dexamethasone|Dronabinol|Fluoxetine|Folic Acid|Gentamicins|Haloperidol|Ketoconazole|Lithium Chloride|Methotrexate|Phenytoin|Plant Extracts|Propofol|Sevoflurane|Valproic Acid|Vitamin U,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Epilepsy, Absence",MESH:D004832,4,Doxorubicin|Haloperidol|Phenytoin|Valproic Acid,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Epilepsy, Complex Partial",MESH:D017029,3,Methotrexate|Phenytoin|Valproic Acid,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Epilepsy, Generalized",MESH:D004829,5,Phenytoin|Prednisolone|Propofol|Valproic Acid|Zidovudine,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Epilepsy, Temporal Lobe",MESH:D004833,5,Lithium Chloride|Methotrexate|Phenytoin|Plant Extracts|Valproic Acid,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Epilepsy, Tonic-Clonic",MESH:D004830,14,Acetaminophen|Aluminum Hydroxide|Caffeine|Cimetidine|Diclofenac|Ethanol|Haloperidol|Lithium Chloride|Mechlorethamine|Methotrexate|Phenytoin|Plant Extracts|Propofol|Valproic Acid,0,
leukocyte migration involved in inflammatory response,GO:0002523,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
leukocyte proliferation,GO:0070661,Epilepsy,MESH:D004827,1,Plant Extracts,1,TGFB1
leukocyte proliferation,GO:0070661,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
leukocyte proliferation,GO:0070661,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
leukocyte tethering or rolling,GO:0050901,Epilepsy,MESH:D004827,5,Dexamethasone|Morphine|Naloxone|Sevoflurane|Thalidomide,0,
leukocyte tethering or rolling,GO:0050901,"Epilepsy, Absence",MESH:D004832,2,Heparin|Naloxone,0,
leukocyte tethering or rolling,GO:0050901,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,0,
leukocyte tethering or rolling,GO:0050901,"Epilepsy, Temporal Lobe",MESH:D004833,1,Tacrolimus,0,
leukocyte tethering or rolling,GO:0050901,"Epilepsy, Tonic-Clonic",MESH:D004830,7,Diclofenac|Fentanyl|Heparin|Morphine|Naloxone|Ropivacaine|Tacrolimus,0,
leukotriene B4 biosynthetic process,GO:0097251,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Aluminum,0,
leukotriene biosynthetic process,GO:0019370,Epilepsy,MESH:D004827,1,Calcium,0,
Leydig cell differentiation,GO:0033327,Epilepsy,MESH:D004827,2,Dexamethasone|Lithium,0,
Leydig cell differentiation,GO:0033327,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium,0,
Leydig cell differentiation,GO:0033327,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Lithium,0,
L-glutamate import,GO:0051938,Epilepsy,MESH:D004827,1,Valproic Acid,2,SLC1A1|SLC1A3
L-glutamate import,GO:0051938,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
L-glutamate import,GO:0051938,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
L-glutamate import,GO:0051938,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
L-glutamate import,GO:0051938,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
L-glutamate import,GO:0051938,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
L-glutamate import,GO:0051938,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,1,SLC1A1
L-glutamate import,GO:0051938,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Valproic Acid,0,
L-glutamate import,GO:0051938,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
L-glutamate import across plasma membrane,GO:0098712,Epilepsy,MESH:D004827,0,,4,GRM1|SLC1A1|SLC1A2|SLC1A3
L-glutamate import across plasma membrane,GO:0098712,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,GRM1|SLC1A1
L-glutamate transmembrane transport,GO:0015813,Epilepsy,MESH:D004827,0,,3,SLC1A1|SLC1A2|SLC1A3
L-glutamate transmembrane transport,GO:0015813,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
ligand-gated ion channel signaling pathway,GO:1990806,Epilepsy,MESH:D004827,1,gamma-Aminobutyric Acid,0,
limb development,GO:0060173,Epilepsy,MESH:D004827,2,Cytarabine|Folic Acid,0,
limb development,GO:0060173,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
limb development,GO:0060173,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
limbic system development,GO:0021761,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
limbic system development,GO:0021761,Epilepsy,MESH:D004827,0,,1,CNTNAP2
limb morphogenesis,GO:0035108,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
lipid biosynthetic process,GO:0008610,Epilepsy,MESH:D004827,13,Azathioprine|Calcium|Clozapine|Dexamethasone|Epinephrine|Estrogens|Fluoxetine|Ketoconazole|Methotrexate|Norepinephrine|Plant Extracts|Topiramate|Valproic Acid,0,
lipid biosynthetic process,GO:0008610,"Epilepsy, Absence",MESH:D004832,3,Doxorubicin|Progesterone|Valproic Acid,0,
lipid biosynthetic process,GO:0008610,"Epilepsy, Complex Partial",MESH:D017029,4,Clozapine|Methotrexate|Topiramate|Valproic Acid,0,
lipid biosynthetic process,GO:0008610,"Epilepsy, Generalized",MESH:D004829,3,Clozapine|Valproic Acid|Zidovudine,0,
lipid biosynthetic process,GO:0008610,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
lipid biosynthetic process,GO:0008610,"Epilepsy, Rolandic",MESH:D019305,2,Topiramate|Valproic Acid,0,
lipid biosynthetic process,GO:0008610,"Epilepsy, Temporal Lobe",MESH:D004833,4,Methotrexate|Plant Extracts|Topiramate|Valproic Acid,1,CNR1
lipid biosynthetic process,GO:0008610,"Epilepsy, Tonic-Clonic",MESH:D004830,9,Caffeine|Chlorpromazine|Clozapine|Epinephrine|Ethanol|Methotrexate|Plant Extracts|Topiramate|Valproic Acid,0,
lipid biosynthetic process,GO:0008610,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
lipid catabolic process,GO:0016042,Epilepsy,MESH:D004827,47,"Adenosine|Bicuculline|Busulfan|Calcium|carbidopa, levodopa drug combination|Chondroitin Sulfates|Cilastatin, Imipenem Drug Combination|Cimetidine|Ciprofloxacin|Cisplatin|Clonidine|daidzin|Dexamethasone|Dextroamphetamine|Diazepam|Dronabinol|Epinephrine|Etoposide|Fluoxetine|Folic Acid|gamma-Aminobutyric Acid|Gentamicins|Griseofulvin|Ifosfamide|Kainic Acid|Ketamine|Ketoconazole|Lidocaine|Lithium|Lithium Chloride|Magnesium|Methotrexate|Methylmercury Compounds|Muscimol|Naloxone|Norepinephrine|Penicillamine|Pentylenetetrazole|Phenobarbital|Phentolamine|Pilocarpine|Plant Extracts|Strychnine|Thiobarbituric Acid Reactive Substances|Topiramate|trimethyltin chloride|Valproic Acid",0,
lipid catabolic process,GO:0016042,"Epilepsy, Absence",MESH:D004832,11,"Cilastatin, Imipenem Drug Combination|Diazepam|Doxorubicin|Heparin|Lithium Carbonate|Naloxone|Pentylenetetrazole|Phenobarbital|Pilocarpine|Progesterone|Valproic Acid",0,
lipid catabolic process,GO:0016042,"Epilepsy, Complex Partial",MESH:D017029,5,Diazepam|Methotrexate|Phenobarbital|Topiramate|Valproic Acid,0,
lipid catabolic process,GO:0016042,"Epilepsy, Generalized",MESH:D004829,5,Diazepam|Naloxone|Phenobarbital|Prednisolone|Valproic Acid,0,
lipid catabolic process,GO:0016042,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
lipid catabolic process,GO:0016042,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
lipid catabolic process,GO:0016042,"Epilepsy, Rolandic",MESH:D019305,2,Topiramate|Valproic Acid,0,
lipid catabolic process,GO:0016042,"Epilepsy, Temporal Lobe",MESH:D004833,10,Capsaicin|Kainic Acid|Lithium|Lithium Chloride|Methotrexate|Phenobarbital|Pilocarpine|Plant Extracts|Topiramate|Valproic Acid,0,
lipid catabolic process,GO:0016042,"Epilepsy, Tonic-Clonic",MESH:D004830,40,"Acetaminophen|Adenosine|Aluminum|Aminophylline|Busulfan|Caffeine|Chlormethiazole|Chloroquine|Cilastatin, Imipenem Drug Combination|Cimetidine|Ciprofloxacin|Clonidine|Cocaine|Deferoxamine|Diazepam|Diclofenac|Dizocilpine Maleate|Ephedrine|Epinephrine|Ethanol|Heparin|Hexachlorocyclohexane|Lidocaine|Lithium|Lithium Carbonate|Lithium Chloride|Methamphetamine|Methotrexate|Naloxone|Pentylenetetrazole|Phenobarbital|Phenoxybenzamine|Pilocarpine|Plant Extracts|pralidoxime|Procaine|Theophylline|Topiramate|Valproic Acid|Venlafaxine Hydrochloride",0,
lipid catabolic process,GO:0016042,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
lipid droplet formation,GO:0140042,Epilepsy,MESH:D004827,9,Ciprofloxacin|Cisplatin|Dexamethasone|Erythromycin|Folic Acid|Magnesium|Methotrexate|Methylmercury Compounds|Valproic Acid,0,
lipid droplet formation,GO:0140042,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Valproic Acid,0,
lipid droplet formation,GO:0140042,"Epilepsy, Complex Partial",MESH:D017029,2,Methotrexate|Valproic Acid,0,
lipid droplet formation,GO:0140042,"Epilepsy, Generalized",MESH:D004829,2,Prednisolone|Valproic Acid,0,
lipid droplet formation,GO:0140042,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
lipid droplet formation,GO:0140042,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
lipid droplet formation,GO:0140042,"Epilepsy, Temporal Lobe",MESH:D004833,3,Methotrexate|Tacrolimus|Valproic Acid,0,
lipid droplet formation,GO:0140042,"Epilepsy, Tonic-Clonic",MESH:D004830,9,Caffeine|Chloroquine|Ciprofloxacin|Deferoxamine|Erythromycin|Ethanol|Methotrexate|Tacrolimus|Valproic Acid,0,
lipid droplet formation,GO:0140042,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
lipid droplet organization,GO:0034389,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
lipid homeostasis,GO:0055088,Epilepsy,MESH:D004827,2,Fluoxetine|Plant Extracts,3,CERT1|DDX3X|TSC1
lipid homeostasis,GO:0055088,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
lipid homeostasis,GO:0055088,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Plant Extracts,0,
lipid import into cell,GO:0140354,Epilepsy,MESH:D004827,1,Dexamethasone,0,
lipid localization,GO:0010876,Epilepsy,MESH:D004827,2,Folic Acid|Lithium Chloride,0,
lipid localization,GO:0010876,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium Chloride,0,
lipid localization,GO:0010876,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Lithium Chloride,0,
lipid metabolic process,GO:0006629,Amish Infantile Epilepsy Syndrome,MESH:C563799,0,,1,ST3GAL5
lipid metabolic process,GO:0006629,Epilepsy,MESH:D004827,9,Anticonvulsants|Azathioprine|Dexamethasone|Dronabinol|Fluoxetine|Folic Acid|Ketoconazole|Methotrexate|Valproic Acid,1,GPX1
lipid metabolic process,GO:0006629,"Epilepsy, Absence",MESH:D004832,2,Anticonvulsants|Valproic Acid,0,
lipid metabolic process,GO:0006629,"Epilepsy, Complex Partial",MESH:D017029,3,Anticonvulsants|Methotrexate|Valproic Acid,0,
lipid metabolic process,GO:0006629,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
lipid metabolic process,GO:0006629,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
lipid metabolic process,GO:0006629,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
lipid metabolic process,GO:0006629,"Epilepsy, Temporal Lobe",MESH:D004833,2,Methotrexate|Valproic Acid,1,TRPV1
lipid metabolic process,GO:0006629,"Epilepsy, Tonic-Clonic",MESH:D004830,8,Acetaminophen|Anticonvulsants|Chlorpromazine|Dinoprost|Ethanol|Methotrexate|Prednisone|Valproic Acid,0,
lipid metabolic process,GO:0006629,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
lipid metabolic process,GO:0006629,SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY,OMIM:159950,0,,1,ASAH1
lipid modification,GO:0030258,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,NES
lipid oxidation,GO:0034440,Epilepsy,MESH:D004827,26,"Amitriptyline|Calcium|Carbamazepine|Cilastatin, Imipenem Drug Combination|Ciprofloxacin|Cisplatin|Dexamethasone|Fluoxetine|Folic Acid|Gentamicins|Haloperidol|Imipramine|Kainic Acid|Ketamine|Methotrexate|Methylmercury Compounds|nimesulide|phosphinothricin|Plant Extracts|Pregabalin|Sevoflurane|Thalidomide|Thiobarbituric Acid Reactive Substances|Valproic Acid|Vitamin B 12|Vitamin U",0,
lipid oxidation,GO:0034440,"Epilepsy, Absence",MESH:D004832,6,"Carbamazepine|Cilastatin, Imipenem Drug Combination|Doxorubicin|Haloperidol|Lithium Carbonate|Valproic Acid",0,
lipid oxidation,GO:0034440,"Epilepsy, Complex Partial",MESH:D017029,3,Carbamazepine|Methotrexate|Valproic Acid,0,
lipid oxidation,GO:0034440,"Epilepsy, Generalized",MESH:D004829,4,Carbamazepine|Prednisolone|Pregabalin|Valproic Acid,0,
lipid oxidation,GO:0034440,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
lipid oxidation,GO:0034440,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
lipid oxidation,GO:0034440,"Epilepsy, Rolandic",MESH:D019305,2,Carbamazepine|Valproic Acid,0,
lipid oxidation,GO:0034440,"Epilepsy, Temporal Lobe",MESH:D004833,6,Carbamazepine|Clioquinol|Kainic Acid|Methotrexate|Plant Extracts|Valproic Acid,0,
lipid oxidation,GO:0034440,"Epilepsy, Tonic-Clonic",MESH:D004830,27,"Acetaminophen|Aluminum Hydroxide|Amitriptyline|Buspirone|Caffeine|Carbamazepine|Chlormethiazole|Chloroquine|Cilastatin, Imipenem Drug Combination|Ciprofloxacin|Deferoxamine|Diclofenac|Dizocilpine Maleate|Ethanol|Haloperidol|Imipramine|Lithium Carbonate|Mechlorethamine|Methamphetamine|Methotrexate|Methylprednisolone|Paroxetine|Plant Extracts|Sodium Chloride|Theophylline|Valproic Acid|Vincristine",0,
lipid oxidation,GO:0034440,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
lipid storage,GO:0019915,Epilepsy,MESH:D004827,4,Dexamethasone|Lithium Chloride|Methylmercury Compounds|Plant Extracts,0,
lipid storage,GO:0019915,"Epilepsy, Temporal Lobe",MESH:D004833,2,Lithium Chloride|Plant Extracts,0,
lipid storage,GO:0019915,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Lithium Chloride|Plant Extracts,0,
lipid transport,GO:0006869,Epilepsy,MESH:D004827,0,,2,CERT1|VDAC1
lipopolysaccharide-mediated signaling pathway,GO:0031663,Epilepsy,MESH:D004827,0,,1,AKT1
lipopolysaccharide metabolic process,GO:0008653,Epilepsy,MESH:D004827,1,Dronabinol,0,
lipopolysaccharide metabolic process,GO:0008653,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
lipopolysaccharide transport,GO:0015920,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
lipoprotein biosynthetic process,GO:0042158,Epilepsy,MESH:D004827,1,Cimetidine,0,
lipoprotein biosynthetic process,GO:0042158,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Cimetidine,0,
lipoxygenase pathway,GO:0019372,Epilepsy,MESH:D004827,0,,1,GPX1
liver development,GO:0001889,Epilepsy,MESH:D004827,1,Carbamazepine,0,
liver development,GO:0001889,"Epilepsy, Absence",MESH:D004832,1,Carbamazepine,0,
liver development,GO:0001889,"Epilepsy, Complex Partial",MESH:D017029,1,Carbamazepine,0,
liver development,GO:0001889,"Epilepsy, Generalized",MESH:D004829,1,Carbamazepine,0,
liver development,GO:0001889,"Epilepsy, Rolandic",MESH:D019305,1,Carbamazepine,0,
liver development,GO:0001889,"Epilepsy, Temporal Lobe",MESH:D004833,1,Carbamazepine,1,CNR1
liver development,GO:0001889,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Carbamazepine|Prednisone,0,
liver regeneration,GO:0097421,Epilepsy,MESH:D004827,1,Adenosine,2,SLCO1A5|TGFB1
liver regeneration,GO:0097421,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Acetaminophen|Adenosine,0,
localization of cell,GO:0051674,Epilepsy,MESH:D004827,0,,1,ANKRD11
locomotion,GO:0040011,Epilepsy,MESH:D004827,5,Amitriptyline|Amphetamine|Dronabinol|Haloperidol|Methylmercury Compounds,3,CHD2|GRIN2A|UBE3A
locomotion,GO:0040011,"Epilepsy, Absence",MESH:D004832,2,Doxorubicin|Haloperidol,0,
locomotion,GO:0040011,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
locomotion,GO:0040011,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
locomotion,GO:0040011,"Epilepsy, Temporal Lobe",MESH:D004833,1,Clioquinol,0,
locomotion,GO:0040011,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Amitriptyline|Ethanol|Haloperidol,0,
locomotion,GO:0040011,"Epilepsy, X-Linked, with Variable Learning Disabilities and Behavior Disorders",MESH:C564505,0,,1,SYN1
locomotion,GO:0040011,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",MESH:C565809,0,,1,SCN1B
locomotion involved in locomotory behavior,GO:0031987,Epilepsy,MESH:D004827,23,Amphetamine|Bicuculline|Carbachol|Cisplatin|Clozapine|Dexamethasone|Dextroamphetamine|Diazepam|Dronabinol|Fluoxetine|Gabapentin|Haloperidol|Ketamine|Lithium|Lithium Chloride|Methimazole|Methylmercury Compounds|Morphine|Penicillamine|Pentylenetetrazole|Plant Extracts|Sevoflurane|Valproic Acid,0,
locomotion involved in locomotory behavior,GO:0031987,"Epilepsy, Absence",MESH:D004832,4,Diazepam|Haloperidol|Pentylenetetrazole|Valproic Acid,0,
locomotion involved in locomotory behavior,GO:0031987,"Epilepsy, Complex Partial",MESH:D017029,4,Clozapine|Diazepam|Gabapentin|Valproic Acid,0,
locomotion involved in locomotory behavior,GO:0031987,"Epilepsy, Generalized",MESH:D004829,3,Clozapine|Diazepam|Valproic Acid,0,
locomotion involved in locomotory behavior,GO:0031987,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
locomotion involved in locomotory behavior,GO:0031987,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
locomotion involved in locomotory behavior,GO:0031987,"Epilepsy, Temporal Lobe",MESH:D004833,5,Lithium|Lithium Chloride|Plant Extracts|Tacrolimus|Valproic Acid,0,
locomotion involved in locomotory behavior,GO:0031987,"Epilepsy, Tonic-Clonic",MESH:D004830,21,Acetaminophen|Caffeine|Chloroquine|Clozapine|Cocaine|Diazepam|Dizocilpine Maleate|Ethanol|Gabapentin|Haloperidol|Hexachlorocyclohexane|Lithium|Lithium Chloride|Methamphetamine|Methylphenidate|Morphine|Pentylenetetrazole|Plant Extracts|Tacrolimus|Valproic Acid|Venlafaxine Hydrochloride,0,
locomotion involved in locomotory behavior,GO:0031987,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
locomotor rhythm,GO:0045475,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
locomotor rhythm,GO:0045475,Epilepsy,MESH:D004827,0,,1,CNTNAP2
locomotor rhythm,GO:0045475,Generalized Epilepsy and Paroxysmal Dyskinesia,MESH:C563719,0,,1,KCNMA1
locomotory behavior,GO:0007626,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
locomotory behavior,GO:0007626,Epilepsy,MESH:D004827,9,"Diazepam|Dronabinol|Estrogens|Haloperidol|Midazolam|N-Methyl-3,4-methylenedioxyamphetamine|Pentylenetetrazole|Picrotoxin|Valproic Acid",10,CNTNAP2|GNAO1|GRIN2A|GRM1|MECP2|NPY2R|OPRM1|SCN8A|SLC1A1|SNAP25
locomotory behavior,GO:0007626,"Epilepsy, Absence",MESH:D004832,5,Diazepam|Haloperidol|Pentylenetetrazole|Picrotoxin|Valproic Acid,0,
locomotory behavior,GO:0007626,"Epilepsy, Complex Partial",MESH:D017029,2,Diazepam|Valproic Acid,0,
locomotory behavior,GO:0007626,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
locomotory behavior,GO:0007626,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
locomotory behavior,GO:0007626,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
locomotory behavior,GO:0007626,"Epilepsy, Frontal Lobe",MESH:D017034,0,,2,CHRNA4|CHRNB2
locomotory behavior,GO:0007626,"Epilepsy, Generalized",MESH:D004829,3,Diazepam|Prednisolone|Valproic Acid,0,
locomotory behavior,GO:0007626,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
locomotory behavior,GO:0007626,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
locomotory behavior,GO:0007626,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
locomotory behavior,GO:0007626,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,1,GRIN2A
locomotory behavior,GO:0007626,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,4,GRM1|GRM5|NPY2R|SLC1A1
locomotory behavior,GO:0007626,"Epilepsy, Tonic-Clonic",MESH:D004830,11,Cocaine|Diazepam|Ethanol|Haloperidol|Methamphetamine|Methylphenidate|Midazolam|Pentylenetetrazole|Picrotoxin|tetramethylenedisulfotetramine|Valproic Acid,0,
locomotory behavior,GO:0007626,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
locomotory exploration behavior,GO:0035641,Epilepsy,MESH:D004827,6,"Dronabinol|Folic Acid|Kainic Acid|Ketamine|N-Methyl-3,4-methylenedioxyamphetamine|Topiramate",2,SLC4A10|UBE3A
locomotory exploration behavior,GO:0035641,"Epilepsy, Complex Partial",MESH:D017029,1,Topiramate,0,
locomotory exploration behavior,GO:0035641,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,SLC4A10
locomotory exploration behavior,GO:0035641,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
locomotory exploration behavior,GO:0035641,"Epilepsy, Rolandic",MESH:D019305,1,Topiramate,0,
locomotory exploration behavior,GO:0035641,"Epilepsy, Temporal Lobe",MESH:D004833,2,Kainic Acid|Topiramate,0,
locomotory exploration behavior,GO:0035641,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Topiramate,0,
long-chain fatty acid biosynthetic process,GO:0042759,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,CYP2D6
long-term memory,GO:0007616,Epilepsy,MESH:D004827,3,"Dronabinol|Methotrexate|N-Methyl-3,4-methylenedioxyamphetamine",4,GRIN2B|MECP2|SNAP25|UBE3A
long-term memory,GO:0007616,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
long-term memory,GO:0007616,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
long-term memory,GO:0007616,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
long-term memory,GO:0007616,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
long-term memory,GO:0007616,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Ethanol|Methamphetamine|Methotrexate,0,
long-term memory,GO:0007616,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
long-term synaptic depression,GO:0060292,Epilepsy,MESH:D004827,2,Amphetamine|Dronabinol,1,STXBP1
long-term synaptic depression,GO:0060292,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,GRM2
long-term synaptic potentiation,GO:0060291,Epilepsy,MESH:D004827,2,Amphetamine|Sevoflurane,6,GFAP|GRIN2A|GRIN2B|MECP2|SLC1A1|SNAP25
long-term synaptic potentiation,GO:0060291,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
long-term synaptic potentiation,GO:0060291,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
long-term synaptic potentiation,GO:0060291,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
long-term synaptic potentiation,GO:0060291,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
long-term synaptic potentiation,GO:0060291,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLC1A1
long-term synaptic potentiation,GO:0060291,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Aluminum|Ethanol,0,
low-density lipoprotein particle clearance,GO:0034383,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
L-phenylalanine metabolic process,GO:0006558,Epilepsy,MESH:D004827,1,Cisplatin,0,
L-pipecolic acid biosynthetic process,GO:0062034,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
L-proline betaine biosynthetic process,GO:0019503,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
L-serine biosynthetic process,GO:0006564,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
lung alveolus development,GO:0048286,Epilepsy,MESH:D004827,0,,2,MECP2|TGFB1
lung alveolus development,GO:0048286,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|VEGFA
lung development,GO:0030324,Epilepsy,MESH:D004827,1,Dexamethasone,1,TGFB1
lung development,GO:0030324,"Epilepsy, Idiopathic Generalized",MESH:C562694,0,,1,CLCN2
lung development,GO:0030324,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|VEGFA
lung development,GO:0030324,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
lung development,GO:0030324,SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY,OMIM:159950,0,,1,ASAH1
lung goblet cell differentiation,GO:0060480,Epilepsy,MESH:D004827,1,Dexamethasone,0,
lung vasculature development,GO:0060426,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
lymphangiogenesis,GO:0001946,Epilepsy,MESH:D004827,1,Cisplatin,0,
lymphangiogenesis,GO:0001946,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
lymphatic endothelial cell migration,GO:1904977,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
lymph gland development,GO:0048542,Epilepsy,MESH:D004827,0,,1,TSC1
lymph node development,GO:0048535,Epilepsy,MESH:D004827,0,,1,TGFB1
lymphocyte activation,GO:0046649,Epilepsy,MESH:D004827,5,Epinephrine|Ketoconazole|Norepinephrine|Phenobarbital|Thalidomide,0,
lymphocyte activation,GO:0046649,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
lymphocyte activation,GO:0046649,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
lymphocyte activation,GO:0046649,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
lymphocyte activation,GO:0046649,"Epilepsy, Temporal Lobe",MESH:D004833,2,Phenobarbital|Tacrolimus,0,
lymphocyte activation,GO:0046649,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Epinephrine|Phenobarbital|Tacrolimus|Theophylline,0,
lymphocyte apoptotic process,GO:0070227,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
lymphocyte homeostasis,GO:0002260,Epilepsy,MESH:D004827,2,Clozapine|Plant Extracts,0,
lymphocyte homeostasis,GO:0002260,"Epilepsy, Absence",MESH:D004832,1,Lithium Carbonate,0,
lymphocyte homeostasis,GO:0002260,"Epilepsy, Complex Partial",MESH:D017029,1,Clozapine,0,
lymphocyte homeostasis,GO:0002260,"Epilepsy, Generalized",MESH:D004829,1,Clozapine,0,
lymphocyte homeostasis,GO:0002260,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
lymphocyte homeostasis,GO:0002260,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
lymphocyte homeostasis,GO:0002260,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Clozapine|Ethanol|Lithium Carbonate|Plant Extracts,0,
lymphocyte mediated immunity,GO:0002449,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
lymphocyte mediated immunity,GO:0002449,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Hexachlorocyclohexane,0,
lymphocyte migration,GO:0072676,Epilepsy,MESH:D004827,2,Cisplatin|Dexamethasone,0,
lymphocyte proliferation,GO:0046651,Epilepsy,MESH:D004827,1,Dexamethasone,1,PURA
lymphoid progenitor cell differentiation,GO:0002320,Epilepsy,MESH:D004827,1,Cytarabine,0,
lymph vessel development,GO:0001945,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
lymph vessel morphogenesis,GO:0036303,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
lysine biosynthetic process,GO:0009085,Epilepsy,MESH:D004827,1,Phenobarbital,0,
lysine biosynthetic process,GO:0009085,"Epilepsy, Absence",MESH:D004832,1,Phenobarbital,0,
lysine biosynthetic process,GO:0009085,"Epilepsy, Complex Partial",MESH:D017029,1,Phenobarbital,0,
lysine biosynthetic process,GO:0009085,"Epilepsy, Generalized",MESH:D004829,1,Phenobarbital,0,
lysine biosynthetic process,GO:0009085,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
lysine biosynthetic process,GO:0009085,"Epilepsy, Temporal Lobe",MESH:D004833,1,Phenobarbital,0,
lysine biosynthetic process,GO:0009085,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Phenobarbital,0,
lysosomal lumen acidification,GO:0007042,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
lysosomal lumen acidification,GO:0007042,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Chloroquine|Methamphetamine,0,
lysosomal lumen acidification,GO:0007042,"Mental Retardation, X-Linked, with Epilepsy",MESH:C564516,0,,1,ATP6AP2
lysosomal lumen pH elevation,GO:0035752,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
lysosomal membrane organization,GO:0097212,Epilepsy,MESH:D004827,1,Methylmercury Compounds,0,
lysosomal membrane organization,GO:0097212,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
lysosomal membrane organization,GO:0097212,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
lysosomal protein catabolic process,GO:1905146,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
lysosomal transport,GO:0007041,Epilepsy,MESH:D004827,1,Ketamine,0,
lysosomal transport,GO:0007041,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
lysosomal transport,GO:0007041,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
lysosome organization,GO:0007040,Epilepsy,MESH:D004827,3,Ciprofloxacin|Dexamethasone|Plant Extracts,0,
lysosome organization,GO:0007040,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
lysosome organization,GO:0007040,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
lysosome organization,GO:0007040,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Chloroquine|Ciprofloxacin|Methamphetamine|Plant Extracts,0,
macrophage activation,GO:0042116,Epilepsy,MESH:D004827,7,Dexamethasone|Epinephrine|Lidocaine|Morphine|Naloxone|nimesulide|Valproic Acid,0,
macrophage activation,GO:0042116,"Epilepsy, Absence",MESH:D004832,2,Naloxone|Valproic Acid,0,
macrophage activation,GO:0042116,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
macrophage activation,GO:0042116,"Epilepsy, Generalized",MESH:D004829,2,Naloxone|Valproic Acid,0,
macrophage activation,GO:0042116,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
macrophage activation,GO:0042116,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
macrophage activation,GO:0042116,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
macrophage activation,GO:0042116,"Epilepsy, Tonic-Clonic",MESH:D004830,9,Cocaine|Epinephrine|Lidocaine|Mechlorethamine|Morphine|Naloxone|Procaine|Tetracaine|Valproic Acid,0,
macrophage activation,GO:0042116,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
macrophage activation involved in immune response,GO:0002281,Epilepsy,MESH:D004827,1,"Cilastatin, Imipenem Drug Combination",0,
macrophage activation involved in immune response,GO:0002281,"Epilepsy, Absence",MESH:D004832,2,"Cilastatin, Imipenem Drug Combination|Doxorubicin",0,
macrophage activation involved in immune response,GO:0002281,"Epilepsy, Tonic-Clonic",MESH:D004830,2,"Cilastatin, Imipenem Drug Combination|Mechlorethamine",0,
macrophage chemotaxis,GO:0048246,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
macrophage chemotaxis,GO:0048246,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Mechlorethamine,0,
macrophage colony-stimulating factor signaling pathway,GO:0038145,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,KDR|TEK
macrophage cytokine production,GO:0010934,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
macrophage derived foam cell differentiation,GO:0010742,Epilepsy,MESH:D004827,0,,1,TGFB1
macrophage differentiation,GO:0030225,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
macrophage homeostasis,GO:0061519,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Mechlorethamine,0,
macrophage migration,GO:1905517,Epilepsy,MESH:D004827,4,Ampicillin|Cisplatin|Dexamethasone|Methotrexate,0,
macrophage migration,GO:1905517,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
macrophage migration,GO:1905517,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
macrophage migration,GO:1905517,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Acetaminophen|Hexachlorocyclohexane|Methotrexate|Metronidazole,0,
macrophage proliferation,GO:0061517,Epilepsy,MESH:D004827,1,Dexamethasone,0,
magnesium ion homeostasis,GO:0010960,Epilepsy,MESH:D004827,1,Magnesium,0,
maintenance of blood-brain barrier,GO:0035633,Epilepsy,MESH:D004827,0,,2,SLC12A2|SLC1A1
maintenance of blood-brain barrier,GO:0035633,"Epilepsy, Temporal Lobe",MESH:D004833,0,,3,BDKRB2|SLC12A2|SLC1A1
maintenance of blood-brain barrier,GO:0035633,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Ethanol|Methamphetamine,0,
maintenance of cell number,GO:0098727,Epilepsy,MESH:D004827,1,Plant Extracts,0,
maintenance of cell number,GO:0098727,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
maintenance of cell number,GO:0098727,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
maintenance of gastrointestinal epithelium,GO:0030277,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Diclofenac,0,
maintenance of postsynaptic density structure,GO:0099562,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
maintenance of postsynaptic specialization structure,GO:0098880,Epilepsy,MESH:D004827,0,,1,SYNGAP1
maintenance of protein location in mitochondrion,GO:0072656,Epilepsy,MESH:D004827,1,nimesulide,1,AKT1
maintenance of protein location in nucleus,GO:0051457,Epilepsy,MESH:D004827,0,,1,HNRNPU
maintenance of protein location in nucleus,GO:0051457,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
maintenance of protein location in plasma membrane,GO:0072660,Epilepsy,MESH:D004827,1,Propofol,0,
maintenance of protein location in plasma membrane,GO:0072660,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
maintenance of protein location in plasma membrane,GO:0072660,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Etomidate|Propofol,0,
maintenance of synapse structure,GO:0099558,Cortical Dysplasia-Focal Epilepsy Syndrome,MESH:C567657,0,,1,CNTNAP2
maintenance of synapse structure,GO:0099558,Epilepsy,MESH:D004827,0,,1,CNTNAP2
malate-aspartate shuttle,GO:0043490,Epilepsy,MESH:D004827,0,,1,SLC1A3
malate metabolic process,GO:0006108,Epilepsy,MESH:D004827,2,"malic acid|N-Methyl-3,4-methylenedioxyamphetamine",0,
malate metabolic process,GO:0006108,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
male germ-line stem cell population maintenance,GO:0036098,Epilepsy,MESH:D004827,1,Busulfan,0,
male germ-line stem cell population maintenance,GO:0036098,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Busulfan,0,
male gonad development,GO:0008584,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
male gonad development,GO:0008584,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Clomiphene,0,
male mating behavior,GO:0060179,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,OXT
male meiosis chromosome separation,GO:0051308,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
mammalian oogenesis stage,GO:0022605,Epilepsy,MESH:D004827,0,,1,AKT1
mammary duct terminal end bud growth,GO:0060763,Epilepsy,MESH:D004827,0,,1,SLC12A2
mammary duct terminal end bud growth,GO:0060763,"Epilepsy, Temporal Lobe",MESH:D004833,0,,2,SLC12A2|SLIT2
mammary gland alveolus development,GO:0060749,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
mammary gland branching involved in pregnancy,GO:0060745,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VDR
mammary gland branching involved in thelarche,GO:0060744,Epilepsy,MESH:D004827,0,,1,TGFB1
mammary gland development,GO:0030879,Epilepsy,MESH:D004827,0,,1,TGFB1
mammary gland duct morphogenesis,GO:0060603,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
mammary gland epithelial cell differentiation,GO:0060644,Epilepsy,MESH:D004827,1,Dexamethasone,1,AKT1
mammary gland epithelial cell differentiation,GO:0060644,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,FGF2
manganese ion homeostasis,GO:0055071,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
manganese ion transmembrane transport,GO:0071421,Epilepsy,MESH:D004827,1,Imipramine,0,
manganese ion transmembrane transport,GO:0071421,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Imipramine|Sodium Chloride,0,
mannosylation,GO:0097502,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Disulfiram,0,
MAPK cascade,GO:0000165,Epilepsy,MESH:D004827,10,Calcium|Cisplatin|Dexamethasone|Lidocaine|Morphine|Norepinephrine|Pentobarbital|Plant Extracts|Propofol|Sevoflurane,1,MEF2C
MAPK cascade,GO:0000165,"Epilepsy, Absence",MESH:D004832,1,Riluzole,0,
MAPK cascade,GO:0000165,"Epilepsy, Generalized",MESH:D004829,1,Propofol,0,
MAPK cascade,GO:0000165,"Epilepsy, Temporal Lobe",MESH:D004833,3,Medroxyprogesterone Acetate|Plant Extracts|Tacrolimus,1,P2RX7
MAPK cascade,GO:0000165,"Epilepsy, Tonic-Clonic",MESH:D004830,8,Cocaine|Lidocaine|Morphine|Paroxetine|Plant Extracts|Propofol|Tacrolimus|Tetracaine,0,
mast cell degranulation,GO:0043303,"Epilepsy, Temporal Lobe",MESH:D004833,1,Capsaicin,0,
mast cell degranulation,GO:0043303,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Chlorpromazine|Dizocilpine Maleate,0,
mast cell migration,GO:0097531,Epilepsy,MESH:D004827,1,Cisplatin,0,
mast cell migration,GO:0097531,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Aluminum Hydroxide,0,
mastication,GO:0071626,Epilepsy,MESH:D004827,3,Ketamine|Lithium Chloride|Pilocarpine,0,
mastication,GO:0071626,"Epilepsy, Absence",MESH:D004832,1,Pilocarpine,0,
mastication,GO:0071626,"Epilepsy, Temporal Lobe",MESH:D004833,2,Lithium Chloride|Pilocarpine,0,
mastication,GO:0071626,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Lithium Chloride|Pilocarpine,0,
maternal aggressive behavior,GO:0002125,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,1,OXT
maternal behavior,GO:0042711,Epilepsy,MESH:D004827,0,,1,HCN1
maternal behavior,GO:0042711,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,1,OXT
maternal placenta development,GO:0001893,Epilepsy,MESH:D004827,1,Valproic Acid,1,AKT1
maternal placenta development,GO:0001893,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
maternal placenta development,GO:0001893,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
maternal placenta development,GO:0001893,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
maternal placenta development,GO:0001893,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
maternal placenta development,GO:0001893,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
maternal placenta development,GO:0001893,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
maternal placenta development,GO:0001893,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
maternal placenta development,GO:0001893,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
maternal process involved in female pregnancy,GO:0060135,Epilepsy,MESH:D004827,1,Valproic Acid,0,
maternal process involved in female pregnancy,GO:0060135,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
maternal process involved in female pregnancy,GO:0060135,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
maternal process involved in female pregnancy,GO:0060135,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
maternal process involved in female pregnancy,GO:0060135,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
maternal process involved in female pregnancy,GO:0060135,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
maternal process involved in female pregnancy,GO:0060135,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,1,CNR1
maternal process involved in female pregnancy,GO:0060135,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Valproic Acid,0,
maternal process involved in female pregnancy,GO:0060135,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
mating behavior,GO:0007617,Epilepsy,MESH:D004827,1,Morphine,0,
mating behavior,GO:0007617,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Morphine,0,
mature conventional dendritic cell differentiation,GO:0097029,Epilepsy,MESH:D004827,1,Plant Extracts,0,
mature conventional dendritic cell differentiation,GO:0097029,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
mature conventional dendritic cell differentiation,GO:0097029,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Plant Extracts,0,
mechanoreceptor differentiation,GO:0042490,Epilepsy,MESH:D004827,0,,1,BDNF
mechanoreceptor differentiation,GO:0042490,"Epilepsy, Tonic-Clonic",MESH:D004830,0,,2,BDNF|NTF3
mechanosensory behavior,GO:0007638,Epilepsy,MESH:D004827,3,Cisplatin|Gabapentin|Pilocarpine,0,
mechanosensory behavior,GO:0007638,"Epilepsy, Absence",MESH:D004832,1,Pilocarpine,0,
mechanosensory behavior,GO:0007638,"Epilepsy, Complex Partial",MESH:D017029,1,Gabapentin,0,
mechanosensory behavior,GO:0007638,"Epilepsy, Temporal Lobe",MESH:D004833,1,Pilocarpine,0,
mechanosensory behavior,GO:0007638,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Gabapentin|Pilocarpine,0,
medium-term memory,GO:0072375,Epilepsy,MESH:D004827,0,,1,FOS
megakaryocyte development,GO:0035855,Epilepsy,MESH:D004827,0,,1,FLNA
meiosis I/meiosis II transition,GO:1990946,Epilepsy,MESH:D004827,1,Dronabinol,0,
meiotic cell cycle,GO:0051321,Epilepsy,MESH:D004827,0,,1,SMC1A
meiotic cell cycle process involved in oocyte maturation,GO:1903537,Epilepsy,MESH:D004827,1,Dronabinol,0,
meiotic metaphase II,GO:0007137,Epilepsy,MESH:D004827,1,Dronabinol,0,
meiotic metaphase II,GO:0007137,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
meiotic spindle assembly checkpoint signaling,GO:0033316,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
melanin biosynthetic process,GO:0042438,Epilepsy,MESH:D004827,1,Plant Extracts,0,
melanin biosynthetic process,GO:0042438,"Epilepsy, Temporal Lobe",MESH:D004833,1,Plant Extracts,0,
melanin biosynthetic process,GO:0042438,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Plant Extracts|Theophylline,0,
melanocyte differentiation,GO:0030318,Epilepsy,MESH:D004827,0,,1,MEF2C
melatonin biosynthetic process,GO:0030187,Epilepsy,MESH:D004827,1,Norepinephrine,0,
membrane depolarization,GO:0051899,Epilepsy,MESH:D004827,8,4-Aminopyridine|Calcium|Cisplatin|Diazepam|Flumazenil|gamma-Aminobutyric Acid|Lithium Chloride|Morphine,2,GRM1|P2RX4
membrane depolarization,GO:0051899,"Epilepsy, Absence",MESH:D004832,1,Diazepam,1,CACNA1A
membrane depolarization,GO:0051899,"Epilepsy, Complex Partial",MESH:D017029,1,Diazepam,0,
membrane depolarization,GO:0051899,"Epilepsy, Frontal Lobe",MESH:D017034,0,,2,CHRNA4|CHRNB2
membrane depolarization,GO:0051899,"Epilepsy, Generalized",MESH:D004829,1,Diazepam,0,
membrane depolarization,GO:0051899,"Epilepsy, Nocturnal Frontal Lobe, Type 1",MESH:C563930,0,,1,CHRNA4
membrane depolarization,GO:0051899,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
membrane depolarization,GO:0051899,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium Chloride,3,GRM1|P2RX4|P2RX7
membrane depolarization,GO:0051899,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Diazepam|Diclofenac|Lithium Chloride|Morphine,0,
membrane depolarization,GO:0051899,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",MESH:C565809,0,,1,SCN1B
membrane depolarization during action potential,GO:0086010,Epilepsy,MESH:D004827,0,,3,SCN1A|SCN2A|SCN8A
membrane depolarization during action potential,GO:0086010,"Epilepsy, Absence",MESH:D004832,0,,1,CACNA1H
membrane depolarization during action potential,GO:0086010,"Epilepsy, Benign Neonatal, 3",MESH:C564274,0,,1,SCN2A
membrane depolarization during action potential,GO:0086010,"Epilepsy, Complex Partial",MESH:D017029,0,,1,SCN3A
membrane depolarization during action potential,GO:0086010,"Epilepsy, Generalized",MESH:D004829,0,,1,SCN1A
membrane depolarization during action potential,GO:0086010,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",MESH:C565809,0,,1,SCN1B
membrane depolarization during action potential,GO:0086010,"Generalized Epilepsy With Febrile Seizures Plus, Type 2",MESH:C565810,0,,1,SCN1A
membrane depolarization during cardiac muscle cell action potential,GO:0086012,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",MESH:C565809,0,,1,SCN1B
membrane depolarization during Purkinje myocyte cell action potential,GO:0086047,"Generalized Epilepsy With Febrile Seizures Plus, Type 1",MESH:C565809,0,,1,SCN1B
membrane fusion,GO:0061025,Epilepsy,MESH:D004827,0,,1,SNAP25
membrane hyperpolarization,GO:0060081,Epilepsy,MESH:D004827,5,Diazepam|Dronabinol|Flumazenil|gamma-Aminobutyric Acid|Ketoconazole,1,KCNQ2
membrane hyperpolarization,GO:0060081,"Epilepsy, Absence",MESH:D004832,1,Diazepam,0,
membrane hyperpolarization,GO:0060081,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
membrane hyperpolarization,GO:0060081,"Epilepsy, Complex Partial",MESH:D017029,1,Diazepam,0,
membrane hyperpolarization,GO:0060081,"Epilepsy, Generalized",MESH:D004829,1,Diazepam,0,
membrane hyperpolarization,GO:0060081,"EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS",OMIM:611726,0,,1,KCTD7
membrane hyperpolarization,GO:0060081,"Epilepsy, Temporal Lobe",MESH:D004833,1,Chlorides,0,
membrane hyperpolarization,GO:0060081,"Epilepsy, Tonic-Clonic",MESH:D004830,2,Diazepam|Quinine,0,
membrane lipid catabolic process,GO:0046466,Epilepsy,MESH:D004827,34,Amitriptyline|Atropine|Busulfan|Calcium|Cephalothin|Ciprofloxacin|Cisplatin|Cytarabine|Dexamethasone|Dextroamphetamine|Epinephrine|Fluoxetine|Gentamicins|Haloperidol|Kainic Acid|Ketamine|Ketoconazole|Lidocaine|Lithium|Lithium Chloride|Methylmercury Compounds|nimesulide|Penicillamine|Pentylenetetrazole|Phenobarbital|Pilocarpine|Plant Extracts|Propofol|Quetiapine Fumarate|Sevoflurane|Thalidomide|Thiobarbituric Acid Reactive Substances|Topiramate|Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,"Epilepsy, Absence",MESH:D004832,9,Doxorubicin|Haloperidol|Heparin|Lithium Carbonate|Pentylenetetrazole|Phenobarbital|Pilocarpine|Riluzole|Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,"Epilepsy, Complex Partial",MESH:D017029,3,Phenobarbital|Topiramate|Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,"Epilepsy, Generalized",MESH:D004829,3,Phenobarbital|Propofol|Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,"Epilepsy, Post-Traumatic",MESH:D004834,1,Kainic Acid,0,
membrane lipid catabolic process,GO:0046466,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,"Epilepsy, Rolandic",MESH:D019305,2,Topiramate|Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,"Epilepsy, Temporal Lobe",MESH:D004833,10,Capsaicin|Kainic Acid|Lithium|Lithium Chloride|Phenobarbital|Pilocarpine|Plant Extracts|Tacrolimus|Topiramate|Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,"Epilepsy, Tonic-Clonic",MESH:D004830,37,Acetaminophen|Acyclovir|Aluminum|Amitriptyline|Atropine|Busulfan|Carbenicillin|Chlorpromazine|Ciprofloxacin|Clomipramine|Cocaine|Deferoxamine|Diclofenac|Disulfiram|Dizocilpine Maleate|Epinephrine|Ethanol|Fentanyl|Haloperidol|Heparin|Hexachlorocyclohexane|Lidocaine|Lithium|Lithium Carbonate|Lithium Chloride|Methylprednisolone|Pentylenetetrazole|Phenobarbital|Pilocarpine|Plant Extracts|Propofol|Sodium Chloride|Tacrolimus|Theophylline|Thiopental|Topiramate|Valproic Acid,0,
membrane lipid catabolic process,GO:0046466,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
membrane organization,GO:0061024,Epilepsy,MESH:D004827,1,Methimazole,0,
membrane organization,GO:0061024,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
membrane organization,GO:0061024,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Chloroquine,0,
membrane protein ectodomain proteolysis,GO:0006509,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
membrane protein intracellular domain proteolysis,GO:0031293,Epilepsy,MESH:D004827,0,,1,TGFB1
membrane repolarization during ventricular cardiac muscle cell action potential,GO:0098915,Epilepsy,MESH:D004827,1,Fluvoxamine,0,
membrane tubulation,GO:0097749,Epilepsy,MESH:D004827,1,Folic Acid,0,
memory,GO:0007613,Epilepsy,MESH:D004827,15,Bicuculline|Cisplatin|Dexamethasone|Dronabinol|Folic Acid|Ketamine|Lithium|Lithium Chloride|Morphine|Muscimol|Pentylenetetrazole|Plant Extracts|Propofol|Sevoflurane|trimethyltin chloride,9,BDNF|GABRB3|GRIN2A|GRIN2B|KCNQ2|MECP2|SCN2A|SLC1A1|SLC6A1
memory,GO:0007613,"Epilepsy, Absence",MESH:D004832,1,Pentylenetetrazole,1,GABRB3
memory,GO:0007613,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
memory,GO:0007613,"Epilepsy, Benign Neonatal, 3",MESH:C564274,0,,1,SCN2A
memory,GO:0007613,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
memory,GO:0007613,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
memory,GO:0007613,"EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT",OMIM:245570,0,,1,GRIN2A
memory,GO:0007613,"Epilepsy, Frontal Lobe",MESH:D017034,0,,1,CHRNB2
memory,GO:0007613,"Epilepsy, Generalized",MESH:D004829,1,Propofol,1,CHRNA7
memory,GO:0007613,"Epilepsy, Nocturnal Frontal Lobe, Type 3",MESH:C565334,0,,1,CHRNB2
memory,GO:0007613,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
memory,GO:0007613,"Epilepsy, Rolandic",MESH:D019305,0,,1,GRIN2A
memory,GO:0007613,"Epilepsy, Temporal Lobe",MESH:D004833,3,Lithium|Lithium Chloride|Plant Extracts,2,CNR1|SLC1A1
memory,GO:0007613,"Epilepsy, Tonic-Clonic",MESH:D004830,10,Aluminum|Dizocilpine Maleate|Ethanol|Lithium|Lithium Chloride|Methamphetamine|Morphine|Pentylenetetrazole|Plant Extracts|Propofol,4,BDNF|NGF|NTF3|OXT
memory,GO:0007613,MYOCLONIC-ATONIC EPILEPSY,OMIM:616421,0,,1,SLC6A1
memory T cell differentiation,GO:0043379,Epilepsy,MESH:D004827,0,,1,TSC1
mercury ion transport,GO:0015694,Epilepsy,MESH:D004827,1,Methylmercury Compounds,0,
mesenchymal cell differentiation involved in kidney development,GO:0072161,Epilepsy,MESH:D004827,1,Lithium,0,
mesenchymal cell differentiation involved in kidney development,GO:0072161,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium,0,
mesenchymal cell differentiation involved in kidney development,GO:0072161,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Lithium,0,
mesenchymal cell proliferation,GO:0010463,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,KDR
mesenchyme development,GO:0060485,Prickle1-Related Progressive Myoclonic Epilepsy with Ataxia,MESH:C580388,0,,1,PRICKLE1
mesoderm development,GO:0007498,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,VEGFA
mesoderm formation,GO:0001707,Epilepsy,MESH:D004827,0,,1,TXNRD1
metabolic process,GO:0008152,Epilepsy,MESH:D004827,10,Adenosine|Calcium|Cisplatin|Epinephrine|gamma-Aminobutyric Acid|Gentamicins|Magnesium|Norepinephrine|Plant Extracts|Vigabatrin,0,
metabolic process,GO:0008152,"Epilepsy, Absence",MESH:D004832,4,4-Butyrolactone|Doxorubicin|Progesterone|Vigabatrin,0,
metabolic process,GO:0008152,"Epilepsy, Benign Neonatal",MESH:D020936,1,Vigabatrin,0,
metabolic process,GO:0008152,"Epilepsy, Complex Partial",MESH:D017029,1,Vigabatrin,0,
metabolic process,GO:0008152,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
metabolic process,GO:0008152,"Epilepsy, Temporal Lobe",MESH:D004833,3,Capsaicin|Plant Extracts|Vigabatrin,0,
metabolic process,GO:0008152,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Adenosine|Epinephrine|Plant Extracts,0,
metal ion homeostasis,GO:0055065,Epilepsy,MESH:D004827,2,Calcium|Lithium,0,
metal ion homeostasis,GO:0055065,"Epilepsy, Temporal Lobe",MESH:D004833,1,Lithium,0,
metal ion homeostasis,GO:0055065,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Lithium,0,
metal ion transport,GO:0030001,Epilepsy,MESH:D004827,1,Calcium,0,
metamorphosis,GO:0007552,Epilepsy,MESH:D004827,2,Epinephrine|Methimazole,0,
metamorphosis,GO:0007552,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Epinephrine,0,
metanephros development,GO:0001656,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,SLIT2
metaphase plate congression,GO:0051310,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Vincristine,0,
metestrus,GO:0060210,Epilepsy,MESH:D004827,1,daidzin,0,
methanol biosynthetic process,GO:0046169,Epilepsy,MESH:D004827,1,Methotrexate,0,
methanol biosynthetic process,GO:0046169,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
methanol biosynthetic process,GO:0046169,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
methanol biosynthetic process,GO:0046169,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
methionine metabolic process,GO:0006555,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,CNR1
methotrexate transport,GO:0051958,Epilepsy,MESH:D004827,2,Folic Acid|Methotrexate,0,
methotrexate transport,GO:0051958,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
methotrexate transport,GO:0051958,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
methotrexate transport,GO:0051958,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methotrexate,0,
methylation,GO:0032259,Epilepsy,MESH:D004827,2,Calcium|Folic Acid,0,
methylation,GO:0032259,"Epilepsy, Reflex",MESH:D020195,1,Polychlorinated Biphenyls,0,
methyl ethyl ketone metabolic process,GO:0018928,Epilepsy,MESH:D004827,1,"N-Methyl-3,4-methylenedioxyamphetamine",0,
microglial cell activation,GO:0001774,Epilepsy,MESH:D004827,9,"Cisplatin|Diazepam|Dronabinol|Ketamine|Lithium Chloride|Morphine|N-Methyl-3,4-methylenedioxyamphetamine|Pilocarpine|Sevoflurane",0,
microglial cell activation,GO:0001774,"Epilepsy, Absence",MESH:D004832,2,Diazepam|Pilocarpine,0,
microglial cell activation,GO:0001774,"Epilepsy, Complex Partial",MESH:D017029,1,Diazepam,0,
microglial cell activation,GO:0001774,"Epilepsy, Generalized",MESH:D004829,1,Diazepam,0,
microglial cell activation,GO:0001774,"Epilepsy, Temporal Lobe",MESH:D004833,2,Lithium Chloride|Pilocarpine,1,TRPV1
microglial cell activation,GO:0001774,"Epilepsy, Tonic-Clonic",MESH:D004830,7,Diazepam|Ethanol|Lithium Chloride|Methamphetamine|Morphine|Pilocarpine|tetramethylenedisulfotetramine,0,
microglial cell proliferation,GO:0061518,Epilepsy,MESH:D004827,4,Atropine|Ketamine|Midazolam|Valproic Acid,0,
microglial cell proliferation,GO:0061518,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
microglial cell proliferation,GO:0061518,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
microglial cell proliferation,GO:0061518,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
microglial cell proliferation,GO:0061518,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
microglial cell proliferation,GO:0061518,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
microglial cell proliferation,GO:0061518,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
microglial cell proliferation,GO:0061518,"Epilepsy, Tonic-Clonic",MESH:D004830,6,Atropine|Ethanol|Methamphetamine|Midazolam|Sarin|Valproic Acid,0,
microglial cell proliferation,GO:0061518,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
micronucleus organization,GO:0032125,Epilepsy,MESH:D004827,10,Calcium|Carbamazepine|Cisplatin|Dexamethasone|Epinephrine|Etoposide|Folic Acid|Oxcarbazepine|Phenobarbital|Plant Extracts,0,
micronucleus organization,GO:0032125,"Epilepsy, Absence",MESH:D004832,4,Carbamazepine|Doxorubicin|Oxcarbazepine|Phenobarbital,0,
micronucleus organization,GO:0032125,"Epilepsy, Complex Partial",MESH:D017029,3,Carbamazepine|Oxcarbazepine|Phenobarbital,0,
micronucleus organization,GO:0032125,"Epilepsy, Generalized",MESH:D004829,2,Carbamazepine|Phenobarbital,0,
micronucleus organization,GO:0032125,"Epilepsy, Rolandic",MESH:D019305,1,Carbamazepine,0,
micronucleus organization,GO:0032125,"Epilepsy, Temporal Lobe",MESH:D004833,3,Carbamazepine|Phenobarbital|Plant Extracts,0,
micronucleus organization,GO:0032125,"Epilepsy, Tonic-Clonic",MESH:D004830,9,Caffeine|Carbamazepine|Diclofenac|Epinephrine|Ethanol|Oxcarbazepine|Phenobarbital|Plant Extracts|Vincristine,0,
microtubule-based process,GO:0007017,Epilepsy,MESH:D004827,0,,1,TSC1
microtubule cytoskeleton organization,GO:0000226,Epilepsy,MESH:D004827,4,Atropine|Ketamine|Midazolam|Valproic Acid,0,
microtubule cytoskeleton organization,GO:0000226,"Epilepsy, Absence",MESH:D004832,1,Valproic Acid,0,
microtubule cytoskeleton organization,GO:0000226,"Epilepsy, Complex Partial",MESH:D017029,1,Valproic Acid,0,
microtubule cytoskeleton organization,GO:0000226,"EPILEPSY, EARLY-ONSET, 5, WITH OR WITHOUT DEVELOPMENTAL DELAY",OMIM:615400,0,,1,CNTN2
microtubule cytoskeleton organization,GO:0000226,"Epilepsy, Generalized",MESH:D004829,1,Valproic Acid,0,
microtubule cytoskeleton organization,GO:0000226,"Epilepsy, Reflex",MESH:D020195,1,Valproic Acid,0,
microtubule cytoskeleton organization,GO:0000226,"Epilepsy, Rolandic",MESH:D019305,1,Valproic Acid,0,
microtubule cytoskeleton organization,GO:0000226,"Epilepsy, Temporal Lobe",MESH:D004833,1,Valproic Acid,0,
microtubule cytoskeleton organization,GO:0000226,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Atropine|Midazolam|Sarin|Valproic Acid|Vincristine,0,
microtubule cytoskeleton organization,GO:0000226,"Myoclonic Epilepsy, Juvenile",MESH:D020190,1,Valproic Acid,0,
micturition,GO:0060073,Epilepsy,MESH:D004827,5,Cisplatin|Ketamine|Methotrexate|Morphine|Naloxone,0,
micturition,GO:0060073,"Epilepsy, Absence",MESH:D004832,1,Naloxone,0,
micturition,GO:0060073,"Epilepsy, Complex Partial",MESH:D017029,1,Methotrexate,0,
micturition,GO:0060073,"Epilepsy, Generalized",MESH:D004829,1,Naloxone,0,
micturition,GO:0060073,"Epilepsy, Temporal Lobe",MESH:D004833,1,Methotrexate,0,
micturition,GO:0060073,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Chloroquine|Methamphetamine|Methotrexate|Morphine|Naloxone,0,
micturition,GO:0060073,Generalized Epilepsy and Paroxysmal Dyskinesia,MESH:C563719,0,,1,KCNMA1
midbrain development,GO:0030901,Epilepsy,MESH:D004827,1,Folic Acid,0,
midbrain development,GO:0030901,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Ethanol,0,
midbrain dopaminergic neuron differentiation,GO:1904948,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Methamphetamine,0,
midgut development,GO:0007494,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 1",OMIM:600512,0,,1,RELN
midgut development,GO:0007494,"EPILEPSY, FAMILIAL TEMPORAL LOBE, 7",OMIM:616436,0,,1,RELN
mini excitatory postsynaptic potential,GO:0098816,Epilepsy,MESH:D004827,1,Pregabalin,0,
mini excitatory postsynaptic potential,GO:0098816,"Epilepsy, Generalized",MESH:D004829,1,Pregabalin,0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,Epilepsy,MESH:D004827,1,Etoposide,0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,"Epilepsy, Generalized",MESH:D004829,1,Zidovudine,0,
mitochondrial ATP synthesis coupled electron transport,GO:0042775,"Epilepsy, Tonic-Clonic",MESH:D004830,3,Acetaminophen|Buspirone|Diclofenac,0,
mitochondrial calcium ion homeostasis,GO:0051560,Epilepsy,MESH:D004827,2,Calcium|malic acid,0,
mitochondrial calcium ion homeostasis,GO:0051560,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
mitochondrial calcium ion homeostasis,GO:0051560,"Epilepsy, Tonic-Clonic",MESH:D004830,4,Cocaine|Ethanol|Methamphetamine|Procaine,0,
mitochondrial calcium ion transmembrane transport,GO:0006851,Epilepsy,MESH:D004827,0,,1,VDAC1
mitochondrial depolarization,GO:0051882,Epilepsy,MESH:D004827,5,Cisplatin|Dexamethasone|Dronabinol|Lidocaine|Methylmercury Compounds,1,KCNQ2
mitochondrial depolarization,GO:0051882,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
mitochondrial depolarization,GO:0051882,"Epilepsy, Benign Neonatal",MESH:D020936,0,,1,KCNQ2
mitochondrial depolarization,GO:0051882,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,P2RX7
mitochondrial depolarization,GO:0051882,"Epilepsy, Tonic-Clonic",MESH:D004830,5,Acetaminophen|Chloroquine|Ethanol|Lidocaine|Methamphetamine,0,
mitochondrial DNA metabolic process,GO:0032042,Epilepsy,MESH:D004827,3,Folic Acid|Vitamin B 12|Vitamin B 6,0,
mitochondrial DNA replication,GO:0006264,Epilepsy,MESH:D004827,3,Cisplatin|Dexamethasone|Methylmercury Compounds,1,POLG
mitochondrial DNA replication,GO:0006264,"Epilepsy, Absence",MESH:D004832,1,Doxorubicin,0,
mitochondrial DNA replication,GO:0006264,"Epilepsy, Generalized",MESH:D004829,1,Zidovudine,0,
mitochondrial DNA replication,GO:0006264,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Acetaminophen,0,
"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,Epilepsy,MESH:D004827,0,,1,VDAC2
"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,"Epilepsy, Temporal Lobe",MESH:D004833,0,,1,COX3
"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,"Epilepsy, Tonic-Clonic",MESH:D004830,1,Etomidate,0,
